[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 181
1. Wilusz JE, Beemon KL: The negative regulator of splicing element of Rous sarcoma virus promotes polyadenylation. J Virol; 2006 Oct;80(19):9634-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The negative regulator of splicing element of Rous sarcoma virus promotes polyadenylation.
  • The Rous sarcoma virus gag gene contains a cis-acting negative regulator of splicing (NRS) element that is implicated in viral polyadenylation regulation.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] RNA. 2004 Sep;10(9):1388-98 [15317975.001]
  • [Cites] Genes Dev. 1990 Sep;4(9):1552-9 [1701407.001]
  • [Cites] Cell. 1988 Jan 29;52(2):221-8 [2830023.001]
  • [Cites] J Virol. 1988 Nov;62(11):4003-8 [2459410.001]
  • [Cites] Mol Cell Biol. 1988 Nov;8(11):4858-67 [2850470.001]
  • [Cites] J Virol. 1992 Jul;66(7):4242-51 [1318403.001]
  • [Cites] Genes Dev. 1993 Oct;7(10):1926-36 [8405999.001]
  • [Cites] Microbiol Rev. 1993 Sep;57(3):511-21 [7902524.001]
  • [Cites] Genes Dev. 1994 Feb 1;8(3):363-75 [7906237.001]
  • [Cites] J Virol. 1996 Feb;70(2):1163-72 [8551577.001]
  • [Cites] Genes Dev. 1996 Feb 1;10(3):325-37 [8595883.001]
  • [Cites] J Virol. 1996 Jun;70(6):3834-43 [8648719.001]
  • [Cites] Nature. 1997 Jan 23;385(6614):357-61 [9002523.001]
  • [Cites] Nucleic Acids Res. 1997 Jul 1;25(13):2547-61 [9185563.001]
  • [Cites] J Virol. 1997 Sep;71(9):6526-33 [9261372.001]
  • [Cites] J Virol. 1997 Sep;71(9):6534-40 [9261373.001]
  • [Cites] Mol Cell Biol. 1998 Jun;18(6):3103-11 [9584151.001]
  • [Cites] Nucleic Acids Res. 1998 Jun 15;26(12):2891-8 [9611233.001]
  • [Cites] Mol Cell. 1998 Jan;1(2):255-64 [9659922.001]
  • [Cites] Nature. 1998 Sep 3;395(6697):93-6 [9738505.001]
  • [Cites] Nucleic Acids Res. 1998 Dec 1;26(23):5343-50 [9826757.001]
  • [Cites] J Virol. 1999 Mar;73(3):2385-93 [9971822.001]
  • [Cites] J Virol. 1999 Mar;73(3):2394-400 [9971823.001]
  • [Cites] RNA. 1999 Mar;5(3):333-43 [10094303.001]
  • [Cites] Mol Cell. 2005 Mar 4;17(5):613-5 [15749011.001]
  • [Cites] Mol Cell Biol. 2005 Jun;25(11):4397-405 [15899846.001]
  • [Cites] J Virol. 1992 Jan;66(1):6-11 [1309264.001]
  • [Cites] Methods Mol Biol. 1999;118:309-14 [10549533.001]
  • [Cites] Genes Dev. 2000 Feb 15;14(4):403-13 [10691733.001]
  • [Cites] RNA. 2000 Sep;6(9):1197-211 [10999598.001]
  • [Cites] J Biol Chem. 2000 Oct 13;275(41):32371-8 [10934202.001]
  • [Cites] J Virol. 2001 Aug;75(16):7763-8 [11462052.001]
  • [Cites] Nucleic Acids Res. 2002 Feb 1;30(3):810-7 [11809895.001]
  • [Cites] Nucleic Acids Res. 2002 Apr 15;30(8):1842-50 [11937639.001]
  • [Cites] Mol Cell Endocrinol. 2002 Apr 25;190(1-2):1-8 [11997173.001]
  • [Cites] Virology. 2002 Oct 25;302(2):405-12 [12441084.001]
  • [Cites] J Virol. 2003 Sep;77(17):9378-87 [12915553.001]
  • [Cites] J Biol Chem. 2003 Nov 7;278(45):44153-60 [12944400.001]
  • [Cites] J Biol Chem. 2004 Apr 9;279(15):14889-98 [14749332.001]
  • [Cites] Mol Cell Biol. 1990 Feb;10(2):696-704 [2153921.001]
  • [Cites] Cell. 1990 Sep 7;62(5):889-99 [2168293.001]
  • [Cites] J Virol. 1986 Nov;60(2):497-505 [3021984.001]
  • (PMID = 16973567.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA048746; United States / NIGMS NIH HHS / GM / T32 GM007231; United States / NCI NIH HHS / CA / R01 CA238796
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Heterogeneous-Nuclear Ribonucleoproteins; 0 / Ribonucleoproteins, Small Nuclear
  • [Other-IDs] NLM/ PMC1617230
  •  go-up   go-down


2. Inayoshi Y, Okino Y, Miyake K, Mizutani A, Yamamoto-Kishikawa J, Kinoshita Y, Morimoto Y, Imamura K, Morshed M, Kono K, Itoh T, Nishijima K, Iijima S: Transcription factor YY1 interacts with retroviral integrases and facilitates integration of moloney murine leukemia virus cDNA into the host chromosomes. J Virol; 2010 Aug;84(16):8250-61
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This study demonstrates that transcription factor Yin Yang 1 binds to Moloney murine leukemia virus, human immunodeficiency virus type 1, and avian sarcoma virus integrases.
  • Yin Yang 1 enhanced the in vitro integrase activity of Moloney murine leukemia virus, human immunodeficiency virus type 1, and avian sarcoma virus integrases.
  • [MeSH-minor] Avian Sarcoma Viruses / enzymology. Cell Fractionation. DNA, Complementary / metabolism. DNA, Viral / metabolism. Gene Knockdown Techniques. HIV-1 / enzymology. Humans. Immunoprecipitation. Protein Binding

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2004 Mar;78(5):2222-31 [14963118.001]
  • [Cites] J Biol Chem. 2004 Apr 23;279(17):17750-5 [14744866.001]
  • [Cites] PLoS One. 2007;2(12):e1340 [18092005.001]
  • [Cites] J Biol Chem. 2007 Dec 28;282(52):37913-20 [17974562.001]
  • [Cites] Retrovirology. 2008;5:48 [18554410.001]
  • [Cites] J Virol. 1999 Mar;73(3):1809-17 [9971758.001]
  • [Cites] J Virol. 1999 Mar;73(3):2126-35 [9971795.001]
  • [Cites] EMBO J. 1999 Jun 15;18(12):3404-18 [10369680.001]
  • [Cites] Gene. 1999 Aug 20;236(2):197-208 [10452940.001]
  • [Cites] Genes Dev. 2004 Nov 1;18(21):2627-38 [15520282.001]
  • [Cites] EMBO J. 2004 Nov 24;23(23):4670-8 [15510219.001]
  • [Cites] J Virol. 2005 Apr;79(8):4610-8 [15795247.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6103-7 [15802467.001]
  • [Cites] J Biol Chem. 2005 Aug 12;280(32):29334-9 [15958388.001]
  • [Cites] PLoS Pathog. 2009 Mar;5(3):e1000327 [19266025.001]
  • [Cites] J Biol Chem. 2009 Mar 20;284(12):7931-9 [19150986.001]
  • [Cites] Methods. 2009 Apr;47(4):283-90 [19233280.001]
  • [Cites] Nat Rev Mol Cell Biol. 2009 Oct;10(10):697-708 [19738629.001]
  • [Cites] Retrovirology. 2009;6:94 [19840380.001]
  • [Cites] J Virol. 2005 Sep;79(17):10864-74 [16103139.001]
  • [Cites] Nat Med. 2005 Dec;11(12):1287-9 [16311605.001]
  • [Cites] Oncogene. 2006 Feb 23;25(8):1125-42 [16314846.001]
  • [Cites] J Biosci Bioeng. 2006 Apr;101(4):361-8 [16716946.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Jul 7;345(3):1099-107 [16713998.001]
  • [Cites] PLoS Pathog. 2006 Jun;2(6):e60 [16789841.001]
  • [Cites] J Virol. 2006 Oct;80(19):9497-510 [16973554.001]
  • [Cites] J Mol Biol. 2007 Feb 2;365(5):1480-92 [17137594.001]
  • [Cites] Nat Rev Microbiol. 2007 Mar;5(3):187-96 [17304248.001]
  • [Cites] J Virol. 2007 Jun;81(12):6731-41 [17409138.001]
  • [Cites] Genome Res. 2007 Jun;17(6):798-806 [17567998.001]
  • [Cites] Genes Dev. 2007 Jul 15;21(14):1767-78 [17639082.001]
  • [Cites] Nat Struct Mol Biol. 2007 Dec;14(12):1165-72 [18026119.001]
  • [Cites] J Virol. 2000 Aug;74(15):6790-9 [10888618.001]
  • [Cites] Mol Cell Biol. 2001 Feb;21(4):1360-9 [11158321.001]
  • [Cites] J Biol Chem. 2001 Mar 16;276(11):7932-6 [11118439.001]
  • [Cites] EMBO J. 2001 Jun 15;20(12):3272-81 [11406603.001]
  • [Cites] Mol Cell Biol. 2001 Sep;21(17):5979-91 [11486036.001]
  • [Cites] J Virol. 2001 Dec;75(23):11365-72 [11689617.001]
  • [Cites] Mol Cell Biol. 2002 May;22(9):2965-73 [11940654.001]
  • [Cites] J Biol Chem. 2003 Jan 3;278(1):372-81 [12407101.001]
  • [Cites] Rev Med Virol. 2003 Mar-Apr;13(2):99-110 [12627393.001]
  • [Cites] Science. 2003 Jun 13;300(5626):1749-51 [12805549.001]
  • [Cites] J Biol Chem. 2003 Aug 29;278(35):33528-39 [12796494.001]
  • [Cites] Virology. 2003 Nov 10;316(1):146-60 [14599799.001]
  • [Cites] J Virol. 2003 Dec;77(23):12507-22 [14610174.001]
  • [Cites] J Virol. 2003 Dec;77(24):13084-92 [14645565.001]
  • [Cites] J Cell Sci. 2004 Jan 26;117(Pt 3):465-76 [14702388.001]
  • [Cites] Trends Cell Biol. 2004 May;14(5):261-6 [15130582.001]
  • [Cites] J Virol. 2004 Jun;78(12):6190-9 [15163712.001]
  • [Cites] PLoS Biol. 2004 Aug;2(8):E234 [15314653.001]
  • [Cites] Cell. 1978 Jul;14(3):601-9 [80281.001]
  • [Cites] J Virol. 1980 Oct;36(1):50-61 [6255214.001]
  • [Cites] Proc Natl Acad Sci U S A. 1986 Oct;83(20):7648-52 [2429313.001]
  • [Cites] Mol Cell Biol. 1992 Jan;12(1):38-44 [1309593.001]
  • [Cites] Mol Cell Biol. 1992 May;12(5):2331-8 [1314954.001]
  • [Cites] Virology. 1992 Jun;188(2):459-68 [1585629.001]
  • [Cites] J Virol. 1992 Nov;66(11):6361-9 [1404595.001]
  • [Cites] EMBO J. 1993 May;12(5):2099-108 [8491198.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6145-9 [8327494.001]
  • [Cites] Nucleic Acids Res. 1993 Jul 25;21(15):3507-11 [8346030.001]
  • [Cites] J Virol. 1994 Jan;68(1):510-6 [8254763.001]
  • [Cites] J Virol. 1994 Sep;68(9):5911-7 [8057470.001]
  • [Cites] Science. 1994 Dec 23;266(5193):2002-6 [7801128.001]
  • [Cites] Genes Dev. 1995 May 15;9(10):1188-98 [7758944.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):12845-50 [8917507.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13659-64 [8942990.001]
  • [Cites] J Biol Chem. 1997 Jan 17;272(3):1709-17 [8999850.001]
  • [Cites] Biochim Biophys Acta. 1997 Apr 18;1332(2):F49-66 [9141463.001]
  • [Cites] J Biol Chem. 1997 Oct 31;272(44):28001-7 [9346952.001]
  • (PMID = 20519390.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Complementary; 0 / DNA, Viral; 0 / Viral Proteins; 0 / YY1 Transcription Factor; EC 2.7.7.- / Integrases
  • [Other-IDs] NLM/ PMC2916549
  •  go-up   go-down


3. Barth RF, Kaur B: Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol; 2009 Sep;94(3):299-312
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.
  • In this review we will describe eight commonly used rat brain tumor models and their application for the development of novel therapeutic and diagnostic modalities.
  • The 9L gliosarcoma has been used widely and has provided important information relating to brain tumor biology and therapy.
  • This tumor has been used for a variety of studies to evaluate new therapeutic modalities.
  • The Avian Sarcoma Virus (ASV) induced tumors, and a continuous cell line derived from one of them designated RT-2, have been useful for studies in which de novo tumor induction is an important requirement.
  • [MeSH-minor] Animals. Cell Line, Tumor / pathology. Disease Models, Animal. Gene Expression Regulation, Neoplastic. Mice. Rats

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • Cellosaurus - a cell line knowledge resource. culture/stock collections - Cell lines described in this publication .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurosurg. 2004 Nov;101(5):826-31 [15540922.001]
  • [Cites] Mol Ther. 2004 Dec;10(6):1071-84 [15564139.001]
  • [Cites] Clin Cancer Res. 2004 Dec 15;10(24):8561-76 [15623640.001]
  • [Cites] Clin Cancer Res. 2005 Jan 1;11(1):341-50 [15671565.001]
  • [Cites] J Immunol. 2005 Mar 1;174(5):2533-43 [15728459.001]
  • [Cites] Mol Cancer. 2005;4(1):12 [15762988.001]
  • [Cites] Brain Res Mol Brain Res. 2005 Apr 27;135(1-2):93-103 [15857672.001]
  • [Cites] Clin Cancer Res. 2005 May 1;11(9):3475-84 [15867250.001]
  • [Cites] Clin Cancer Res. 2005 May 15;11(10):3821-7 [15897582.001]
  • [Cites] J Neurooncol. 2005 May;72(3):209-15 [15937642.001]
  • [Cites] Brain Res. 2005 Jun 14;1047(1):56-64 [15893739.001]
  • [Cites] Am J Pathol. 2005 Aug;167(2):565-76 [16049340.001]
  • [Cites] J Neurosurg. 2005 Jan;102(1 Suppl):53-8 [16206734.001]
  • [Cites] Neurosurg Focus. 2005 Oct 15;19(4):E1 [16241103.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):603-11 [16338098.001]
  • [Cites] Mol Cancer Ther. 2006 Jan;5(1):52-9 [16432162.001]
  • [Cites] J Neurosurg. 2006 Jan;104(1):118-28 [16509155.001]
  • [Cites] J Neurooncol. 2007 Nov;85(2):133-48 [17874037.001]
  • [Cites] Neurochem Res. 2007 Dec;32(12):2235-42 [17701349.001]
  • [Cites] Free Radic Biol Med. 2008 Jan 1;44(1):63-72 [18045548.001]
  • [Cites] J Natl Cancer Inst. 2007 Dec 5;99(23):1768-81 [18042934.001]
  • [Cites] J Neurooncol. 2008 Jan;86(1):13-21 [17611717.001]
  • [Cites] Clin Cancer Res. 2008 Feb 1;14(3):883-91 [18245552.001]
  • [Cites] J Neurosurg. 2008 Feb;108(2):320-9 [18240929.001]
  • [Cites] Phys Med Biol. 2008 Feb 21;53(4):861-78 [18263945.001]
  • [Cites] Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):227-31 [18336750.001]
  • [Cites] Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1977 Aug 15;89(3):273-95 [198983.001]
  • [Cites] J Neurosurg. 1979 Mar;50(3):298-304 [217977.001]
  • [Cites] Acta Neuropathol. 1980;51(1):23-31 [7435138.001]
  • [Cites] J Neurosurg. 1980 Dec;53(6):808-15 [7003068.001]
  • [Cites] Eur J Cancer Clin Oncol. 1982 Sep;18(9):891-5 [6891332.001]
  • [Cites] J Neuropathol Exp Neurol. 1983 Mar;42(2):122-35 [6600780.001]
  • [Cites] J Neuropathol Exp Neurol. 1984 Jul;43(4):426-38 [6610726.001]
  • [Cites] Cancer Res. 1986 Oct;46(10):5276-81 [3019523.001]
  • [Cites] Cancer. 1987 Jan 15;59(2):266-70 [3026604.001]
  • [Cites] Ann Neurol. 1987 Sep;22(3):300-5 [3118762.001]
  • [Cites] Cancer Res. 1991 May 1;51(9):2373-8 [2015600.001]
  • [Cites] Cancer Res. 1991 May 1;51(9):2430-7 [2015604.001]
  • [Cites] J Clin Neurosci. 2008 May;15(5):545-51 [18378459.001]
  • [Cites] J Neurooncol. 2008 May;88(1):1-9 [18228115.001]
  • [Cites] Neuroimage. 2008 Apr 1;40(2):973-83 [18441552.001]
  • [Cites] J Neurosurg. 2008 May;108(5):972-8 [18447715.001]
  • [Cites] J Chemother. 2008 Apr;20(2):253-62 [18467254.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1192-203 [18264706.001]
  • [Cites] Toxicol Lett. 2008 Jun 10;179(1):29-33 [18485629.001]
  • [Cites] Cancer Res. 2008 Jul 15;68(14):5508-11 [18632599.001]
  • [Cites] Neuro Oncol. 2008 Jun;10(3):292-9 [18430796.001]
  • [Cites] J Cereb Blood Flow Metab. 2008 Aug;28(8):1431-9 [18414496.001]
  • [Cites] Brain Res. 2008 Aug 28;1227:198-206 [18602898.001]
  • [Cites] In Vitro Cell Dev Biol Anim. 2008 Jul-Aug;44(7):280-9 [18594936.001]
  • [Cites] J Neurooncol. 2008 Oct;90(1):19-24 [18594766.001]
  • [Cites] Eur J Pharm Biopharm. 2008 Sep;70(1):66-74 [18555675.001]
  • [Cites] Cancer Gene Ther. 2008 Oct;15(10):685-92 [18535615.001]
  • [Cites] Neurol Res. 2008 Jun;30(5):511-7 [18953742.001]
  • [Cites] NMR Biomed. 2008 Nov;21(10):1043-56 [18615861.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):530-6 [19147017.001]
  • [Cites] Eur J Radiol. 2009 Apr;70(1):180-9 [18541399.001]
  • [Cites] J Neurosurg. 2000 Feb;92(2):326-33 [10659021.001]
  • [Cites] IEEE Trans Biomed Eng. 2000 Feb;47(2):259-65 [10721633.001]
  • [Cites] Clin Exp Metastasis. 1992 Sep;10(5):345-50 [1505124.001]
  • [Cites] J Neurooncol. 1991 Dec;11(3):185-97 [1823340.001]
  • [Cites] Int J Cancer. 1992 Sep 30;52(3):409-13 [1399117.001]
  • [Cites] Cancer Res. 1993 Jan 1;53(1):176-82 [8416743.001]
  • [Cites] Science. 1993 Jan 1;259(5091):94-7 [8418502.001]
  • [Cites] J Neurosurg. 1993 Nov;79(5):729-35 [8410252.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1994 Mar 30;28(5):1067-77 [8175391.001]
  • [Cites] J Neurooncol. 1994;19(3):259-68 [7807177.001]
  • [Cites] J Neurooncol. 1994;22(3):191-200 [7760095.001]
  • [Cites] J Surg Oncol. 1995 Jun;59(2):105-9 [7776650.001]
  • [Cites] Br J Cancer. 1995 Sep;72(3):607-14 [7669569.001]
  • [Cites] Leukemia. 1995 Oct;9 Suppl 1:S106-12 [7475300.001]
  • [Cites] Int J Cancer. 1995 Sep 15;62(6):767-71 [7558428.001]
  • [Cites] Hum Gene Ther. 1995 Nov;6(11):1467-76 [8573619.001]
  • [Cites] Cancer Lett. 1997 May 1;115(1):81-90 [9097982.001]
  • [Cites] Invasion Metastasis. 1996;16(3):107-15 [9186546.001]
  • [Cites] Klin Padiatr. 1997 Jul-Aug;209(4):275-7 [9293462.001]
  • [Cites] J Neurooncol. 1998 Jan;36(1):91-102 [9525831.001]
  • [Cites] Cancer Res. 1998 May 1;58(9):2020-8 [9581848.001]
  • [Cites] Hum Gene Ther. 1999 Jan 1;10(1):95-101 [10022534.001]
  • [Cites] Cancer Res. 1999 Aug 15;59(16):3861-5 [10463570.001]
  • [Cites] Cancer Gene Ther. 2004 Nov;11(11):721-32 [15475879.001]
  • [Cites] Pathobiology. 1999 Jul-Aug;67(4):202-6 [10738182.001]
  • [Cites] Gene Ther. 2000 Jun;7(12):993-9 [10871746.001]
  • [Cites] Cancer Gene Ther. 2000 Jun;7(6):879-84 [10880018.001]
  • [Cites] Cancer Gene Ther. 2000 Jun;7(6):947-53 [10880027.001]
  • [Cites] J Neurooncol. 2000;46(3):231-40 [10902854.001]
  • [Cites] J Biol Chem. 2000 Jul 28;275(30):22695-703 [10801887.001]
  • [Cites] Neurosurgery. 2000 Oct;47(4):993-9; discussion 999-1000 [11014444.001]
  • [Cites] Cancer Gene Ther. 2001 Jan;8(1):3-8 [11219491.001]
  • [Cites] Neurol Res. 2001 Jun;23(4):359-66 [11428516.001]
  • [Cites] J Neurooncol. 2001 Mar;52(1):37-47 [11451201.001]
  • [Cites] Histol Histopathol. 2001 Jul;16(3):735-44 [11510963.001]
  • [Cites] Cancer Res. 2001 Oct 1;61(19):7056-9 [11585735.001]
  • [Cites] J Neurooncol. 2001 Jul;53(3):275-87 [11718260.001]
  • [Cites] J Neurooncol. 2002 Jan;56(1):1-12 [11949821.001]
  • [Cites] Gene Ther. 2002 May;9(9):584-91 [11973634.001]
  • [Cites] J Neurooncol. 2002 Jan;56(2):143-8 [11995815.001]
  • [Cites] J Pharmacol Exp Ther. 2002 Jun;301(3):838-51 [12023511.001]
  • [Cites] Med Oncol. 2002;19(1):1-9 [12025885.001]
  • [Cites] J Neuropathol Exp Neurol. 2002 Aug;61(8):725-35 [12152787.001]
  • [Cites] Gene Ther. 2002 Sep;9(17):1139-45 [12170377.001]
  • [Cites] Cancer Lett. 2003 Mar 20;192(1):97-107 [12637158.001]
  • [Cites] Am J Pathol. 2003 Apr;162(4):1083-93 [12651601.001]
  • [Cites] Neoplasia. 2003 Jan-Feb;5(1):17-22 [12659666.001]
  • [Cites] J Neurooncol. 2003 Mar-Apr;62(1-2):61-74 [12749703.001]
  • [Cites] Cancer Res. 2003 Jun 15;63(12):3195-201 [12810648.001]
  • [Cites] J Neurooncol. 2003 May;63(1):1-7 [12814248.001]
  • [Cites] Ann Neurol. 2003 Sep;54(3):388-92 [12953273.001]
  • [Cites] Cell Immunol. 2003 Oct;225(2):113-21 [14698145.001]
  • [Cites] Gene Ther. 2004 Jan;11(2):161-9 [14712300.001]
  • [Cites] Gene Ther. 2004 Jan;11(2):214-23 [14712306.001]
  • [Cites] Mol Ther. 2004 Feb;9(2):282-91 [14759812.001]
  • [Cites] Cancer Res. 2004 Apr 1;64(7):2317-23 [15059878.001]
  • [Cites] Acta Neurochir (Wien). 2004 Jul;146(7):731-4 [15197617.001]
  • [Cites] Clin Cancer Res. 2004 Aug 1;10(15):5187-201 [15297423.001]
  • [Cites] Science. 1968 Jul 26;161(3839):370-1 [4873531.001]
  • [Cites] J Cell Physiol. 1970 Jun;75(3):329-39 [4988781.001]
  • [Cites] J Neurosurg. 1971 Mar;34(3):310-23 [4323142.001]
  • [Cites] J Neurosurg. 1971 Mar;34(3):335-40 [5547317.001]
  • [Cites] Cancer Res. 1973 May;33(5):976-86 [4703128.001]
  • [Cites] J Med. 1975;6(3-4):249-59 [1059719.001]
  • [Cites] J Natl Cancer Inst. 1975 Nov;55(5):1177-87 [1206744.001]
  • [Cites] Am J Pathol. 1976 Apr;83(1):149-76 [179328.001]
  • [Cites] Can J Neurol Sci. 2006 Feb;33(1):86-91 [16583728.001]
  • [Cites] Neurosurg Focus. 2006;20(4):E25 [16709031.001]
  • [Cites] J Nucl Med. 2006 Jun;47(6):989-98 [16741309.001]
  • [Cites] J Neurosci. 2006 Jun 21;26(25):6781-90 [16793885.001]
  • [Cites] J Neurooncol. 2006 Aug;79(1):9-17 [16575532.001]
  • [Cites] Clin Cancer Res. 2006 Sep 15;12(18):5288-97 [17000661.001]
  • [Cites] NMR Biomed. 2006 Dec;19(8):1035-42 [16894643.001]
  • [Cites] Childs Nerv Syst. 2006 Dec;22(12):1519-25 [17021732.001]
  • [Cites] J Neurooncol. 2007 Jan;81(2):149-62 [16941073.001]
  • [Cites] Clin Cancer Res. 2007 Feb 15;13(4):1260-8 [17317838.001]
  • [Cites] J Magn Reson. 2007 May;186(1):150-5 [17303454.001]
  • [Cites] Clin Cancer Res. 2007 May 1;13(9):2728-37 [17473206.001]
  • [Cites] Cancer Res. 2007 May 15;67(10):4541-4 [17510377.001]
  • [Cites] Mol Ther. 2007 Jul;15(7):1373-81 [17457322.001]
  • [Cites] Stem Cells. 2007 Jul;25(7):1645-53 [17412894.001]
  • [Cites] Behav Brain Res. 2007 Aug 22;182(1):42-50 [17572515.001]
  • [Cites] Mol Cancer Ther. 2007 Aug;6(8):2290-302 [17699724.001]
  • [Cites] Neoplasia. 2007 Jul;9(7):546-55 [17710157.001]
  • [Cites] Clin Cancer Res. 2007 Sep 1;13(17):5195-201 [17726137.001]
  • [Cites] Magn Reson Med. 2007 Sep;58(3):454-62 [17763344.001]
  • [Cites] Can J Neurol Sci. 2007 Aug;34(3):296-306 [17803026.001]
  • [Cites] J Neurooncol. 2007 Nov;85(2):191-202 [17557137.001]
  • (PMID = 19381449.001).
  • [ISSN] 1573-7373
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA150153; United States / NINDS NIH HHS / NS / R01 NS064607; United States / NINDS NIH HHS / NS / R21 NS056203; United States / NINDS NIH HHS / NS / K01 NS059575; United States / NINDS NIH HHS / NS / K01 NS059575-02; United States / NINDS NIH HHS / NS / R01 NS064607-01; United States / NINDS NIH HHS / NS / R21 NS056203-02
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 149
  • [Other-IDs] NLM/ NIHMS127810; NLM/ PMC2730996
  •  go-up   go-down


Advertisement
4. LeBlanc JJ, Uddowla S, Abraham B, Clatterbuck S, Beemon KL: Tap and Dbp5, but not Gag, are involved in DR-mediated nuclear export of unspliced Rous sarcoma virus RNA. Virology; 2007 Jul 5;363(2):376-86
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tap and Dbp5, but not Gag, are involved in DR-mediated nuclear export of unspliced Rous sarcoma virus RNA.
  • While the unspliced RNA export pathways for HIV and Mason-Pfizer monkey virus are well characterized, that of Rous sarcoma virus (RSV) is not.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] RNA. 1999 Dec;5(12):1645-55 [10606274.001]
  • [Cites] J Virol. 1996 Jun;70(6):3834-43 [8648719.001]
  • [Cites] J Virol. 2000 Oct;74(20):9507-14 [11000220.001]
  • [Cites] Nature. 2000 Sep 21;407(6802):401-5 [11014198.001]
  • [Cites] Mol Cell. 2001 Apr;7(4):899-905 [11336712.001]
  • [Cites] EMBO J. 2001 Sep 3;20(17):4987-97 [11532962.001]
  • [Cites] Curr Biol. 2001 Oct 30;11(21):1716-21 [11696332.001]
  • [Cites] RNA. 2001 Dec;7(12):1768-80 [11780633.001]
  • [Cites] EMBO J. 2002 Mar 1;21(5):1177-87 [11867546.001]
  • [Cites] Mol Cell Biol. 1997 Jan;17(1):135-44 [8972193.001]
  • [Cites] EMBO J. 1997 Feb 17;16(4):807-16 [9049309.001]
  • [Cites] Cell. 1997 Sep 19;90(6):1051-60 [9323133.001]
  • [Cites] Curr Biol. 1997 Oct 1;7(10):767-75 [9368759.001]
  • [Cites] J Virol. 1997 Dec;71(12):9150-6 [9371572.001]
  • [Cites] EMBO J. 1997 Dec 15;16(24):7500-10 [9405378.001]
  • [Cites] J Virol. 1998 Apr;72(4):3407-11 [9525671.001]
  • [Cites] EMBO J. 1998 May 1;17(9):2663-76 [9564048.001]
  • [Cites] Mol Cell. 1998 Apr;1(5):649-59 [9660949.001]
  • [Cites] Virology. 1998 Jul 20;247(1):86-96 [9683574.001]
  • [Cites] Mol Cell Biol. 1998 Nov;18(11):6826-38 [9774696.001]
  • [Cites] J Biol Chem. 1998 Dec 11;273(50):33414-22 [9837918.001]
  • [Cites] EMBO J. 1999 Apr 1;18(7):1953-65 [10202158.001]
  • [Cites] Genes Dev. 1999 May 1;13(9):1126-39 [10323864.001]
  • [Cites] EMBO J. 1999 Aug 2;18(15):4332-47 [10428971.001]
  • [Cites] J Virol. 1999 Sep;73(9):7421-9 [10438832.001]
  • [Cites] EMBO J. 1999 Oct 15;18(20):5778-88 [10523319.001]
  • [Cites] Mol Cell. 2005 Nov 23;20(4):645-51 [16307927.001]
  • [Cites] J Mol Biol. 2005 Dec 16;354(5):1118-28 [16289115.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] Cell. 2002 Feb 22;108(4):523-31 [11909523.001]
  • [Cites] J Virol. 2002 Dec;76(24):12877-89 [12438613.001]
  • [Cites] Mol Cell. 2003 Mar;11(3):837-43 [12667464.001]
  • [Cites] Genes Dev. 2003 Dec 15;17(24):3075-86 [14701875.001]
  • [Cites] Mol Cell. 2004 Jan 30;13(2):201-12 [14759366.001]
  • [Cites] Exp Cell Res. 2004 May 15;296(1):12-20 [15120988.001]
  • [Cites] Curr Opin Cell Biol. 2004 Jun;16(3):285-92 [15145353.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9666-70 [15210956.001]
  • [Cites] EMBO J. 2004 Jul 7;23(13):2632-40 [15201866.001]
  • [Cites] J Biol Chem. 2004 Jul 23;279(30):31745-9 [15184380.001]
  • [Cites] Cell. 2004 Oct 29;119(3):381-92 [15507209.001]
  • [Cites] Mol Cell Biol. 1982 Sep;2(9):1044-51 [6960240.001]
  • [Cites] J Virol. 1983 Dec;48(3):667-75 [6313966.001]
  • [Cites] Nature. 1989 Mar 16;338(6212):254-7 [2784194.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Oct;87(19):7787-91 [2217212.001]
  • [Cites] Methods Cell Biol. 1991;35:73-99 [1723481.001]
  • [Cites] Mol Cell Biol. 1992 May;12(5):2331-8 [1314954.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1256-60 [8108397.001]
  • [Cites] J Virol. 1994 Dec;68(12):7944-52 [7966585.001]
  • [Cites] RNA. 2000 Apr;6(4):638-50 [10786854.001]
  • (PMID = 17328934.001).
  • [ISSN] 0042-6822
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / T32 GM007231; United States / NCI NIH HHS / CA / R01 CA048746-19; United States / NCI NIH HHS / CA / CA048746-19; United States / NCI NIH HHS / CA / R01 CA048746-18; United States / NCI NIH HHS / CA / CA048746-17; United States / NCI NIH HHS / CA / CA048746-18; United States / NCI NIH HHS / CA / R01 CA048746-17; United States / NIGMS NIH HHS / GM / T32GM07231; United States / NCI NIH HHS / CA / R01 CA048746; United States / NCI NIH HHS / CA / R01 CA48746
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / Nucleocytoplasmic Transport Proteins; 0 / RNA, Viral; 0 / Transcription Factors
  • [Other-IDs] NLM/ NIHMS25189; NLM/ PMC2564995
  •  go-up   go-down


5. Snásel J, Krejcík Z, Jencová V, Rosenberg I, Ruml T, Alexandratos J, Gustchina A, Pichová I: Integrase of Mason-Pfizer monkey virus. FEBS J; 2005 Jan;272(1):203-16
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The structure-based sequence alignment of M-PMV, HIV-1, SIV, and ASV integrases predicted critical amino acids and motifs of M-PMV integrase for metal binding, interaction with nucleic acids, dimerization, protein structure maintenance and function, as well as for binding of human immunodeficiency virus type 1 and Rous avian sarcoma virus integrase inhibitors 5-CI-TEP, DHPTPB and Y-3.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15634344.001).
  • [ISSN] 1742-464X
  • [Journal-full-title] The FEBS journal
  • [ISO-abbreviation] FEBS J.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] EC 2.7.7.- / Integrases
  •  go-up   go-down


6. Markosyan RM, Kielian M, Cohen FS: Fusion induced by a class II viral fusion protein, semliki forest virus E1, is dependent on the voltage of the target cell. J Virol; 2007 Oct;81(20):11218-25
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In contrast, fusion induced by the class I fusion proteins of human immunodeficiency virus, avian sarcoma leukosis virus, and influenza virus was independent of the voltage polarity across the target cell.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] EMBO J. 2004 Feb 25;23(4):728-38 [14963486.001]
  • [Cites] Nature. 1995 May 25;375(6529):291-8 [7753193.001]
  • [Cites] J Virol. 2004 Apr;78(7):3753-62 [15016895.001]
  • [Cites] J Cell Biol. 1996 Aug;134(4):863-72 [8769412.001]
  • [Cites] J Cell Biol. 1997 Mar 10;136(5):995-1005 [9060465.001]
  • [Cites] J Cell Biol. 1998 Mar 23;140(6):1369-82 [9508770.001]
  • [Cites] Cell. 1998 Dec 23;95(7):871-4 [9875840.001]
  • [Cites] Mol Cell. 1999 Mar;3(3):309-19 [10198633.001]
  • [Cites] Biophys J. 1999 Aug;77(2):943-52 [10423439.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8967-72 [10430879.001]
  • [Cites] Curr Top Microbiol Immunol. 2005;285:25-66 [15609500.001]
  • [Cites] Curr Biol. 2005 Apr 12;15(7):678-83 [15823542.001]
  • [Cites] J Cell Biol. 2005 Apr 11;169(1):167-77 [15809312.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9288-93 [15964978.001]
  • [Cites] Virology. 2006 Jan 5;344(1):38-47 [16364734.001]
  • [Cites] Structure. 2006 Jan;14(1):75-86 [16407067.001]
  • [Cites] J Biol Chem. 2006 Mar 3;281(9):5760-70 [16407195.001]
  • [Cites] Science. 1996 May 10;272(5263):872-7 [8629022.001]
  • [Cites] Virology. 2000 Mar 30;269(1):37-46 [10725196.001]
  • [Cites] Mol Biol Cell. 2000 Jul;11(7):2359-71 [10888674.001]
  • [Cites] J Virol. 2000 Sep;74(17):7772-80 [10933683.001]
  • [Cites] J Cell Biol. 2000 Oct 16;151(2):413-23 [11038187.001]
  • [Cites] Cell. 2000 Nov 10;103(4):679-89 [11106737.001]
  • [Cites] Cell. 2001 Apr 6;105(1):137-48 [11301009.001]
  • [Cites] Neuron. 2001 Apr;30(1):171-82 [11343653.001]
  • [Cites] J Virol. 2001 Aug;75(16):7392-8 [11462011.001]
  • [Cites] J Gen Physiol. 2001 Nov;118(5):471-80 [11696606.001]
  • [Cites] J Cell Biol. 2001 Nov 26;155(5):833-44 [11724823.001]
  • [Cites] J Virol. 2002 Dec;76(24):12691-702 [12438595.001]
  • [Cites] Mol Biol Cell. 2003 Mar;14(3):926-38 [12631714.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6986-91 [12759475.001]
  • [Cites] Biophys J. 2003 Sep;85(3):1725-33 [12944287.001]
  • [Cites] Cell. 2003 Sep 5;114(5):573-83 [13678581.001]
  • [Cites] Virology. 2003 Nov 25;316(2):234-44 [14644606.001]
  • [Cites] Nature. 2004 Jan 22;427(6972):313-9 [14737159.001]
  • [Cites] Nature. 2004 Jan 22;427(6972):320-5 [14737160.001]
  • [Cites] Science. 2004 Sep 17;305(5691):1747-52 [15297626.001]
  • [Cites] Proc Natl Acad Sci U S A. 1980 Jun;77(6):3273-7 [6997876.001]
  • [Cites] Nature. 1981 Jan 29;289(5796):366-73 [7464906.001]
  • [Cites] J Cell Biol. 1981 Dec;91(3 Pt 1):601-13 [7328111.001]
  • [Cites] Proc Natl Acad Sci U S A. 1985 Mar;82(6):1692-6 [3856850.001]
  • [Cites] J Biol Chem. 1985 May 10;260(9):5691-7 [3988769.001]
  • [Cites] Biophys J. 1988 May;53(5):771-83 [2455552.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 Jan;86(2):539-43 [2536167.001]
  • [Cites] Biochemistry. 1990 Oct 16;29(41):9697-707 [2271610.001]
  • [Cites] EMBO J. 1993 Feb;12(2):693-701 [8440260.001]
  • [Cites] J Virol. 2004 Apr;78(7):3312-8 [15016852.001]
  • (PMID = 17686870.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / R01 GM027367; United States / NIGMS NIH HHS / GM / R01 GM057454; United States / NIGMS NIH HHS / GM / GM057454; United States / NIGMS NIH HHS / GM / R01 GM27367
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Viral Envelope Proteins; 0 / Viral Fusion Proteins
  • [Other-IDs] NLM/ PMC2045574
  •  go-up   go-down


7. Hu J, Renaud G, Gomes TJ, Ferris A, Hendrie PC, Donahue RE, Hughes SH, Wolfsberg TG, Russell DW, Dunbar CE: Reduced genotoxicity of avian sarcoma leukosis virus vectors in rhesus long-term repopulating cells compared to standard murine retrovirus vectors. Mol Ther; 2008 Sep;16(9):1617-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Reduced genotoxicity of avian sarcoma leukosis virus vectors in rhesus long-term repopulating cells compared to standard murine retrovirus vectors.
  • In this study, we report for the first time a systematic analysis of 198 avian sarcoma leukosis virus (ASLV) insertion sites identified in rhesus long-term repopulating cells, and a comparison of ASLV insertion patterns to Moloney murine leukemia virus (MLV) (n = 396) and simian immunodeficiency virus (SIV) (n = 289) using the newly released rhesus genome databank.
  • [MeSH-major] Avian Leukosis Virus / genetics. Avian Sarcoma Viruses / genetics. Genetic Vectors / genetics. Hematopoietic Stem Cells / metabolism. Moloney murine leukemia virus / genetics. Transduction, Genetic. Virus Integration

  • MedlinePlus Health Information. consumer health - Stem Cells.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Ther. 2006 Jun;13(6):1031-49 [16624621.001]
  • [Cites] Blood. 2006 Oct 15;108(8):2545-53 [16825499.001]
  • [Cites] Science. 2007 Apr 13;316(5822):222-34 [17431167.001]
  • [Cites] Science. 2007 Apr 13;316(5822):238-40 [17431169.001]
  • [Cites] Curr Gene Ther. 2007 Jun;7(3):155-61 [17584034.001]
  • [Cites] PLoS One. 2007;2(6):e570 [17593969.001]
  • [Cites] J Clin Invest. 2007 Aug;117(8):2225-32 [17671652.001]
  • [Cites] J Clin Invest. 2007 Aug;117(8):2241-9 [17671654.001]
  • [Cites] Hum Gene Ther. 2007 Aug;18(8):691-700 [17655493.001]
  • [Cites] Hum Gene Ther. 2001 Jun 10;12(9):1103-8 [11399231.001]
  • [Cites] Mol Ther. 2002 Sep;6(3):321-8 [12231167.001]
  • [Cites] Ann N Y Acad Sci. 2003 May;996:112-21 [12799289.001]
  • [Cites] Science. 2003 Jun 13;300(5626):1749-51 [12805549.001]
  • [Cites] Science. 2003 Oct 17;302(5644):415-9 [14564000.001]
  • [Cites] Nucleic Acids Res. 2004 Jan 1;32(Database issue):D523-7 [14681473.001]
  • [Cites] Mol Ther. 2004 Jan;9(1):5-13 [14741772.001]
  • [Cites] PLoS Biol. 2004 Aug;2(8):E234 [15314653.001]
  • [Cites] Folia Biol (Praha). 2004;50(3-4):107-19 [15373344.001]
  • [Cites] J Virol. 2004 Nov;78(21):11656-63 [15479807.001]
  • [Cites] Semin Hematol. 2004 Oct;41(4):303-18 [15508116.001]
  • [Cites] J Hematother. 1996 Aug;5(4):323-9 [8877707.001]
  • [Cites] PLoS Biol. 2004 Dec;2(12):e423 [15550989.001]
  • [Cites] Science. 2005 May 20;308(5725):1171-4 [15905401.001]
  • [Cites] Blood. 2005 Oct 1;106(7):2530-3 [15933056.001]
  • [Cites] Blood. 2005 Oct 1;106(7):2498-505 [15961513.001]
  • [Cites] Nat Rev Microbiol. 2005 Nov;3(11):848-58 [16175173.001]
  • [Cites] Blood. 2005 Dec 1;106(12):3932-9 [16109773.001]
  • [Cites] Virology. 2006 Jan 20;344(2):292-5 [16271739.001]
  • [Cites] Nat Med. 2006 Apr;12(4):401-9 [16582916.001]
  • [Cites] Blood. 2006 May 15;107(10):3865-7 [16439674.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Jul 7;345(3):1099-107 [16713998.001]
  • [Cites] Blood. 2007 Sep 15;110(6):1770-8 [17507662.001]
  • [Cites] Gene Ther. 2008 Jan;15(2):143-53 [17972922.001]
  • [Cites] Mol Ther. 2008 Mar;16(3):534-40 [18209733.001]
  • [ErratumIn] Mol Ther. 2008 Oct;16(10):1770.. Golmes, Theotonius [corrected to Gomes, Theotonius J]
  • (PMID = 18578011.001).
  • [ISSN] 1525-0024
  • [Journal-full-title] Molecular therapy : the journal of the American Society of Gene Therapy
  • [ISO-abbreviation] Mol. Ther.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z01 HL002339-16; United States / Intramural NIH HHS / / Z99 HL999999
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / MDS1-EVI1 fusion protein, mouse; 0 / Oncogene Proteins, Fusion
  • [Other-IDs] NLM/ NIHMS51855; NLM/ PMC2561952
  •  go-up   go-down


8. Scheifele LZ, Kenney SP, Cairns TM, Craven RC, Parent LJ: Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology. J Virol; 2007 Oct;81(19):10718-28
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology.
  • Nucleocytoplasmic shuttling of the Rous sarcoma virus (RSV) Gag polyprotein is an integral step in virus particle assembly.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Jan;74(1):16-23 [10590086.001]
  • [Cites] J Exp Med. 1960 Nov 1;112:945-52 [13693270.001]
  • [Cites] Nature. 1999 Dec 9;402(6762):681-5 [10604476.001]
  • [Cites] EMBO J. 2000 Jan 4;19(1):103-13 [10619849.001]
  • [Cites] J Virol. 2000 Aug;74(16):7250-60 [10906179.001]
  • [Cites] J Virol. 2000 Nov;74(21):10260-8 [11024160.001]
  • [Cites] J Virol. 2001 Jan;75(1):260-8 [11119596.001]
  • [Cites] J Virol. 2001 Jul;75(13):6016-21 [11390603.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] J Virol. 2002 May;76(10):4679-87 [11967285.001]
  • [Cites] J Virol. 2002 Nov;76(22):11177-85 [12388677.001]
  • [Cites] Virology. 2002 Dec 5;304(1):89-96 [12490406.001]
  • [Cites] J Virol. 2003 Feb;77(3):1820-9 [12525616.001]
  • [Cites] J Gen Virol. 2003 Mar;84(Pt 3):517-27 [12604801.001]
  • [Cites] J Virol. 2003 Sep;77(17):9388-98 [12915554.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11678-83 [14504385.001]
  • [Cites] J Mol Biol. 2004 Jan 2;335(1):275-82 [14659756.001]
  • [Cites] J Virol. 2004 Feb;78(3):1411-20 [14722296.001]
  • [Cites] J Gen Virol. 2004 Jul;85(Pt 7):1885-93 [15218173.001]
  • [Cites] J Virol. 1990 Sep;64(9):4169-79 [2166812.001]
  • [Cites] J Virol. 1991 Jan;65(1):272-80 [1845888.001]
  • [Cites] Arch Virol. 1991;118(3-4):279-84 [2069508.001]
  • [Cites] AIDS. 1991 Jun;5(6):639-54 [1883539.001]
  • [Cites] J Virol. 1993 Mar;67(3):1350-6 [8437220.001]
  • [Cites] J Virol. 1993 Jul;67(7):3826-34 [7685400.001]
  • [Cites] J Virol. 1993 Oct;67(10):6246-52 [8396679.001]
  • [Cites] Nature. 1993 Oct 14;365(6447):666-9 [8105392.001]
  • [Cites] J Virol. 1995 Jul;69(7):4213-27 [7769681.001]
  • [Cites] J Virol. 1995 Oct;69(10):6430-8 [7666544.001]
  • [Cites] J Cell Sci. 1995 Sep;108 ( Pt 9):3039-50 [8537443.001]
  • [Cites] J Virol. 1996 Feb;70(2):1016-26 [8551559.001]
  • [Cites] J Exp Med. 1960 Mar 1;111:387-406 [13755924.001]
  • [Cites] J Virol. 2005 Jan;79(2):1262-70 [15613353.001]
  • [Cites] J Virol. 2005 Jul;79(14):8732-41 [15994767.001]
  • [Cites] J Mol Biol. 2006 Jan 6;355(1):157-68 [16289202.001]
  • [Cites] J Virol. 2006 Feb;80(3):1242-9 [16415001.001]
  • [Cites] Nature. 2006 Jan 26;439(7075):490-2 [16437116.001]
  • [Cites] J Virol. 2006 Feb;80(4):1798-806 [16439536.001]
  • [Cites] J Virol. 2006 Jun;80(11):5233-40 [16699003.001]
  • [Cites] J Virol. 2000 Jan;74(1):164-72 [10590103.001]
  • [Cites] Curr Top Microbiol Immunol. 1996;214:65-94 [8791725.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] Curr Biol. 1997 Oct 1;7(10):729-38 [9368755.001]
  • [Cites] J Virol. 1998 Jan;72(1):564-77 [9420260.001]
  • [Cites] Virology. 1998 Jan 5;240(1):127-37 [9448697.001]
  • [Cites] J Virol. 1998 Jun;72(6):4798-810 [9573245.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 May 12;95(10):5746-51 [9576955.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304 [9636143.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Science. 1999 Jan 1;283(5398):80-3 [9872746.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • (PMID = 17634229.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA076534; United States / NCI NIH HHS / CA / R01 CA100322; United States / NCI NIH HHS / CA / R01 CA76534
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / Nuclear Export Signals; 0 / RNA, Viral; 0 / Recombinant Fusion Proteins; 147336-22-9 / Green Fluorescent Proteins
  • [Other-IDs] NLM/ PMC2045444
  •  go-up   go-down


9. Wiegand HL, Cullen BR: Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins. J Virol; 2007 Dec;81(24):13694-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here, we have examined whether the alpharetrovirus Rous sarcoma virus (RSV) is susceptible to inhibition by a range of human APOBEC3 proteins.
  • These data represent the first report of inhibition of retroviral infectivity and induction of proviral DNA editing by human APOBEC3A and reveal that alpharetroviruses, which do not normally encounter APOBEC3 proteins in their avian hosts, are susceptible to inhibition by all human APOBEC3 proteins tested.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2004 Nov;78(21):12058-61 [15479846.001]
  • [Cites] J Biol Chem. 2006 Jun 23;281(25):16837-41 [16648136.001]
  • [Cites] J Virol. 1987 Oct;61(10):3004-12 [3041020.001]
  • [Cites] J Virol. 1990 Sep;64(9):4169-79 [2166812.001]
  • [Cites] J Virol. 1993 Aug;67(8):4945-55 [8331734.001]
  • [Cites] Genomics. 2002 Mar;79(3):285-96 [11863358.001]
  • [Cites] Nature. 2002 Aug 8;418(6898):646-50 [12167863.001]
  • [Cites] Cell. 2003 Jun 13;113(6):803-9 [12809610.001]
  • [Cites] Nature. 2003 Jul 3;424(6944):94-8 [12808465.001]
  • [Cites] Nature. 2003 Jul 3;424(6944):99-103 [12808466.001]
  • [Cites] Cell. 2003 Jul 11;114(1):21-31 [12859895.001]
  • [Cites] J Biol Chem. 2003 Nov 7;278(45):44412-6 [12970355.001]
  • [Cites] Nat Med. 2003 Nov;9(11):1404-7 [14528300.001]
  • [Cites] Nat Med. 2003 Nov;9(11):1398-403 [14528301.001]
  • [Cites] Science. 2003 Nov 7;302(5647):1056-60 [14564014.001]
  • [Cites] Curr Biol. 2003 Nov 11;13(22):2009-13 [14614829.001]
  • [Cites] J Biol Chem. 2004 Feb 27;279(9):7792-8 [14672928.001]
  • [Cites] J Biol Chem. 2006 Aug 4;281(31):22161-72 [16735504.001]
  • [Cites] J Virol. 2006 Sep;80(17):8450-8 [16912295.001]
  • [Cites] J Virol. 2006 Dec;80(23):11710-22 [16971427.001]
  • [Cites] J Virol. 2006 Dec;80(24):12102-8 [17035335.001]
  • [Cites] J Biol Chem. 2007 Jan 26;282(4):2587-95 [17121840.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2915-20 [17299050.001]
  • [Cites] J Virol. 2007 May;81(9):4465-72 [17314171.001]
  • [Cites] Virology. 2007 Aug 1;364(2):486-93 [17434555.001]
  • [Cites] J Virol. 2007 Jul;81(13):7238-48 [17428847.001]
  • [Cites] J Virol. 2007 Jul;81(13):7099-110 [17428871.001]
  • [Cites] J Virol. 2007 Jul;81(13):7048-60 [17459941.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3927-32 [14978281.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3770-4 [14999100.001]
  • [Cites] Science. 2004 Mar 19;303(5665):1829 [15031497.001]
  • [Cites] Nat Struct Mol Biol. 2004 May;11(5):435-42 [15098018.001]
  • [Cites] EMBO J. 2004 Jun 16;23(12):2451-8 [15152192.001]
  • [Cites] J Virol. 2004 Aug;78(15):8238-44 [15254195.001]
  • [Cites] Hum Mol Genet. 2004 Aug 15;13(16):1785-91 [15198990.001]
  • [Cites] J Biol Chem. 2004 Aug 6;279(32):33177-84 [15159405.001]
  • [Cites] Curr Biol. 2004 Aug 10;14(15):1385-91 [15296757.001]
  • [Cites] Curr Biol. 2004 Aug 10;14(15):1392-6 [15296758.001]
  • [Cites] J Biol Chem. 2004 Aug 13;279(33):34083-6 [15215254.001]
  • [Cites] PLoS Biol. 2004 Sep;2(9):E275 [15269786.001]
  • [Cites] Virology. 2004 Oct 25;328(2):163-8 [15464836.001]
  • [Cites] J Virol. 1996 Aug;70(8):5297-305 [8764040.001]
  • [Cites] Methods Cell Biol. 1997;52:179-214 [9379950.001]
  • [Cites] Mol Biol Evol. 2005 Feb;22(2):367-77 [15496550.001]
  • [Cites] J Biol Chem. 2004 Dec 17;279(51):53379-86 [15466872.001]
  • [Cites] Curr Biol. 2005 Jan 26;15(2):166-70 [15668174.001]
  • [Cites] Nature. 2005 Jan 27;433(7024):430-3 [15674295.001]
  • [Cites] Virology. 2005 Mar 15;333(2):374-86 [15721369.001]
  • [Cites] J Biol Chem. 2005 Mar 25;280(12):10920-4 [15647250.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 May 31;102(22):7982-7 [15911774.001]
  • [Cites] J Virol. 2005 Jul;79(13):8201-7 [15956565.001]
  • [Cites] Hepatology. 2005 Aug;42(2):301-9 [16025511.001]
  • [Cites] Virology. 2005 Sep 1;339(2):281-8 [15993456.001]
  • [Cites] Nucleic Acids Res. 2006;34(1):89-95 [16407327.001]
  • [Cites] J Virol. 2006 Feb;80(3):1067-76 [16414984.001]
  • [Cites] Curr Biol. 2006 Mar 7;16(5):480-5 [16527742.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8780-5 [16728505.001]
  • [Cites] Proc Natl Acad Sci U S A. 1983 May;80(10):2946-50 [6574464.001]
  • (PMID = 17913830.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI065301; United States / NIAID NIH HHS / AI / AI065301
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] EC 3.5.4.1 / APOBEC3 protein, human; EC 3.5.4.1 / APOBEC3F protein, human; EC 3.5.4.1 / Cytosine Deaminase; EC 3.5.4.5 / APOBEC3B protein, human; EC 3.5.4.5 / APOBEC3G protein, human; EC 3.5.4.5 / Cytidine Deaminase
  • [Other-IDs] NLM/ PMC2168862
  •  go-up   go-down


10. Konsavage WM Jr, Burkholder S, Sudol M, Harper AL, Katzman M: A substitution in rous sarcoma virus integrase that separates its two biologically relevant enzymatic activities. J Virol; 2005 Apr;79(8):4691-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A substitution in rous sarcoma virus integrase that separates its two biologically relevant enzymatic activities.
  • However, it has been known since the processing assay was first described that avian integrases frequently nick 3 nucleotides, as well as 2 nucleotides, from viral DNA ends when reaction mixtures contain Mn2+.
  • We now report that specificity for the biologically relevant "-2" site is enhanced when the serine at amino acid 124 of Rous sarcoma virus (RSV) integrase is replaced by alanine, valine, glycine, lysine, or aspartate.
  • [MeSH-major] Avian Sarcoma Viruses / enzymology. Integrases / metabolism

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. MAGNESIUM, ELEMENTAL .
  • Hazardous Substances Data Bank. MANGANESE, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Virus Res. 2000 Jan;66(1):87-100 [10653920.001]
  • [Cites] Adv Virus Res. 1999;52:371-95 [10384243.001]
  • [Cites] J Gen Virol. 2000 Mar;81(Pt 3):839-49 [10675422.001]
  • [Cites] J Biol Chem. 2001 Jan 5;276(1):114-24 [11024025.001]
  • [Cites] J Virol. 2001 Aug;75(16):7756-62 [11462051.001]
  • [Cites] J Acquir Immune Defic Syndr. 2001 Nov 1;28(3):203-10 [11694825.001]
  • [Cites] Arch Virol. 2002 Sep;147(9):1761-78 [12209315.001]
  • [Cites] J Virol. 2003 Mar;77(6):3838-45 [12610159.001]
  • [Cites] Nucleic Acids Res. 2004;32(4):1527-38 [14999095.001]
  • [Cites] Cell. 1977 May;11(1):95-103 [194709.001]
  • [Cites] Nucleic Acids Res. 1985 Sep 11;13(17):6205-21 [2995920.001]
  • [Cites] Cell. 1987 May 8;49(3):347-56 [3032450.001]
  • [Cites] J Virol. 1988 Jul;62(7):2358-65 [2836618.001]
  • [Cites] Cell. 1988 Aug 12;54(4):497-504 [3401925.001]
  • [Cites] J Virol. 1989 Dec;63(12):5319-27 [2555556.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jul;87(13):5119-23 [2164223.001]
  • [Cites] Cell. 1990 Aug 24;62(4):829-37 [2167180.001]
  • [Cites] Cell. 1990 Oct 5;63(1):87-95 [2170022.001]
  • [Cites] J Virol. 1990 Nov;64(11):5656-9 [2214031.001]
  • [Cites] Cell. 1991 Dec 20;67(6):1211-21 [1760846.001]
  • [Cites] Nucleic Acids Res. 1991 Dec 25;19(24):6691-8 [1662361.001]
  • [Cites] J Virol. 1992 Feb;66(2):865-74 [1370559.001]
  • [Cites] Science. 1992 Feb 7;255(5045):723-6 [1738845.001]
  • [Cites] J Biol Chem. 1992 Aug 15;267(23):16037-40 [1322888.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9598-602 [1409671.001]
  • [Cites] J Virol. 1993 Jan;67(1):425-37 [8416376.001]
  • [Cites] J Biol Chem. 1993 Jan 25;268(3):2113-9 [8420982.001]
  • [Cites] Nucleic Acids Res. 1993 Mar 25;21(6):1419-25 [8464733.001]
  • [Cites] Methods Enzymol. 1993;217:270-9 [8474334.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3428-32 [8386373.001]
  • [Cites] J Virol. 1994 Jun;68(6):3558-69 [8189495.001]
  • [Cites] Virology. 1995 Jan 10;206(1):448-56 [7831800.001]
  • [Cites] J Virol. 1995 Sep;69(9):5687-96 [7637015.001]
  • [Cites] J Virol. 1996 Apr;70(4):2598-604 [8642692.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Mol Biol. 2000 Jan 28;295(4):755-65 [10656788.001]
  • (PMID = 15795255.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Recombinant Proteins; 42Z2K6ZL8P / Manganese; EC 2.7.7.- / Integrases; I38ZP9992A / Magnesium
  • [Other-IDs] NLM/ PMC1069555
  •  go-up   go-down


11. Dilley KA, Gregory D, Johnson MC, Vogt VM: An LYPSL late domain in the gag protein contributes to the efficient release and replication of Rous sarcoma virus. J Virol; 2010 Jul;84(13):6276-87
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An LYPSL late domain in the gag protein contributes to the efficient release and replication of Rous sarcoma virus.
  • The major late domain of Rous sarcoma virus (RSV) has been mapped to a PPPY motif in Gag that binds members of the Nedd4 family of ubiquitin ligases.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2009 Jul;83(14):7185-93 [19403673.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10541-6 [18641129.001]
  • [Cites] Virology. 2009 Sep 1;391(2):284-92 [19596386.001]
  • [Cites] J Cell Biol. 2005 Jan 3;168(1):89-101 [15623582.001]
  • [Cites] J Virol. 2005 Mar;79(5):2988-97 [15709019.001]
  • [Cites] Dev Cell. 2005 Jun;8(6):937-47 [15935782.001]
  • [Cites] J Virol. 2005 Jul;79(14):9038-45 [15994797.001]
  • [Cites] Traffic. 2005 Oct;6(10):880-94 [16138902.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15453-8 [16230638.001]
  • [Cites] Virology. 2006 Jan 5;344(1):55-63 [16364736.001]
  • [Cites] Virology. 2006 Mar 30;347(1):226-33 [16406458.001]
  • [Cites] J Virol. 2006 Oct;80(19):9634-40 [16973567.001]
  • [Cites] Retrovirology. 2006;3:77 [17083721.001]
  • [Cites] J Biol Chem. 2007 Feb 9;282(6):3847-55 [17158451.001]
  • [Cites] Nat Struct Mol Biol. 2007 Mar;14(3):194-9 [17277784.001]
  • [Cites] Cell. 2007 Mar 9;128(5):841-52 [17350572.001]
  • [Cites] J Virol. 2008 Oct;82(19):9770-5 [18667521.001]
  • [Cites] Biochem Soc Trans. 2009 Feb;37(Pt 1):181-4 [19143627.001]
  • [Cites] PLoS Pathog. 2009 Mar;5(3):e1000339 [19282983.001]
  • [Cites] J Virol. 2000 Aug;74(16):7250-60 [10906179.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13871-6 [11095724.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7724-9 [11427703.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11199-204 [11562473.001]
  • [Cites] Cell. 2001 Oct 5;107(1):55-65 [11595185.001]
  • [Cites] Nat Med. 2001 Dec;7(12):1313-9 [11726971.001]
  • [Cites] J Virol. 2002 Jan;76(1):105-17 [11739676.001]
  • [Cites] J Virol. 2002 Feb;76(4):1569-77 [11799151.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):955-60 [11805336.001]
  • [Cites] Virology. 2002 Oct 25;302(2):405-12 [12441084.001]
  • [Cites] J Virol. 2003 Feb;77(3):1812-9 [12525615.001]
  • [Cites] J Virol. 2003 Sep;77(17):9474-85 [12915562.001]
  • [Cites] Cell. 2003 Sep 19;114(6):689-99 [14505569.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12414-9 [14519844.001]
  • [Cites] J Virol. 2003 Nov;77(22):11882-95 [14581525.001]
  • [Cites] J Virol. 2003 Nov;77(22):12373-7 [14581576.001]
  • [Cites] J Virol. 2004 Feb;78(3):1503-12 [14722305.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 Apr;5(4):317-23 [15071556.001]
  • [Cites] J Virol. 2004 Jun;78(11):5554-63 [15140952.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9 [2014240.001]
  • [Cites] Virology. 1991 Nov;185(1):99-108 [1656608.001]
  • [Cites] J Virol. 2007 Jun;81(12):6614-22 [17428861.001]
  • [Cites] Science. 2007 Jun 29;316(5833):1908-12 [17556548.001]
  • [Cites] Nat Rev Microbiol. 2007 Dec;5(12):912-6 [17982468.001]
  • [Cites] Nat Struct Mol Biol. 2008 Jan;15(1):43-9 [18066081.001]
  • [Cites] J Virol. 2008 Feb;82(3):1389-98 [18032513.001]
  • [Cites] J Virol. 1992 Jan;66(1):6-11 [1309264.001]
  • [Cites] J Virol. 1994 Oct;68(10):6605-18 [8083996.001]
  • [Cites] J Virol. 1995 Sep;69(9):5455-60 [7636991.001]
  • [Cites] J Virol. 1996 Aug;70(8):5695-700 [8764091.001]
  • [Cites] J Virol. 1997 Sep;71(9):6541-6 [9261374.001]
  • [Cites] Methods Cell Biol. 1997;52:179-214 [9379950.001]
  • [Cites] J Virol. 2004 Dec;78(24):13943-53 [15564502.001]
  • [Cites] Virus Res. 2004 Dec;106(2):87-102 [15567490.001]
  • [Cites] J Virol. 2008 Feb;82(3):1610-4 [18057258.001]
  • [Cites] Virology. 2008 Jun 5;375(2):637-45 [18355887.001]
  • [Cites] Retrovirology. 2008;5:39 [18477395.001]
  • [Cites] Nature. 2008 Jul 10;454(7201):236-40 [18500329.001]
  • [Cites] PLoS Biol. 2009 Jul;7(7):e1000163 [19636361.001]
  • (PMID = 20392845.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / AI073098; United States / NIAID NIH HHS / AI / R01 AI073098-03; United States / NCI NIH HHS / CA / R01 CA020081; United States / NIAID NIH HHS / AI / R01 AI073098; United States / NCI NIH HHS / CA / CA20081
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Calcium-Binding Proteins; 0 / Cell Cycle Proteins; 0 / Endosomal Sorting Complexes Required for Transport; 0 / Gene Products, gag; 0 / PDCD6IP protein, human
  • [Other-IDs] NLM/ PMC2903267
  •  go-up   go-down


12. Liu Y, Okada T, Nomoto T, Ke X, Kume A, Ozawa K, Xiao S: Promoter effects of adeno-associated viral vector for transgene expression in the cochlea in vivo. Exp Mol Med; 2007 Apr 30;39(2):170-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aims of this study were to evaluate the expression of enhanced green fluorescent protein (EGFP) driven by 6 different promoters, including cytomegalovirus IE enhancer and chicken beta-actin promoter (CAG), cytomegalovirus promoter (CMV), neuron-specific enolase promoter (NSE), myosin 7A promoter (Myo), elongation factor 1alpha promoter (EF-1alpha), and Rous sarcoma virus promoter (RSV), and assess the dose response of CAG promoter to transgene expression in the cochlea.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17464178.001).
  • [ISSN] 1226-3613
  • [Journal-full-title] Experimental & molecular medicine
  • [ISO-abbreviation] Exp. Mol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / enhanced green fluorescent protein; 147336-22-9 / Green Fluorescent Proteins
  •  go-up   go-down


13. Konsavage WM Jr, Sudol M, Lee NE, Katzman M: Retroviral integrases that are improved for processing but impaired for joining. Virus Res; 2007 May;125(2):198-210
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We previously showed that Rous sarcoma virus integrase with a serine-to-aspartate substitution at amino acid 124 was markedly improved for processing but dramatically impaired for joining, making it the first mutant to separate the activities of integrase in this way.
  • [MeSH-major] Integrases / physiology. Rous sarcoma virus / enzymology. Virus Integration

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. MAGNESIUM, ELEMENTAL .
  • Hazardous Substances Data Bank. MANGANESE, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17289204.001).
  • [ISSN] 0168-1702
  • [Journal-full-title] Virus research
  • [ISO-abbreviation] Virus Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / DNA, Viral; 42Z2K6ZL8P / Manganese; EC 2.7.7.- / Integrases; I38ZP9992A / Magnesium
  •  go-up   go-down


14. Bruzzaniti A, Neff L, Sanjay A, Horne WC, De Camilli P, Baron R: Dynamin forms a Src kinase-sensitive complex with Cbl and regulates podosomes and osteoclast activity. Mol Biol Cell; 2005 Jul;16(7):3301-13
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Podosomes are highly dynamic actin-containing adhesion structures found in osteoclasts, macrophages, and Rous sarcoma virus (RSV)-transformed fibroblasts.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arthritis Res. 2002;4 Suppl 3:S227-32 [12110142.001]
  • [Cites] J Biol Chem. 2002 Jul 19;277(29):26642-51 [12011079.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12191-6 [12218189.001]
  • [Cites] FEBS Lett. 2002 Oct 2;529(1):110-5 [12354621.001]
  • [Cites] Curr Opin Cell Biol. 2003 Feb;15(1):31-9 [12517701.001]
  • [Cites] Mol Biol Cell. 2003 Feb;14(2):407-16 [12589043.001]
  • [Cites] Trends Cell Biol. 2003 Jul;13(7):376-85 [12837608.001]
  • [Cites] Dev Biol. 2003 Sep 15;261(2):537-47 [14499658.001]
  • [Cites] Front Biosci. 2004 May 1;9:1944-53 [14977600.001]
  • [Cites] J Biol Chem. 2004 Apr 23;279(17):17660-6 [14739300.001]
  • [Cites] Front Biosci. 1998;3:d757-68 [9682033.001]
  • [Cites] J Bone Miner Res. 1988 Oct;3(5):517-23 [3195364.001]
  • [Cites] Nat Cell Biol. 2000 Jul;2(7):385-91 [10878802.001]
  • [Cites] J Biol Chem. 2000 Jul 21;275(29):21946-52 [10781580.001]
  • [Cites] J Cell Biol. 2000 Jul 24;150(2):377-89 [10908579.001]
  • [Cites] J Cell Biol. 2000 Sep 4;150(5):F111-6 [10974009.001]
  • [Cites] J Cell Biol. 2000 Oct 2;151(1):187-98 [11018064.001]
  • [Cites] Biochem Biophys Res Commun. 2000 Nov 11;278(1):167-74 [11071869.001]
  • [Cites] Exp Cell Res. 2000 Nov 25;261(1):25-36 [11082272.001]
  • [Cites] J Cell Biol. 2001 Jan 8;152(1):181-95 [11149930.001]
  • [Cites] Nat Rev Neurosci. 2000 Dec;1(3):161-72 [11257904.001]
  • [Cites] J Clin Invest. 2001 May;107(9):1137-44 [11342577.001]
  • [Cites] J Biol Chem. 2001 Feb 16;276(7):4957-63 [11067845.001]
  • [Cites] J Biol Chem. 2001 Sep 14;276(37):35185-93 [11448952.001]
  • [Cites] Mol Biol Cell. 2001 Sep;12(9):2578-89 [11553700.001]
  • [Cites] EMBO J. 2001 Oct 15;20(20):5603-14 [11598004.001]
  • [Cites] J Cell Biol. 2001 Oct 15;155(2):193-200 [11604418.001]
  • [Cites] J Cell Sci. 2001 Aug;114(Pt 15):2775-86 [11683411.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):161-6 [11782545.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):167-72 [11782546.001]
  • [Cites] Curr Opin Cell Biol. 2002 Feb;14(1):76-81 [11792548.001]
  • [Cites] Nature. 2002 Mar 14;416(6877):183-7 [11894095.001]
  • [Cites] Nature. 2002 Mar 14;416(6877):187-90 [11894096.001]
  • [Cites] Cell. 2002 Apr 5;109(1):101-12 [11955450.001]
  • [Cites] J Exp Zool. 1989 Aug;251(2):167-85 [2549171.001]
  • [Cites] J Cell Biol. 1989 Oct;109(4 Pt 1):1817-26 [2477382.001]
  • [Cites] Cancer. 1989 Dec 1;64(11):2243-9 [2804914.001]
  • [Cites] Exp Cell Res. 1991 Aug;195(2):368-75 [1712731.001]
  • [Cites] J Cell Biol. 1991 Nov;115(4):1179-86 [1720122.001]
  • [Cites] J Bone Miner Res. 1992 Mar;7(3):345-51 [1585837.001]
  • [Cites] J Cell Biol. 1992 Nov;119(4):1003-13 [1385441.001]
  • [Cites] J Bone Miner Res. 1993 May;8(5):527-33 [8511980.001]
  • [Cites] J Cell Sci. 1993 Mar;104 ( Pt 3):663-70 [7686168.001]
  • [Cites] J Biol Chem. 1993 Aug 5;268(22):16737-45 [8344953.001]
  • [Cites] Cell. 1993 Oct 8;75(1):25-36 [8402898.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11468-72 [7505438.001]
  • [Cites] EMBO J. 1994 Jun 1;13(11):2574-82 [8013457.001]
  • [Cites] J Cell Biol. 1994 Nov;127(4):915-34 [7962076.001]
  • [Cites] Nature. 1995 Mar 9;374(6518):186-90 [7877693.001]
  • [Cites] EMBO J. 1995 Apr 3;14(7):1322-8 [7537212.001]
  • [Cites] J Cell Sci. 1995 Aug;108 ( Pt 8):2729-32 [7593313.001]
  • [Cites] Nature. 1996 Oct 10;383(6600):528-31 [8849724.001]
  • [Cites] J Biol Chem. 1996 Dec 20;271(51):33141-7 [8955163.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8569-74 [9238017.001]
  • [Cites] Genes Dev. 1997 Nov 1;11(21):2835-44 [9353253.001]
  • [Cites] J Biol Chem. 1998 Feb 6;273(6):3791-7 [9452513.001]
  • [Cites] EMBO J. 1998 Aug 3;17(15):4391-403 [9687507.001]
  • [Cites] J Cell Sci. 1998 Sep;111 ( Pt 17):2563-74 [9701555.001]
  • [Cites] Mol Biol Cell. 1998 Sep;9(9):2595-609 [9725914.001]
  • [Cites] J Bone Miner Res. 1998 Nov;13(11):1714-20 [9797480.001]
  • [Cites] J Cell Biol. 1998 Dec 28;143(7):1871-81 [9864361.001]
  • [Cites] J Biol Chem. 1999 Jan 15;274(3):1185-8 [9880482.001]
  • [Cites] Curr Biol. 1999 Mar 11;9(5):261-4 [10074457.001]
  • [Cites] J Bone Miner Metab. 1999;17(1):1-6 [10084394.001]
  • [Cites] J Biol Chem. 1999 Oct 22;274(43):30887-95 [10521482.001]
  • [Cites] J Cell Biol. 1985 Dec;101(6):2210-22 [3905822.001]
  • [Cites] Exp Cell Res. 1987 Mar;169(1):202-14 [3028844.001]
  • [Cites] J Cell Biol. 1987 Jun;104(6):1521-6 [3034916.001]
  • [Cites] Nat Cell Biol. 1999 May;1(1):33-9 [10559861.001]
  • [Cites] Nat Cell Biol. 1999 Aug;1(4):200-6 [10559917.001]
  • [Cites] J Cell Sci. 2000 Feb;113 ( Pt 3):377-81 [10639325.001]
  • [Cites] J Bone Miner Res. 2000 Jan;15(1):41-51 [10646113.001]
  • [Cites] Biochem Biophys Res Commun. 2000 Feb 16;268(2):321-8 [10679202.001]
  • [Cites] J Clin Invest. 2000 Feb;105(4):433-40 [10683372.001]
  • [Cites] J Neurosci. 2000 Jun 1;20(11):4177-88 [10818153.001]
  • [Cites] J Biol Chem. 2002 Jul 12;277(28):24967-75 [11994282.001]
  • (PMID = 15872089.001).
  • [ISSN] 1059-1524
  • [Journal-full-title] Molecular biology of the cell
  • [ISO-abbreviation] Mol. Biol. Cell
  • [Language] ENG
  • [Grant] United States / NIAMS NIH HHS / AR / R01 AR042927; United States / NIAMS NIH HHS / AR / AR42927
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 147336-22-9 / Green Fluorescent Proteins; 86-01-1 / Guanosine Triphosphate; EC 2.5.1.18 / Glutathione Transferase; EC 2.7.10.2 / src-Family Kinases; EC 3.6.5.5 / Dynamins
  • [Other-IDs] NLM/ PMC1165412
  •  go-up   go-down


15. Bruce JW, Hierl M, Young JA, Ahlquist P: Cellular transcription factor ZASC1 regulates murine leukemia virus transcription. J Virol; 2010 Aug;84(15):7473-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The defect in this cell line was specific for the MLV long terminal repeat (LTR) promoter, as normal levels of reporter gene expression were obtained from both an internal cytomegalovirus (CMV) promoter contained within an LTR-defective MLV vector and LTR expression from an avian sarcoma and leukosis virus (ASLV) vector.

  • COS Scholar Universe. author profiles.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nucleic Acids Res. 1999 Dec 15;27(24):e35 [10572187.001]
  • [Cites] J Biol Chem. 2009 Jul 17;284(29):19463-73 [19460752.001]
  • [Cites] J Virol. 2001 Apr;75(8):3520-6 [11264341.001]
  • [Cites] Cancer Res. 2003 Sep 15;63(18):5691-6 [14522885.001]
  • [Cites] Cell. 1978 Aug;14(4):1007-13 [688393.001]
  • [Cites] J Virol. 1980 Jan;33(1):494-506 [6245246.001]
  • [Cites] Int J Cancer. 1980 Aug;26(2):171-6 [6970727.001]
  • [Cites] Nature. 1988 Aug 25;334(6184):721-4 [3412449.001]
  • [Cites] J Virol. 1990 Feb;64(2):534-42 [2153223.001]
  • [Cites] J Virol. 1990 Feb;64(2):543-50 [2104942.001]
  • [Cites] Cell. 1990 Apr 20;61(2):213-22 [2331748.001]
  • [Cites] Genes Dev. 1990 Feb;4(2):233-42 [2338244.001]
  • [Cites] Mol Cell Biol. 1992 Nov;12(11):4817-23 [1328863.001]
  • [Cites] Annu Rev Cell Biol. 1992;8:275-306 [1282352.001]
  • [Cites] J Virol. 1993 Apr;67(4):1811-6 [8383211.001]
  • [Cites] J Virol. 1993 Apr;67(4):1967-75 [8445718.001]
  • [Cites] J Virol. 1993 Apr;67(4):1976-86 [8445719.001]
  • [Cites] Cell. 1993 Sep 24;74(6):1043-51 [8402880.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11241-5 [7972042.001]
  • [Cites] J Virol. 1995 Aug;69(8):4941-9 [7609063.001]
  • [Cites] Nature. 1997 Nov 27;390(6658):349-50 [9389473.001]
  • [Cites] Arch Biochem Biophys. 1999 May 15;365(2):199-210 [10328813.001]
  • [Cites] J Virol. 1999 Jul;73(7):5535-47 [10364302.001]
  • [Cites] Mol Endocrinol. 2005 Oct;19(10):2451-65 [16051665.001]
  • [Cites] J Virol. 2005 Oct;79(20):12969-78 [16188999.001]
  • [Cites] Exp Cell Res. 2005 Nov 15;311(1):1-13 [16182284.001]
  • [Cites] Cell. 2006 May 19;125(4):801-14 [16713569.001]
  • [Cites] EMBO J. 2007 Jan 10;26(1):41-52 [17170707.001]
  • [Cites] Nat Rev Microbiol. 2007 Apr;5(4):253-63 [17325726.001]
  • [Cites] Curr Opin Immunol. 2007 Aug;19(4):402-7 [17707624.001]
  • [Cites] Science. 2008 Feb 15;319(5865):921-6 [18187620.001]
  • [Cites] Cell. 2008 Oct 3;135(1):49-60 [18854154.001]
  • [Cites] Annu Rev Genet. 2008;42:143-63 [18624631.001]
  • [Cites] Cell Host Microbe. 2008 Nov 13;4(5):495-504 [18976975.001]
  • [Cites] PLoS Pathog. 2008 Nov;4(11):e1000207 [19008949.001]
  • [Cites] PLoS Pathog. 2009 May;5(5):e1000437 [19478882.001]
  • [Cites] Biotechniques. 2000 Apr;28(4):702-8 [10769748.001]
  • (PMID = 20484494.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / AI072645-05; United States / NIAID NIH HHS / AI / AI72645; United States / NIAID NIH HHS / AI / R01 AI072645; United States / NIAID NIH HHS / AI / R01 AI072645-05; United States / Howard Hughes Medical Institute / / ; United States / NCI NIH HHS / CA / P01 CA022443; United States / NCI NIH HHS / CA / CA22443
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Transcription Factors
  • [Other-IDs] NLM/ PMC2897642
  •  go-up   go-down


16. Al-Dosari M, Zhang G, Knapp JE, Liu D: Evaluation of viral and mammalian promoters for driving transgene expression in mouse liver. Biochem Biophys Res Commun; 2006 Jan 13;339(2):673-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Fifteen luciferase plasmid constructs driven by various promoters including cytomegalovirus (CMV), Rous sarcoma virus (RSV), human serum albumin (SA), alpha-1 antitrypsin (AAT), cytochrome P450 CYP1A2, CYP2C9, CYP2C18, CYP2D6, CYP3A4, mouse CYP2b10, human amyloid precursor protein (APP), chicken beta actin (ACT), nuclear factor kappa B (NFkappaB), and heat shock protein 70 (HS) promoters were hydrodynamically introduced into mouse hepatocytes, and the level and persistence of luciferase gene expression were examined.
  • [MeSH-major] Avian Sarcoma Viruses / genetics. Cytomegalovirus / genetics. Gene Expression Regulation / genetics. Liver / metabolism. Promoter Regions, Genetic / genetics. Transgenes / genetics

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16316630.001).
  • [ISSN] 0006-291X
  • [Journal-full-title] Biochemical and biophysical research communications
  • [ISO-abbreviation] Biochem. Biophys. Res. Commun.
  • [Language] eng
  • [Grant] United States / NIBIB NIH HHS / EB / R01 EB002946; United States / NHLBI NIH HHS / HL / R01 HL075542
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] EC 1.13.12.- / Luciferases
  •  go-up   go-down


17. Sanjuán R: Quantifying antagonistic epistasis in a multifunctional RNA secondary structure of the Rous sarcoma virus. J Gen Virol; 2006 Jun;87(Pt 6):1595-602
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Quantifying antagonistic epistasis in a multifunctional RNA secondary structure of the Rous sarcoma virus.
  • Here, by re-analysing previously published data from a random viral library, selection and epistasis coefficients were estimated in the U5-IR stem and loop of the Rous sarcoma virus, a region that adopts a conserved secondary structure and is involved in various essential steps of viral infection.
  • [MeSH-major] Avian Sarcoma Viruses / genetics. Epistasis, Genetic. RNA, Small Nuclear / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16690924.001).
  • [ISSN] 0022-1317
  • [Journal-full-title] The Journal of general virology
  • [ISO-abbreviation] J. Gen. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Small Nuclear; 0 / RNA, Viral; 0 / U5 small nuclear RNA
  •  go-up   go-down


18. Vojtechová M, Turecková J, Kucerová D, Sloncová E, Vachtenheim J, Tuhácková Z: Regulation of mTORC1 signaling by Src kinase activity is Akt1-independent in RSV-transformed cells. Neoplasia; 2008 Feb;10(2):99-107
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the present study, a critical role of the Src activity in the deregulation of mTOR signaling pathway in Rous sarcoma virus (RSV)-transformed hamster fibroblasts, H19 cells, was shown using these cells treated with the Src-specific inhibitor, SU6656, and clones of fibroblasts expressing either the active Src or the dominant-negative Src kinase-dead mutant.
  • [MeSH-minor] Adenoviridae / genetics. Animals. Cell Line. Cell Line, Transformed. Cricetinae. Indoles / pharmacology. Phosphorylation. Protein Kinase Inhibitors / pharmacology. Rous sarcoma virus / genetics. Signal Transduction. Sulfonamides / pharmacology


19. Xia HB, Chen ZY, Chen XG: Overexpression of hepatitis B virus-binding protein, squamous cell carcinoma antigen 1, extends retention of hepatitis B virus in mouse liver. Acta Biochim Biophys Sin (Shanghai); 2006 Jul;38(7):484-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • SCCA1 transgene under the control of Rous sarcoma virus promoter was constructed in a minicircle DNA vector that was delivered to NOD/SCID mouse liver using the hydrodynamic technique.

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • Genetic Alliance. consumer health - Hepatitis.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16820864.001).
  • [ISSN] 1672-9145
  • [Journal-full-title] Acta biochimica et biophysica Sinica
  • [ISO-abbreviation] Acta Biochim. Biophys. Sin. (Shanghai)
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ DQ132809
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Hepatitis B Surface Antigens; 0 / Receptors, Virus; 0 / Serpins; 0 / hepatitis B virus-binding protein, human; 0 / squamous cell carcinoma-related antigen
  •  go-up   go-down


20. Lei B, Zhang K, Yue Y, Ghosh A, Duan D: Adeno-associated virus serotype-9 efficiently transduces the retinal outer plexiform layer. Mol Vis; 2009 Jul 17;15:1374-82
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In these vectors, two different promoters (the cytomegalovirus promoter-CMV promoter and the Rous sarcoma virus-RSV promoter) were used to express three different transgenes including the alkaline phosphatase (AP) gene, the enhanced green fluorescent protein (eGFP) gene, and a therapeutic microdystrophin gene (the R4-23/C).

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Invest Ophthalmol Vis Sci. 1992 Mar;33(3):477-83 [1544774.001]
  • [Cites] Hum Gene Ther. 2008 Oct;19(10):979-90 [18774912.001]
  • [Cites] J Clin Invest. 1994 Jun;93(6):2425-30 [8200977.001]
  • [Cites] Invest Ophthalmol Vis Sci. 1995 Feb;36(2):462-6 [7843915.001]
  • [Cites] Histochem Cell Biol. 1997 Sep;108(3):249-55 [9342619.001]
  • [Cites] Prog Retin Eye Res. 1998 Oct;17(4):485-521 [9777648.001]
  • [Cites] Mol Genet Metab. 1999 Feb;66(2):100-10 [10068512.001]
  • [Cites] Mol Ther. 2005 Feb;11(2):245-56 [15668136.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4884-9 [15781871.001]
  • [Cites] Curr Gene Ther. 2005 Jun;5(3):285-97 [15975006.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2006 Jan;47(1):17-24 [16384939.001]
  • [Cites] Mol Ther. 2006 Mar;13(3):565-72 [16223604.001]
  • [Cites] Vis Neurosci. 2006 Jan-Feb;23(1):11-24 [16597347.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2732-8 [16723493.001]
  • [Cites] Mol Ther. 2006 Jul;14(1):45-53 [16713360.001]
  • [Cites] Circ Res. 2006 Aug 18;99(4):e3-9 [16873720.001]
  • [Cites] J Neurosci Res. 2006 Oct;84(5):1139-49 [16881055.001]
  • [Cites] Expert Opin Biol Ther. 2006 Dec;6(12):1279-94 [17223737.001]
  • [Cites] Mol Ther. 2007 Apr;15(4):750-5 [17264855.001]
  • [Cites] Nat Med. 2007 Jun;13(6):685-7 [17515894.001]
  • [Cites] J Virol. 2007 Oct;81(20):11372-80 [17699581.001]
  • [Cites] Gene Ther. 2007 Nov;14(22):1605-9 [17898796.001]
  • [Cites] Curr Eye Res. 2008 Jan;33(1):81-90 [18214745.001]
  • [Cites] J Gene Med. 2008 Apr;10(4):375-82 [18278824.001]
  • [Cites] N Engl J Med. 2008 May 22;358(21):2240-8 [18441370.001]
  • [Cites] N Engl J Med. 2008 May 22;358(21):2231-9 [18441371.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15112-7 [18809924.001]
  • [Cites] J Clin Invest. 2000 Jun;105(11):1573-87 [10841516.001]
  • [Cites] Nat Genet. 2000 Jul;25(3):306-10 [10888879.001]
  • [Cites] Nat Genet. 2001 May;28(1):92-5 [11326284.001]
  • [Cites] Mol Cell Neurosci. 2001 May;17(5):908-20 [11358487.001]
  • [Cites] J Virol. 2002 Jan;76(2):791-801 [11752169.001]
  • [Cites] Nat Med. 2002 Mar;8(3):253-61 [11875496.001]
  • [Cites] J Virol. 2002 Aug;76(15):7651-60 [12097579.001]
  • [Cites] Circulation. 2003 Sep 30;108(13):1626-32 [12952841.001]
  • [Cites] J Virol. 2004 Jun;78(12):6381-8 [15163731.001]
  • [Cites] Arch Ophthalmol. 1986 Jul;104(7):1013-20 [3488053.001]
  • [Cites] Nat Biotechnol. 2009 Jan;27(1):59-65 [19098898.001]
  • [Cites] Nat Genet. 1993 May;4(1):82-6 [8513332.001]
  • (PMID = 19626133.001).
  • [ISSN] 1090-0535
  • [Journal-full-title] Molecular vision
  • [ISO-abbreviation] Mol. Vis.
  • [Language] ENG
  • [Grant] United States / NIAMS NIH HHS / AR / R01 AR049419; United States / NIAMS NIH HHS / AR / AR-49419
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Dystrophin; 0 / enhanced green fluorescent protein; 147336-22-9 / Green Fluorescent Proteins
  • [Other-IDs] NLM/ PMC2713732
  •  go-up   go-down


21. Van Hoeven NS, Miller AD: Use of different but overlapping determinants in a retrovirus receptor accounts for non-reciprocal interference between xenotropic and polytropic murine leukemia viruses. Retrovirology; 2005 Dec 15;2:76
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the case of avian sarcoma and leukosis virus types B, D, and E, the two receptors are distinct protein products of a single gene.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2001 Apr;75(8):3520-6 [11264341.001]
  • [Cites] J Virol. 2001 Jun;75(12):5584-92 [11356966.001]
  • [Cites] J Virol. 1999 Jan;73(1):495-500 [9847355.001]
  • [Cites] J Virol. 1998 Dec;72(12):10242-5 [9811768.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11617-22 [9326659.001]
  • [Cites] J Virol. 1997 Oct;71(10):7619-22 [9311843.001]
  • [Cites] J Virol. 1997 Jun;71(6):4531-5 [9151846.001]
  • [Cites] Cell. 1996 Nov 29;87(5):845-55 [8945512.001]
  • [Cites] J Virol. 1996 Aug;70(8):5564-71 [8764070.001]
  • [Cites] J Virol. 2005 Jan;79(1):87-94 [15596804.001]
  • [Cites] J Virol. 1999 Nov;73(11):9362-8 [10516044.001]
  • [Cites] Mol Membr Biol. 1999 Jan-Mar;16(1):3-9 [10332732.001]
  • [Cites] J Virol. 1999 Apr;73(4):3169-75 [10074169.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1385-90 [9990033.001]
  • [Cites] Nat Genet. 1999 Feb;21(2):216-9 [9988277.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):927-32 [9927670.001]
  • [Cites] J Virol. 2001 Jul;75(13):6007-15 [11390602.001]
  • [Cites] Nat Rev Mol Cell Biol. 2003 Apr;4(4):309-19 [12671653.001]
  • [Cites] J Mol Biol. 1967 Jun 14;26(2):365-9 [4291934.001]
  • [Cites] Science. 1970 Oct 16;170(3955):326-7 [4318971.001]
  • [Cites] Science. 1973 Dec 14;182(4117):1151-3 [4356281.001]
  • [Cites] Proc Natl Acad Sci U S A. 1977 Feb;74(2):789-92 [191826.001]
  • [Cites] J Virol. 1980 Jan;33(1):494-506 [6245246.001]
  • [Cites] J Virol. 1982 Jan;41(1):183-91 [6283112.001]
  • [Cites] J Virol. 1983 Oct;48(1):300-3 [6310150.001]
  • [Cites] Virology. 1985 Feb;141(1):119-29 [2983494.001]
  • [Cites] J Virol. 1985 Sep;55(3):690-5 [2991590.001]
  • [Cites] Mol Cell Biol. 1986 Aug;6(8):2895-902 [3785217.001]
  • [Cites] J Virol. 1990 Feb;64(2):757-66 [2153240.001]
  • [Cites] Biotechniques. 1989 Oct;7(9):980-2, 984-6, 989-90 [2631796.001]
  • [Cites] Virology. 1990 May;176(1):58-69 [1691887.001]
  • [Cites] J Virol. 1990 Dec;64(12):6176-83 [1700832.001]
  • [Cites] Cell Growth Differ. 1990 Mar;1(3):119-27 [2078500.001]
  • [Cites] J Virol. 1991 May;65(5):2220-4 [1850008.001]
  • [Cites] J Virol. 1992 Feb;66(2):1219-22 [1309898.001]
  • [Cites] J Virol. 1992 Mar;66(3):1468-75 [1310758.001]
  • [Cites] J Virol. 1993 Sep;67(9):5153-62 [8394443.001]
  • [Cites] J Virol. 1993 Nov;67(11):6733-6 [8411375.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):78-82 [8278411.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1168-72 [8302848.001]
  • [Cites] J Virol. 1994 Dec;68(12):8270-6 [7966619.001]
  • [Cites] J Virol. 1995 Apr;69(4):2401-5 [7884886.001]
  • [Cites] J Biol Chem. 1995 Oct 27;270(43):25435-44 [7592711.001]
  • [Cites] J Virol. 1995 Dec;69(12):7430-6 [7494248.001]
  • (PMID = 16354307.001).
  • [ISSN] 1742-4690
  • [Journal-full-title] Retrovirology
  • [ISO-abbreviation] Retrovirology
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / P30 DK047754; United States / NHLBI NIH HHS / HL / HL36444; United States / NHLBI NIH HHS / HL / P01 HL036444; United States / NHLBI NIH HHS / HL / HL54881; United States / NIDDK NIH HHS / DK / DK47754; United States / NHLBI NIH HHS / HL / P50 HL054881
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Gene Products, env; 0 / Receptors, G-Protein-Coupled; 0 / Receptors, Virus; 0 / Recombinant Fusion Proteins; 0 / xenotropic and polytropic retrovirus receptor
  • [Other-IDs] NLM/ PMC1325250
  •  go-up   go-down


22. Johnson MC, Spidel JL, Ako-Adjei D, Wills JW, Vogt VM: The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters Gag into unique nonendosomal structures. J Virol; 2005 Mar;79(6):3775-86
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters Gag into unique nonendosomal structures.
  • Rous sarcoma virus (RSV) and murine leukemia virus (MLV) Gag proteins are selectively recruited to these structures, but HIV type 1 Gag is completely excluded.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Biol Cell. 2000 Jan;11(1):227-39 [10637304.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol. 2000 Sep;74(18):8670-9 [10954568.001]
  • [Cites] J Virol. 2000 Nov;74(21):10260-8 [11024160.001]
  • [Cites] J Virol. 2000 Dec;74(23):11222-9 [11070020.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13057-62 [11087859.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13069-74 [11087861.001]
  • [Cites] Trends Cell Biol. 2000 Dec;10(12):524-30 [11121744.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7724-9 [11427703.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11199-204 [11562473.001]
  • [Cites] Cell. 2001 Oct 5;107(1):55-65 [11595185.001]
  • [Cites] J Cell Biol. 2002 Feb 4;156(3):511-8 [11827983.001]
  • [Cites] J Virol. 2002 Mar;76(6):2641-7 [11861830.001]
  • [Cites] J Virol. 2002 Mar;76(6):3038-44 [11861870.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3944-9 [11891341.001]
  • [Cites] J Virol. 2002 May;76(10):4679-87 [11967285.001]
  • [Cites] Nature. 2002 May 9;417(6885):177-82 [12000969.001]
  • [Cites] Methods Enzymol. 1998;298:570-92 [9751908.001]
  • [Cites] J Cell Biol. 1999 Sep 20;146(6):1239-54 [10491388.001]
  • [Cites] Traffic. 2002 Jun;3(6):388-96 [12010457.001]
  • [Cites] J Virol. 2002 Nov;76(22):11177-85 [12388677.001]
  • [Cites] Nat Rev Mol Cell Biol. 2002 Dec;3(12):893-905 [12461556.001]
  • [Cites] J Virol. 2003 Jun;77(11):6507-19 [12743307.001]
  • [Cites] Curr Opin Cell Biol. 2003 Aug;15(4):446-55 [12892785.001]
  • [Cites] J Virol. 2003 Sep;77(17):9173-82 [12915533.001]
  • [Cites] J Virol. 2003 Sep;77(17):9388-98 [12915554.001]
  • [Cites] Cell. 2003 Sep 19;114(6):689-99 [14505569.001]
  • [Cites] Cell. 2003 Sep 19;114(6):701-13 [14505570.001]
  • [Cites] J Cell Biol. 2003 Sep 29;162(7):1233-44 [14517204.001]
  • [Cites] Traffic. 2003 Nov;4(11):785-801 [14617360.001]
  • [Cites] J Virol. 2004 Jan;78(2):724-32 [14694104.001]
  • [Cites] J Cell Biol. 2004 Mar 1;164(5):667-75 [14981091.001]
  • [Cites] J Cell Sci. 2004 Mar 1;117(Pt 7):1033-45 [14970261.001]
  • [Cites] Mol Cell. 2004 Mar 26;13(6):783-9 [15053872.001]
  • [Cites] J Virol. 2004 Jun;78(12):6636-48 [15163754.001]
  • [Cites] J Virol. 2004 Oct;78(19):10606-16 [15367628.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jan;87(2):523-7 [2405382.001]
  • [Cites] J Virol. 1990 Sep;64(9):4169-79 [2166812.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9 [2014240.001]
  • [Cites] J Virol. 1994 Oct;68(10):6605-18 [8083996.001]
  • [Cites] J Virol. 1995 Nov;69(11):6810-8 [7474093.001]
  • [Cites] J Virol. 1996 Aug;70(8):5695-700 [8764091.001]
  • [Cites] J Virol. 1997 Sep;71(9):6541-6 [9261374.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] J Virol. 2000 Aug;74(16):7250-60 [10906179.001]
  • (PMID = 15731271.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA47482; United States / NCI NIH HHS / CA / R01 CA047482; United States / NCI NIH HHS / CA / R37 CA047482; United States / NCI NIH HHS / CA / R01 CA020081; United States / NCI NIH HHS / CA / CA20081
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / Endosomal Sorting Complexes Required for Transport; 0 / Gag protein p12, moloney murine leukemia virus; 0 / Gene Products, gag; 0 / Macromolecular Substances; 0 / Recombinant Fusion Proteins; 0 / Transcription Factors; 0 / Tsg101 protein; 0 / Ubiquitin; 0 / gag protein p19, Rous sarcoma virus; 147336-22-9 / Green Fluorescent Proteins
  • [Other-IDs] NLM/ PMC1075695
  •  go-up   go-down


23. Barnard RJ, Elleder D, Young JA: Avian sarcoma and leukosis virus-receptor interactions: from classical genetics to novel insights into virus-cell membrane fusion. Virology; 2006 Jan 5;344(1):25-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Avian sarcoma and leukosis virus-receptor interactions: from classical genetics to novel insights into virus-cell membrane fusion.
  • For over 40 years, avian sarcoma and leukosis virus (ASLV)-receptor interactions have been employed as a useful model system to study the mechanism of retroviral entry into cells.
  • [MeSH-major] Avian Leukosis Virus / metabolism. Receptors, Virus / metabolism. Sarcoma, Avian / virology. Viral Fusion Proteins / metabolism

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16364732.001).
  • [ISSN] 0042-6822
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptors, Virus; 0 / Viral Fusion Proteins; 0 / Viral Proteins
  • [Number-of-references] 32
  •  go-up   go-down


24. Ott DE, Coren LV, Gagliardi TD, Nagashima K: Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1. J Virol; 2005 Jul;79(14):9038-45
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • One exception was the 11-amino-acid p2b sequence of Rous sarcoma virus (RSV) Gag, which could fully restore HIV-1 budding, while a PPPPY sequence exchange alone did not.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13069-74 [11087861.001]
  • [Cites] J Biochem Biophys Methods. 1984 Dec;10(3-4):203-9 [6530509.001]
  • [Cites] J Virol. 2001 Oct;75(20):9762-70 [11559809.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11199-204 [11562473.001]
  • [Cites] Cell. 2001 Oct 5;107(1):55-65 [11595185.001]
  • [Cites] J Virol. 1987 Jan;61(1):209-13 [3640832.001]
  • [Cites] J Virol. 2000 Aug;74(16):7250-60 [10906179.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13057-62 [11087859.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13063-8 [11087860.001]
  • [Cites] J Virol. 1990 Jul;64(7):3207-11 [2191147.001]
  • [Cites] Biotechniques. 1990 May;8(5):528-35 [2357375.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9 [2014240.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 May 15;88(10):4528-32 [2034693.001]
  • [Cites] AIDS. 1991 Jun;5(6):617-37 [1652977.001]
  • [Cites] J Virol. 1994 Oct;68(10):6605-18 [8083996.001]
  • [Cites] J Virol. 1994 Oct;68(10):6782-6 [8084015.001]
  • [Cites] J Virol. 1995 Sep;69(9):5455-60 [7636991.001]
  • [Cites] J Virol. 1995 Nov;69(11):6810-8 [7474093.001]
  • [Cites] J Virol. 1996 Aug;70(8):5695-700 [8764091.001]
  • [Cites] J Virol. 1997 Sep;71(9):6541-6 [9261374.001]
  • [Cites] J Virol. 1998 May;72(5):4095-103 [9557699.001]
  • [Cites] J Virol. 1998 Dec;72(12):10218-21 [9811764.001]
  • [Cites] J Virol. 2004 Dec;78(24):13943-53 [15564502.001]
  • [Cites] Virus Res. 2004 Dec;106(2):87-102 [15567490.001]
  • [Cites] J Cell Biol. 2005 Jan 3;168(1):89-101 [15623582.001]
  • [Cites] J Virol. 2005 Apr;79(7):4055-65 [15767407.001]
  • [Cites] J Virol. 2001 Nov;75(22):10623-9 [11602704.001]
  • [Cites] Nat Med. 2001 Dec;7(12):1313-9 [11726971.001]
  • [Cites] J Virol. 2002 Jan;76(1):105-17 [11739676.001]
  • [Cites] J Virol. 2002 Feb;76(4):1569-77 [11799151.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):955-60 [11805336.001]
  • [Cites] J Virol. 2002 Mar;76(6):2641-7 [11861830.001]
  • [Cites] J Virol. 2002 Mar;76(6):2789-95 [11861846.001]
  • [Cites] J Virol. 2002 Mar;76(6):3038-44 [11861870.001]
  • [Cites] J Virol. 2002 May;76(10):4679-87 [11967285.001]
  • [Cites] J Virol. 2002 Jun;76(11):5472-9 [11991975.001]
  • [Cites] EMBO Rep. 2002 Jul;3(7):636-40 [12101095.001]
  • [Cites] J Virol. 2002 Oct;76(19):10024-9 [12208980.001]
  • [Cites] Traffic. 2002 Oct;3(10):718-29 [12230470.001]
  • [Cites] Trends Microbiol. 2003 Feb;11(2):56-9 [12598123.001]
  • [Cites] J Virol. 2003 Mar;77(6):3384-93 [12610113.001]
  • [Cites] J Virol. 2003 Apr;77(8):4794-804 [12663786.001]
  • [Cites] J Virol. 2003 Jun;77(11):6507-19 [12743307.001]
  • [Cites] J Virol. 2003 Aug;77(15):8440-7 [12857913.001]
  • [Cites] J Cell Biol. 2003 Aug 4;162(3):443-55 [12885763.001]
  • [Cites] J Cell Biol. 2003 Aug 4;162(3):425-34 [12900394.001]
  • [Cites] J Virol. 2003 Sep;77(17):9173-82 [12915533.001]
  • [Cites] J Virol. 2003 Sep;77(17):9474-85 [12915562.001]
  • [Cites] Cell. 2003 Sep 19;114(6):689-99 [14505569.001]
  • [Cites] Cell. 2003 Sep 19;114(6):701-13 [14505570.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12414-9 [14519844.001]
  • [Cites] J Virol. 2003 Nov;77(22):12373-7 [14581576.001]
  • [Cites] J Virol. 2004 Jan;78(2):724-32 [14694104.001]
  • [Cites] J Virol. 2004 Feb;78(3):1552-63 [14722309.001]
  • [Cites] J Gen Virol. 2004 Apr;85(Pt 4):921-7 [15039534.001]
  • [Cites] J Cell Sci. 2004 May 1;117(Pt 11):2357-67 [15126635.001]
  • [Cites] J Virol. 2004 Jun;78(11):5554-63 [15140952.001]
  • [Cites] J Virol. 2004 Jun;78(12):6636-48 [15163754.001]
  • [Cites] Annu Rev Cell Dev Biol. 2004;20:395-425 [15473846.001]
  • [Cites] Virology. 1973 Apr;52(2):456-67 [4705382.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7724-9 [11427703.001]
  • (PMID = 15994797.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / N01CO12400; United States / NCI NIH HHS / CO / N01-CO-12400
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cysteine Proteinase Inhibitors; 0 / Gene Products, gag; 0 / Proteasome Inhibitors
  • [Other-IDs] NLM/ PMC1168796
  •  go-up   go-down


25. Park SH, Kim JN, Park TS, Lee SD, Kim TH, Han BK, Han JY: CpG methylation modulates tissue-specific expression of a transgene in chickens. Theriogenology; 2010 Sep 15;74(5):805-16.e1
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The gPGC population was enriched (magnetic-activated cell sorting technique) and then they were transduced with a lentiviral vector expressing enhanced green fluorescent protein (eGFP), under the control of the Rous sarcoma virus (RSV) promoter.
  • In conclusion, the PGC-mediated approach used may be an efficient tool for avian transgenesis, and transgenic chickens could provide a useful model for investigating regulation of gene expression.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20570335.001).
  • [ISSN] 1879-3231
  • [Journal-full-title] Theriogenology
  • [ISO-abbreviation] Theriogenology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 147336-22-9 / Green Fluorescent Proteins
  •  go-up   go-down


26. Medina G, Zhang Y, Tang Y, Gottwein E, Vana ML, Bouamr F, Leis J, Carter CA: The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101. Traffic; 2005 Oct;6(10):880-94
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The functionally exchangeable L domains of HIV-1 and Rous sarcoma virus (RSV) Gag bind Tsg101 and Nedd4, respectively.

  • Genetic Alliance. consumer health - HIV.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Curr Opin Cell Biol. 2000 Aug;12(4):457-66 [10873832.001]
  • [Cites] J Membr Biol. 2000 Jul 1;176(1):1-17 [10882424.001]
  • [Cites] J Virol. 2000 Aug;74(16):7250-60 [10906179.001]
  • [Cites] J Virol. 2000 Sep;74(18):8670-9 [10954568.001]
  • [Cites] J Virol. 2000 Nov;74(21):9818-27 [11024108.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13069-74 [11087861.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13871-6 [11095724.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1619-24 [11172000.001]
  • [Cites] Traffic. 2000 Mar;1(3):248-58 [11208108.001]
  • [Cites] J Biol Chem. 2001 Apr 13;276(15):11735-42 [11134028.001]
  • [Cites] J Biol Chem. 2001 Mar 9;276(10):7069-78 [11110793.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7724-9 [11427703.001]
  • [Cites] Cell. 2001 Jul 27;106(2):145-55 [11511343.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11199-204 [11562473.001]
  • [Cites] Cell. 2001 Oct 5;107(1):55-65 [11595185.001]
  • [Cites] J Virol. 2002 Jan;76(1):105-17 [11739676.001]
  • [Cites] J Virol. 2002 Feb;76(4):1569-77 [11799151.001]
  • [Cites] Cell. 2002 Jan 25;108(2):261-9 [11832215.001]
  • [Cites] J Cell Biol. 2002 Apr 1;157(1):91-101 [11916981.001]
  • [Cites] Nat Cell Biol. 2002 May;4(5):394-8 [11988743.001]
  • [Cites] EMBO J. 2002 May 15;21(10):2397-406 [12006492.001]
  • [Cites] Dev Cell. 2002 Aug;3(2):271-82 [12194857.001]
  • [Cites] Dev Cell. 2002 Aug;3(2):283-9 [12194858.001]
  • [Cites] Traffic. 2002 Oct;3(10):740-51 [12230472.001]
  • [Cites] J Virol. 2002 Nov;76(22):11226-35 [12388682.001]
  • [Cites] J Cell Sci. 2003 Jan 15;116(Pt 2):401-14 [12482925.001]
  • [Cites] Trends Cell Biol. 2002 Dec;12(12):569-79 [12495845.001]
  • [Cites] J Virol. 2003 Feb;77(3):1812-9 [12525615.001]
  • [Cites] Science. 2003 Apr 11;300(5617):342-4 [12690203.001]
  • [Cites] J Virol. 2003 Jun;77(11):6507-19 [12743307.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7626-31 [12802020.001]
  • [Cites] J Virol. 2003 Aug;77(15):8440-7 [12857913.001]
  • [Cites] J Cell Biol. 2003 Aug 4;162(3):443-55 [12885763.001]
  • [Cites] J Cell Biol. 2003 Aug 4;162(3):413-23 [12900393.001]
  • [Cites] J Cell Biol. 2003 Aug 4;162(3):425-34 [12900394.001]
  • [Cites] J Cell Biol. 2003 Aug 4;162(3):435-42 [12900395.001]
  • [Cites] J Virol. 2003 Sep;77(17):9173-82 [12915533.001]
  • [Cites] J Virol. 2003 Sep;77(17):9474-85 [12915562.001]
  • [Cites] Cell. 2003 Sep 19;114(6):689-99 [14505569.001]
  • [Cites] Cell. 2003 Sep 19;114(6):701-13 [14505570.001]
  • [Cites] J Biol Chem. 2003 Oct 3;278(40):39104-13 [12860994.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12414-9 [14519844.001]
  • [Cites] J Virol. 2003 Nov;77(22):11882-95 [14581525.001]
  • [Cites] J Virol. 2003 Nov;77(22):12373-7 [14581576.001]
  • [Cites] Traffic. 2003 Nov;4(11):785-801 [14617360.001]
  • [Cites] Traffic. 2003 Dec;4(12):902-10 [14617353.001]
  • [Cites] J Virol. 2004 Jan;78(2):724-32 [14694104.001]
  • [Cites] J Virol. 2004 Feb;78(3):1503-12 [14722305.001]
  • [Cites] J Virol. 2004 Feb;78(3):1552-63 [14722309.001]
  • [Cites] Genes Dev. 2004 Jul 15;18(14):1737-52 [15256501.001]
  • [Cites] Prog Neurobiol. 2004 Aug;73(5):311-57 [15312912.001]
  • [Cites] Annu Rev Cell Dev Biol. 2004;20:395-425 [15473846.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9 [2014240.001]
  • [Cites] J Virol. 1994 Oct;68(10):6605-18 [8083996.001]
  • [Cites] Curr Biol. 1995 Apr 1;5(4):364-7 [7542990.001]
  • [Cites] J Virol. 1995 Sep;69(9):5455-60 [7636991.001]
  • [Cites] J Virol. 1995 Nov;69(11):6810-8 [7474093.001]
  • [Cites] Nature. 1996 Jun 27;381(6585):744-5 [8657277.001]
  • [Cites] J Virol. 1996 Aug;70(8):5695-700 [8764091.001]
  • [Cites] Am J Physiol. 1997 Jun;272(6 Pt 1):C1871-80 [9227416.001]
  • [Cites] Nat Genet. 1997 Aug;16(4):330-1 [9241264.001]
  • [Cites] J Mol Med (Berl). 1997 Jul;75(7):467-9 [9253709.001]
  • [Cites] J Biol Chem. 1997 Aug 15;272(33):20538-44 [9252367.001]
  • [Cites] J Virol. 1997 Sep;71(9):6541-6 [9261374.001]
  • [Cites] J Virol. 1998 May;72(5):4095-103 [9557699.001]
  • [Cites] J Virol. 1999 Apr;73(4):2921-9 [10074141.001]
  • [Cites] J Virol. 1999 Apr;73(4):3359-65 [10074190.001]
  • [Cites] Cancer. 1999 Aug 15;86(4):689-96 [10440698.001]
  • [Cites] EMBO J. 1999 Sep 1;18(17):4700-10 [10469649.001]
  • [Cites] J Virol. 2004 Dec;78(24):13943-53 [15564502.001]
  • [Cites] Virus Res. 2004 Dec;106(2):87-102 [15567490.001]
  • [Cites] J Biol Chem. 2005 Jan 7;280(1):628-36 [15509564.001]
  • [Cites] J Cell Biol. 2005 Jan 3;168(1):89-101 [15623582.001]
  • [Cites] J Virol. 2005 Mar;79(6):3775-86 [15731271.001]
  • [Cites] Virology. 2000 Mar 1;268(1):178-91 [10683340.001]
  • (PMID = 16138902.001).
  • [ISSN] 1398-9219
  • [Journal-full-title] Traffic (Copenhagen, Denmark)
  • [ISO-abbreviation] Traffic
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / R01 GM048294; United States / NCI NIH HHS / CA / R01 CA052047; United States / NCI NIH HHS / CA / R01 CA052047-13; United States / NCI NIH HHS / CA / CA 52047; United States / NCI NIH HHS / CA / CA052047-13; United States / NIGMS NIH HHS / GM / GM 48294
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / Endosomal Sorting Complexes Required for Transport; 0 / Gene Products, gag; 0 / Hemagglutinins; 0 / Peptide Fragments; 0 / Recombinant Fusion Proteins; 0 / Repressor Proteins; 0 / Transcription Factors; 0 / Tsg101 protein; 0 / Vesicular Transport Proteins; EC 3.6.1.- / Adenosine Triphosphatases; EC 3.6.1.- / VPS4A protein, human; EC 3.6.1.- / Vacuolar Proton-Translocating ATPases; EC 6.3.2.19 / Nedd4 ubiquitin protein ligases; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  • [Other-IDs] NLM/ NIHMS92022; NLM/ PMC2692930
  •  go-up   go-down


27. Côté M, Zheng YM, Liu SL: Receptor binding and low pH coactivate oncogenic retrovirus envelope-mediated fusion. J Virol; 2009 Nov;83(22):11447-55
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Fusion of enveloped viruses with host cells is triggered by either receptor binding or low pH but rarely requires both except for avian sarcoma leukosis virus (ASLV).

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Jul;74(14):6469-75 [10864659.001]
  • [Cites] J Virol. 2008 Sep;82(18):9023-34 [18632865.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4443-8 [11296287.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4449-54 [11296288.001]
  • [Cites] Annu Rev Biochem. 2001;70:777-810 [11395423.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12386-90 [12218182.001]
  • [Cites] J Virol. 2003 Mar;77(5):2850-8 [12584308.001]
  • [Cites] Curr Top Microbiol Immunol. 2003;275:139-77 [12596898.001]
  • [Cites] J Virol. 2003 Apr;77(8):4722-30 [12663779.001]
  • [Cites] J Virol. 2003 Jul;77(14):7924-35 [12829832.001]
  • [Cites] J Virol. 2004 Feb;78(3):1403-10 [14722295.001]
  • [Cites] EMBO J. 2004 Jan 14;23(1):54-65 [14685283.001]
  • [Cites] J Virol. 2004 Aug;78(15):8201-9 [15254191.001]
  • [Cites] Virology. 1986 Dec;155(2):484-97 [3788061.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14306-13 [9405608.001]
  • [Cites] J Virol. 2004 Dec;78(24):13430-9 [15564453.001]
  • [Cites] J Virol. 2005 Jan;79(1):79-86 [15596803.001]
  • [Cites] Nature. 2005 Apr 14;434(7035):904-7 [15829964.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8728-33 [15937118.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11876-81 [16081529.001]
  • [Cites] J Virol. 2005 Oct;79(20):12714-20 [16188974.001]
  • [Cites] J Virol. 2005 Dec;79(23):14482-8 [16282447.001]
  • [Cites] J Virol. 2005 Dec;79(23):14489-97 [16282448.001]
  • [Cites] Nat Rev Microbiol. 2006 Jan;4(1):67-76 [16357862.001]
  • [Cites] Virology. 2006 Jan 5;344(1):38-47 [16364734.001]
  • [Cites] J Biol Chem. 2006 Feb 10;281(6):3198-203 [16339146.001]
  • [Cites] Virology. 2006 Mar 15;346(2):251-7 [16460775.001]
  • [Cites] J Virol. 2006 Apr;80(8):4174-8 [16571833.001]
  • [Cites] Science. 2006 Jul 14;313(5784):187-91 [16840692.001]
  • [Cites] Science. 2006 Jul 14;313(5784):217-20 [16840698.001]
  • [Cites] J Virol. 2006 Aug;80(16):8030-7 [16873259.001]
  • [Cites] Retrovirology. 2006;3:94 [17177996.001]
  • [Cites] J Virol. 2007 Apr;81(7):3124-9 [17229709.001]
  • [Cites] Virus Genes. 2007 Aug;35(1):73-80 [17043760.001]
  • [Cites] J Virol. 2007 Jul;81(14):7702-9 [17475648.001]
  • [Cites] J Virol. 2007 Oct;81(19):10506-14 [17634228.001]
  • [Cites] PLoS Pathog. 2007 Dec 21;3(12):e198 [18260686.001]
  • [Cites] J Virol. 2008 Mar;82(5):2555-9 [18094164.001]
  • [Cites] J Virol. 2008 Mar;82(5):2543-54 [18094165.001]
  • [Cites] J Virol. 2008 Mar;82(5):2358-66 [18094169.001]
  • [Cites] Crit Rev Biochem Mol Biol. 2008 May-Jun;43(3):189-219 [18568847.001]
  • [Cites] Cell. 2000 Nov 10;103(4):679-89 [11106737.001]
  • (PMID = 19726505.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] Canada / Canadian Institutes of Health Research / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Receptors, Virus; 0 / Viral Fusion Proteins
  • [Other-IDs] NLM/ PMC2772678
  •  go-up   go-down


28. Pincetic A, Medina G, Carter C, Leis J: Avian sarcoma virus and human immunodeficiency virus, type 1 use different subsets of ESCRT proteins to facilitate the budding process. J Biol Chem; 2008 Oct 31;283(44):29822-30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Avian sarcoma virus and human immunodeficiency virus, type 1 use different subsets of ESCRT proteins to facilitate the budding process.
  • Members of the Nedd4 family of E3 ubiquitin ligases bind the L domain in avian sarcoma virus (ASV) Gag and facilitate viral particle release.

  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 2004 Aug 20;279(34):36059-71 [15218037.001]
  • [Cites] J Virol. 2004 Jun;78(11):5554-63 [15140952.001]
  • [Cites] Virology. 1990 Jun;176(2):633-7 [2161153.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3195-9 [2014240.001]
  • [Cites] J Virol. 1994 Oct;68(10):6605-18 [8083996.001]
  • [Cites] J Virol. 1995 Sep;69(9):5455-60 [7636991.001]
  • [Cites] J Virol. 1996 Aug;70(8):5695-700 [8764091.001]
  • [Cites] J Virol. 1998 Apr;72(4):2962-8 [9525617.001]
  • [Cites] J Virol. 2004 Dec;78(24):13943-53 [15564502.001]
  • [Cites] Traffic. 2005 Jan;6(1):2-9 [15569240.001]
  • [Cites] J Biol Chem. 2005 Jan 7;280(1):628-36 [15509564.001]
  • [Cites] J Cell Biol. 2005 Jan 3;168(1):89-101 [15623582.001]
  • [Cites] Traffic. 2005 Oct;6(10):880-94 [16138902.001]
  • [Cites] Curr Biol. 2006 Jan 24;16(2):160-5 [16431367.001]
  • [Cites] J Biol Chem. 2006 Feb 24;281(8):5094-105 [16371348.001]
  • [Cites] J Cell Biol. 2006 Mar 13;172(6):923-35 [16533950.001]
  • [Cites] Traffic. 2006 Jun;7(6):731-45 [16683918.001]
  • [Cites] Annu Rev Biophys Biomol Struct. 2006;35:277-98 [16689637.001]
  • [Cites] J Virol. 2006 Jul;80(13):6267-75 [16775314.001]
  • [Cites] Curr Opin Cell Biol. 2006 Aug;18(4):422-8 [16781134.001]
  • [Cites] J Biol Chem. 2006 Aug 11;281(32):23083-91 [16760479.001]
  • [Cites] J Virol. 2006 Oct;80(19):9465-80 [16973552.001]
  • [Cites] Cell Struct Funct. 2007;31(2):159-72 [17159328.001]
  • [Cites] Traffic. 2007 Aug;8(8):1068-79 [17547705.001]
  • [Cites] Mol Biol Cell. 2008 Feb;19(2):754-63 [18077552.001]
  • [Cites] J Virol. 2008 May;82(10):4884-97 [18321968.001]
  • [Cites] J Virol. 2008 May;82(10):4898-907 [18321969.001]
  • [Cites] Virology. 2008 Jul 20;377(1):30-8 [18555885.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13057-62 [11087859.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13069-74 [11087861.001]
  • [Cites] Virology. 2000 Dec 5;278(1):111-21 [11112487.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7724-9 [11427703.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11199-204 [11562473.001]
  • [Cites] Cell. 2001 Oct 5;107(1):55-65 [11595185.001]
  • [Cites] J Virol. 2003 Apr;77(8):4794-804 [12663786.001]
  • [Cites] Curr Opin Cell Biol. 2003 Aug;15(4):446-55 [12892785.001]
  • [Cites] J Cell Biol. 2003 Aug 4;162(3):425-34 [12900394.001]
  • [Cites] J Virol. 2003 Sep;77(17):9173-82 [12915533.001]
  • [Cites] Cell. 2003 Sep 19;114(6):689-99 [14505569.001]
  • [Cites] Cell. 2003 Sep 19;114(6):701-13 [14505570.001]
  • [Cites] J Virol. 2004 Jan;78(2):724-32 [14694104.001]
  • [Cites] Cell Struct Funct. 2003 Oct;28(5):443-53 [14745136.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 Apr;5(4):317-23 [15071556.001]
  • [Cites] J Virol. 2004 Oct;78(19):10606-16 [15367628.001]
  • (PMID = 18723511.001).
  • [ISSN] 0021-9258
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / AI68463; United States / NIAID NIH HHS / AI / R01 AI068463; United States / NCI NIH HHS / CA / 5T32 CA-09176; United States / NIAID NIH HHS / AI / R01 AI068463-04; United States / NIAID NIH HHS / AI / AI054143; United States / NIAID NIH HHS / AI / T32 AI060523; United States / NIAID NIH HHS / AI / R56 AI054143
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag; 0 / Recombinant Fusion Proteins; 0 / Ubiquitin; 0 / Vesicular Transport Proteins
  • [Other-IDs] NLM/ PMC2573067
  •  go-up   go-down


29. Krishnan L, Matreyek KA, Oztop I, Lee K, Tipper CH, Li X, Dar MJ, Kewalramani VN, Engelman A: The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J Virol; 2010 Jan;84(1):397-406
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we correlate infectivity defects in transportin 3 knockdown cells with in vitro protein binding affinities for an expanded set of retroviruses that include simian immunodeficiency virus (SIV), bovine immunodeficiency virus (BIV), equine infectious anemia virus (EIAV), feline immunodeficiency virus (FIV), and Rous sarcoma virus (RSV) to critically address the role of integrase-transportin 3 interactions in viral infection.

  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gene Ther. 1998 Nov;5(11):1481-7 [9930301.001]
  • [Cites] J Biol Chem. 1993 Jan 15;268(2):1462-9 [8419346.001]
  • [Cites] J Virol. 1999 Apr;73(4):2886-92 [10074136.001]
  • [Cites] J Virol. 1992 Nov;66(11):6361-9 [1404595.001]
  • [Cites] Retrovirology. 2009;6:11 [19193229.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3428-32 [8386373.001]
  • [Cites] EMBO J. 1993 May;12(5):2099-108 [8491198.001]
  • [Cites] J Virol. 1994 Jan;68(1):510-6 [8254763.001]
  • [Cites] J Virol. 1996 Jan;70(1):651-7 [8523588.001]
  • [Cites] Science. 1996 Apr 12;272(5259):263-7 [8602510.001]
  • [Cites] Protein Expr Purif. 1996 Nov;8(3):299-304 [8936591.001]
  • [Cites] Nature. 1997 Feb 13;385(6617):645-9 [9024664.001]
  • [Cites] Virology. 1997 Mar 31;230(1):1-10 [9126257.001]
  • [Cites] J Virol. 1997 Jul;71(7):5382-90 [9188609.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9825-30 [9275210.001]
  • [Cites] Annu Rev Biochem. 1998;67:265-306 [9759490.001]
  • [Cites] J Cell Biol. 1999 Jun 14;145(6):1145-52 [10366588.001]
  • [Cites] J Virol. 2009 Jul;83(13):6522-33 [19369352.001]
  • [Cites] PLoS Pathog. 2007 Oct 26;3(10):1502-10 [17967060.001]
  • [Cites] J Virol. 2001 Apr;75(7):3371-82 [11238863.001]
  • [Cites] J Virol. 2001 Apr;75(8):3626-35 [11264352.001]
  • [Cites] J Virol. 2002 Feb;76(3):1510-5 [11773424.001]
  • [Cites] Methods Mol Biol. 2003;229:251-71 [12824636.001]
  • [Cites] EMBO J. 2003 Jul 15;22(14):3675-85 [12853482.001]
  • [Cites] J Virol. 2004 Jun;78(11):5670-8 [15140964.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11827-32 [15280539.001]
  • [Cites] J Virol. 1982 Apr;42(1):346-51 [6283156.001]
  • [Cites] Genes Dev. 1989 Apr;3(4):469-78 [2721960.001]
  • [Cites] Mol Cell Biol. 1990 Aug;10(8):4239-42 [2370865.001]
  • [Cites] J Exp Med. 1991 Dec 1;174(6):1477-82 [1720811.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6580-4 [1631159.001]
  • [Cites] EMBO J. 1992 Aug;11(8):3053-8 [1322294.001]
  • [Cites] J Virol. 1999 Nov;73(11):8919-25 [10515996.001]
  • [Cites] Dev Biol. 1999 Oct 15;214(2):370-84 [10525341.001]
  • [Cites] J Biol Chem. 2004 Nov 19;279(47):48883-92 [15371438.001]
  • [Cites] J Biol Chem. 2005 May 6;280(18):17841-7 [15749713.001]
  • [Cites] Virology. 2006 Jan 5;344(1):88-93 [16364740.001]
  • [Cites] Virology. 2006 Mar 15;346(2):415-26 [16337983.001]
  • [Cites] PLoS Pathog. 2005 Nov;1(3):e18 [16292356.001]
  • [Cites] Biochem J. 2006 Sep 15;398(3):475-84 [16716146.001]
  • [Cites] Retrovirology. 2006;3:74 [17067381.001]
  • [Cites] J Virol. 2007 Jan;81(1):166-72 [17035312.001]
  • [Cites] Nucleic Acids Res. 2007;35(1):113-24 [17158150.001]
  • [Cites] Bioessays. 2007 May;29(5):441-51 [17450594.001]
  • [Cites] J Biol Chem. 2007 May 4;282(18):13456-67 [17360709.001]
  • [Cites] Virology. 2007 Jul 5;363(2):245-55 [17343889.001]
  • [Cites] Mol Ther. 2008 Jan;16(1):97-106 [17912236.001]
  • [Cites] Science. 2008 Feb 15;319(5865):921-6 [18187620.001]
  • [Cites] PLoS Pathog. 2008 Mar;4(3):e1000046 [18369482.001]
  • [Cites] Cell Mol Life Sci. 2008 May;65(9):1403-24 [18264802.001]
  • [Cites] Curr Biol. 2008 Aug 26;18(16):1192-202 [18722123.001]
  • [Cites] Cell. 2008 Oct 3;135(1):49-60 [18854154.001]
  • [Cites] AIDS Res Hum Retroviruses. 1999 Jan 1;15(1):11-21 [10024048.001]
  • (PMID = 19846519.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / P30 AI060354; United States / NIAID NIH HHS / AI / R01 AI052014; United States / NIAID NIH HHS / AI / AI052014; United States / NIAID NIH HHS / AI / P30AI060354
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Human Immunodeficiency Virus Proteins; 0 / Karyopherins; 0 / TNPO3 protein, human; 0 / beta Karyopherins; EC 2.7.7.- / Integrases
  • [Other-IDs] NLM/ PMC2798409
  •  go-up   go-down


31. Amin DN, Tuck D, Stern DF: Neuregulin-regulated gene expression in mammary carcinoma cells. Exp Cell Res; 2005 Sep 10;309(1):12-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recent studies have suggested that autocrine production of Neuregulin (NRG), a growth factor that activates members of the Epidermal Growth Factor Receptor/ErbB family of proto-oncogenes, is sufficient for breast tumor initiation and progression.
  • The NRG targets are FBJ murine osteosarcoma viral oncogene homolog B, Early growth response 1, v-jun avian sarcoma virus 17 oncogene homolog, Activating transcription factor 3, Homo sapiens cDNA FLJ31636 fis, Jun B proto-oncogene, Forkhead box C1, Platelet/endothelial cell adhesion molecule 1, NADPH-dependent retinol dehydrogenase/reductase, Dual specificity phosphatase 5, NGF inducible protein TIS21, Connective tissue growth factor, Jun D proto-oncogene, Serum response factor, Cullin 1, v-myc avian myelocytomatosis viral oncogene, Transient receptor potential channel 1, Low density lipoprotein receptor, Transforming growth factor beta 1, Nucleoporin 88 kDa, and Pleckstrin homology-like domain A1.
  • Since NRG activation of these cells induces resistance to anti-hormonal therapy, the identified genes may provide clues to molecular events regulating mammary tumor progression and hormone independence.
  • [MeSH-minor] Cell Line, Tumor. DNA, Complementary / genetics. Female. Humans. Neoplasm Proteins / genetics. Neuregulin-1. Oligonucleotide Array Sequence Analysis


32. Greger JG, Katz RA, Ishov AM, Maul GG, Skalka AM: The cellular protein daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription. J Virol; 2005 Apr;79(8):4610-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The cellular protein daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription.
  • The cellular protein Daxx was identified as an interactor with avian sarcoma virus (ASV) integrase (IN) in a yeast two-hybrid screen.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] EMBO J. 1999 Nov 1;18(21):6037-49 [10545115.001]
  • [Cites] J Cell Biol. 1999 Oct 18;147(2):221-34 [10525530.001]
  • [Cites] J Virol. 2000 Nov;74(21):9994-10005 [11024128.001]
  • [Cites] J Virol. 2001 Feb;75(4):1909-17 [11160690.001]
  • [Cites] Mol Cell Biol. 2001 Feb;21(4):1164-72 [11158303.001]
  • [Cites] Oncogene. 2001 Jan 4;20(1):1-9 [11244500.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3364-8 [11248084.001]
  • [Cites] J Virol. 2001 Jul;75(13):6204-8 [11390623.001]
  • [Cites] Mol Cell. 2001 Jun;7(6):1245-54 [11430827.001]
  • [Cites] EMBO J. 2001 Jul 2;20(13):3495-505 [11432836.001]
  • [Cites] Nat Med. 2001 Aug;7(8):920-6 [11479624.001]
  • [Cites] J Virol. 2002 Jun;76(11):5422-34 [11991971.001]
  • [Cites] Virology. 2002 Mar 30;295(1):97-107 [12033769.001]
  • [Cites] J Virol. 2002 Aug;76(15):7705-12 [12097584.001]
  • [Cites] J Cell Sci. 2002 Aug 15;115(Pt 16):3319-30 [12140263.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Jul 12;295(2):495-500 [12150977.001]
  • [Cites] Nature. 2002 Aug 8;418(6898):646-50 [12167863.001]
  • [Cites] J Virol. 2002 Oct;76(19):9744-55 [12208953.001]
  • [Cites] Oncogene. 2002 Oct 17;21(47):7241-6 [12370815.001]
  • [Cites] J Virol. 2003 Jan;77(2):1357-67 [12502852.001]
  • [Cites] J Biol Chem. 2003 Jan 3;278(1):372-81 [12407101.001]
  • [Cites] J Virol. 2003 Mar;77(5):3167-80 [12584341.001]
  • [Cites] Biochem J. 2003 Mar 15;370(Pt 3):737-49 [12429021.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4778-83 [12679521.001]
  • [Cites] EMBO J. 2003 Jul 15;22(14):3675-85 [12853482.001]
  • [Cites] Cell. 2003 Aug 8;114(3):281-3 [12914693.001]
  • [Cites] Virology. 2003 Sep 15;314(1):161-7 [14517069.001]
  • [Cites] J Virol. 2003 Nov;77(21):11809-21 [14557665.001]
  • [Cites] J Virol. 2003 Dec;77(23):12671-8 [14610189.001]
  • [Cites] Nature. 2004 Feb 26;427(6977):848-53 [14985764.001]
  • [Cites] J Cell Sci. 2004 Aug 1;117(Pt 17):3807-20 [15252119.001]
  • [Cites] J Biol Chem. 2004 Oct 29;279(44):45810-4 [15308627.001]
  • [Cites] Science. 1994 Dec 23;266(5193):2002-6 [7801128.001]
  • [Cites] J Virol. 1995 Sep;69(9):5631-9 [7637009.001]
  • [Cites] Cell. 1997 Feb 21;88(4):483-92 [9038339.001]
  • [Cites] Methods Mol Biol. 1997;63:197-218 [9113651.001]
  • [Cites] Cell. 1997 Jun 27;89(7):1067-76 [9215629.001]
  • [Cites] J Virol. 1997 Dec;71(12):9375-82 [9371597.001]
  • [Cites] J Virol. 1998 Feb;72(2):1043-51 [9444998.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1528-33 [9465049.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] Annu Rev Biochem. 1998;67:227-64 [9759489.001]
  • [Cites] Mediators Inflamm. 1998;7(5):319-25 [9883966.001]
  • [Cites] Science. 1999 Apr 23;284(5414):644-7 [10213687.001]
  • [Cites] Virology. 1999 Jun 5;258(2):435-40 [10366581.001]
  • [Cites] EMBO J. 1999 Jul 1;18(13):3702-11 [10393185.001]
  • [Cites] Stem Cells. 2000;18(5):352-9 [11007919.001]
  • (PMID = 15795247.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA071515; United States / NCI NIH HHS / CA / CA06927; United States / NCI NIH HHS / CA / CA71515; United States / NIAID NIH HHS / AI / AI40385; United States / NIAID NIH HHS / AI / R01 AI040385; United States / NCI NIH HHS / CA / P30 CA006927
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adaptor Proteins, Signal Transducing; 0 / Carrier Proteins; 0 / DAXX protein, human; 0 / DNA Primers; 0 / DNA, Viral; 0 / Histone Deacetylase Inhibitors; 0 / Intracellular Signaling Peptides and Proteins; 0 / Nuclear Proteins; EC 2.7.7.- / Integrases
  • [Other-IDs] NLM/ PMC1069566
  •  go-up   go-down


33. Stewart-Maynard KM, Cruceanu M, Wang F, Vo MN, Gorelick RJ, Williams MC, Rouzina I, Musier-Forsyth K: Retroviral nucleocapsid proteins display nonequivalent levels of nucleic acid chaperone activity. J Virol; 2008 Oct;82(20):10129-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this work, complementary experimental approaches were used to characterize and compare the chaperone activities of NC proteins from four different retroviruses: HIV-1, Moloney murine leukemia virus (MLV), Rous sarcoma virus (RSV), and human T-cell lymphotropic virus type 1 (HTLV-1).

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Mol Biol. 2003 Feb 21;326(3):691-700 [12581633.001]
  • [Cites] J Mol Biol. 2003 Mar 28;327(3):571-8 [12634053.001]
  • [Cites] J Mol Biol. 2003 Apr 18;328(1):95-108 [12684000.001]
  • [Cites] Nucleic Acids Res. 2003 Jul 1;31(13):3406-15 [12824337.001]
  • [Cites] J Mol Biol. 2004 Mar 19;337(2):427-42 [15003457.001]
  • [Cites] J Mol Biol. 2004 Apr 2;337(4):951-68 [15033363.001]
  • [Cites] J Mol Biol. 2004 Feb 27;336(4):851-70 [15095865.001]
  • [Cites] J Mol Biol. 2004 May 7;338(4):711-23 [15099739.001]
  • [Cites] Annu Rev Biophys Biomol Struct. 2004;33:415-40 [15139820.001]
  • [Cites] J Mol Biol. 2004 Jul 30;341(1):27-36 [15312760.001]
  • [Cites] Q Rev Biophys. 1978 May;11(2):179-246 [353876.001]
  • [Cites] J Biol Chem. 1981 Aug 25;256(16):8400-6 [6267042.001]
  • [Cites] Science. 1986 Apr 25;232(4749):485-7 [2421409.001]
  • [Cites] J Biol Chem. 1987 Apr 15;262(11):4961-7 [2435721.001]
  • [Cites] J Virol. 1987 Oct;61(10):3004-12 [3041020.001]
  • [Cites] EMBO J. 1988 Jun;7(6):1777-83 [2458920.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Aug;87(16):6403-7 [2385599.001]
  • [Cites] J Mol Biol. 1990 Dec 5;216(3):689-99 [2124274.001]
  • [Cites] Nucleic Acids Res. 1991 Jul 11;19(13):3533-41 [1906602.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6472-6 [1631144.001]
  • [Cites] Protein Sci. 1993 Jan;2(1):3-19 [8443588.001]
  • [Cites] Protein Sci. 1993 Feb;2(2):231-43 [8443601.001]
  • [Cites] J Biol Chem. 1993 Aug 5;268(22):16519-27 [8344933.001]
  • [Cites] Annu Rev Biochem. 1993;62:255-87 [7688943.001]
  • [Cites] J Virol. 1994 Aug;68(8):5013-8 [8035501.001]
  • [Cites] J Virol. 1994 Sep;68(9):5863-70 [8057466.001]
  • [Cites] J Biol Chem. 1994 Sep 9;269(36):22538-46 [8077202.001]
  • [Cites] J Virol. 1995 Mar;69(3):1907-12 [7853532.001]
  • [Cites] Biopolymers. 1995 Sep;36(3):345-64 [7669919.001]
  • [Cites] J Biol Chem. 1995 Sep 8;270(36):20871-4 [7545662.001]
  • [Cites] J Mol Biol. 1995 Dec 8;254(4):523-37 [7500330.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7577-81 [8755517.001]
  • [Cites] J Virol. 1996 Aug;70(8):4996-5004 [8764006.001]
  • [Cites] Mol Endocrinol. 1996 Jun;10(6):607-12 [8776720.001]
  • [Cites] Curr Top Microbiol Immunol. 1996;214:177-218 [8791728.001]
  • [Cites] Nucleic Acids Res. 1997 Mar 1;25(5):1042-9 [9023116.001]
  • [Cites] Biopolymers. 1997 Mar;41(3):301-12 [9057495.001]
  • [Cites] J Mol Biol. 1997 May 2;268(2):250-60 [9159468.001]
  • [Cites] J Virol. 1997 Jul;71(7):5178-88 [9188585.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13530-5 [9391060.001]
  • [Cites] Science. 1998 Jan 16;279(5349):384-8 [9430589.001]
  • [Cites] Biopolymers. 1998 Mar;45(3):217-29 [9465785.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):459-64 [9892655.001]
  • [Cites] J Mol Biol. 1999 Mar 19;287(1):59-75 [10074407.001]
  • [Cites] Biochemistry. 1999 Mar 23;38(12):3821-30 [10090772.001]
  • [Cites] J Virol. 1999 May;73(5):4251-6 [10196321.001]
  • [Cites] J Virol. 1999 Aug;73(8):6670-9 [10400764.001]
  • [Cites] Nature. 2004 Sep 30;431(7008):586-90 [15457265.001]
  • [Cites] J Biol Chem. 2004 Oct 15;279(42):44154-65 [15271979.001]
  • [Cites] J Mol Biol. 1968 Feb 14;31(3):349-70 [5637197.001]
  • [Cites] Biopolymers. 1976 Jul;15(7):1345-75 [949539.001]
  • [Cites] J Mol Biol. 1976 Oct 25;107(2):145-58 [1003464.001]
  • [Cites] J Virol. 1998 Mar;72(3):1902-9 [9499042.001]
  • [Cites] J Mol Biol. 1998 Mar 27;277(2):225-35 [9514748.001]
  • [Cites] J Biol Chem. 1998 May 8;273(19):11463-71 [9565558.001]
  • [Cites] Biopolymers. 1997;44(3):269-82 [9591479.001]
  • [Cites] Trends Biochem Sci. 1998 Aug;23(8):297-301 [9757830.001]
  • [Cites] Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W577-81 [15980540.001]
  • [Cites] Nucleic Acids Res. 2005;33(14):4395-403 [16077025.001]
  • [Cites] Biophys J. 2005 Sep;89(3):1941-56 [15994897.001]
  • [Cites] Prog Nucleic Acid Res Mol Biol. 2005;80:217-86 [16164976.001]
  • [Cites] Phys Rev Lett. 2005 Oct 7;95(15):158102 [16241765.001]
  • [Cites] Biophys J. 2005 Nov;89(5):3470-9 [16100256.001]
  • [Cites] Nucleic Acids Res. 2006;34(2):472-84 [16434700.001]
  • [Cites] Nucleic Acids Res. 2006;34(2):593-605 [16449201.001]
  • [Cites] J Mol Biol. 2006 Oct 13;363(1):244-61 [16962137.001]
  • [Cites] Biochemistry. 2006 Oct 17;45(41):12617-28 [17029416.001]
  • [Cites] Anal Biochem. 2006 Nov 15;358(2):159-70 [17034752.001]
  • [Cites] J Mol Biol. 2006 Nov 10;363(5):867-77 [16997322.001]
  • [Cites] J Mol Biol. 2006 Dec 1;364(3):496-511 [17020765.001]
  • [Cites] J Biol Chem. 2006 Dec 15;281(50):38689-96 [17050544.001]
  • [Cites] J Mol Biol. 2007 Jan 12;365(2):453-67 [17070546.001]
  • [Cites] Biopolymers. 2007 Feb 5;85(2):154-68 [17080421.001]
  • [Cites] PLoS One. 2007;2(7):e669 [17712401.001]
  • [Cites] Biochemistry. 2007 Dec 18;46(50):14650-62 [18027912.001]
  • [Cites] J Mol Biol. 2002 May 3;318(3):749-64 [12054820.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Jun 28;294(5):949-55 [12074568.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8614-9 [12084921.001]
  • [Cites] Curr Opin Struct Biol. 2002 Jun;12(3):330-6 [12127451.001]
  • [Cites] Prog Nucleic Acid Res Mol Biol. 2002;72:223-68 [12206453.001]
  • [Cites] J Mol Biol. 2003 Jan 3;325(1):1-10 [12473448.001]
  • [Cites] J Virol. 2003 Jan;77(2):1598-603 [12502875.001]
  • [Cites] Biophys J. 1999 Sep;77(3):1547-55 [10465765.001]
  • [Cites] Biochemistry. 2005 Mar 15;44(10):3735-44 [15751950.001]
  • [Cites] J Mol Biol. 2005 May 6;348(3):549-61 [15826653.001]
  • [Cites] J Mol Biol. 2005 May 20;348(5):1059-77 [15854644.001]
  • [Cites] J Mol Biol. 2005 May 20;348(5):1113-26 [15854648.001]
  • [Cites] J Mol Biol. 2005 Jun 3;349(2):317-30 [15890198.001]
  • [Cites] J Mol Biol. 2005 Jun 24;349(5):976-88 [15907938.001]
  • [Cites] Biochemistry. 1999 Dec 21;38(51):16816-25 [10606514.001]
  • [Cites] Nucleic Acids Res. 2000 Jan 15;28(2):634-40 [10606665.001]
  • [Cites] Biopolymers. 2000 Apr 5;53(4):329-41 [10685053.001]
  • [Cites] J Mol Biol. 2000 May 26;299(1):145-56 [10860728.001]
  • [Cites] J Mol Biol. 2000 Aug 11;301(2):491-511 [10926523.001]
  • [Cites] J Virol. 2000 Oct;74(19):8785-92 [10982320.001]
  • [Cites] J Virol. 2000 Oct;74(19):8980-8 [10982342.001]
  • [Cites] Biochim Biophys Acta. 2000 Sep 29;1481(2):381-94 [11018730.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 May 22;98(11):6121-6 [11344257.001]
  • [Cites] J Mol Biol. 2001 May 25;309(1):57-68 [11491301.001]
  • [Cites] J Mol Biol. 2001 Oct 5;312(5):985-97 [11580244.001]
  • [Cites] Biochemistry. 2001 Nov 13;40(45):13644-51 [11695913.001]
  • [Cites] J Mol Biol. 2001 Nov 23;314(2):217-32 [11718556.001]
  • [Cites] J Mol Biol. 2001 Dec 14;314(5):961-70 [11743714.001]
  • [Cites] Protein Eng. 2001 Dec;14(12):993-1000 [11809930.001]
  • [Cites] Acc Chem Res. 2002 Mar;35(3):159-66 [11900519.001]
  • [Cites] J Mol Biol. 2002 Mar 29;317(3):385-99 [11922672.001]
  • (PMID = 18684831.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIGMS NIH HHS / GM / GM072396; United States / NIGMS NIH HHS / GM / F32 GM072396; United States / NIGMS NIH HHS / GM / R01 GM065056; United States / NIGMS NIH HHS / GM / GM073462; United States / NIGMS NIH HHS / GM / GM065056; United States / NCI NIH HHS / CA / N01CO12400; United States / NCI NIH HHS / CO / N01-CO-12400
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / Molecular Chaperones; 0 / Nucleic Acids; 0 / Nucleocapsid Proteins; 0 / RNA, Viral
  • [Other-IDs] NLM/ PMC2566285
  •  go-up   go-down


34. Chang KW, Oh J, Alvord WG, Hughes SH: The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase. J Virol; 2008 Sep;82(17):8592-604
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase.
  • We previously reported that a mutant Rous sarcoma virus (RSV) with an alternate polypurine tract (PPT), DuckHepBFlipPPT, had unexpectedly high titers and that the PPT was miscleaved primarily at one position following a GA dinucleotide by the RNase H of reverse transcriptase (RT).

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. GUANINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Nov;74(22):10293-303 [11044073.001]
  • [Cites] J Virol. 2008 Jan;82(1):503-12 [17959663.001]
  • [Cites] J Virol. 2001 Jun;75(11):4973-83 [11333876.001]
  • [Cites] EMBO J. 2001 Jun 15;20(12):3272-81 [11406603.001]
  • [Cites] Biochemistry. 2002 Apr 16;41(15):4856-65 [11939780.001]
  • [Cites] J Biol Chem. 2002 May 10;277(19):16689-96 [11875059.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9515-20 [12093908.001]
  • [Cites] J Virol. 2008 Jan;82(2):719-27 [17989171.001]
  • [Cites] J Virol. 2003 Oct;77(20):11150-7 [14512562.001]
  • [Cites] J Mol Biol. 2003 Dec 5;334(4):653-65 [14636594.001]
  • [Cites] Nucleic Acids Res. 2004;32(4):1539-47 [15004241.001]
  • [Cites] Int J Biochem Cell Biol. 2004 Sep;36(9):1752-66 [15183342.001]
  • [Cites] EMBO J. 1990 Apr;9(4):1171-6 [1691093.001]
  • [Cites] J Acquir Immune Defic Syndr. 1990;3(9):852-8 [2384863.001]
  • [Cites] J Virol. 1990 Oct;64(10):4903-6 [1697909.001]
  • [Cites] Biochemistry. 1990 Nov 6;29(44):10141-7 [1703002.001]
  • [Cites] Biochemistry. 1991 Jul 23;30(29):7041-6 [1713059.001]
  • [Cites] J Virol. 1992 Jan;66(1):367-73 [1370087.001]
  • [Cites] J Biol Chem. 1992 Jul 25;267(21):15071-9 [1378844.001]
  • [Cites] Annu Rev Cell Biol. 1992;8:275-306 [1282352.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6320-4 [7687065.001]
  • [Cites] EMBO J. 1998 Jul 1;17(13):3766-74 [9649446.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol. 1999 Feb;73(2):948-57 [9882295.001]
  • [Cites] J Virol. 2004 Dec;78(23):13315-24 [15542682.001]
  • [Cites] J Virol. 2005 Jun;79(11):6859-67 [15890925.001]
  • [Cites] J Biol Chem. 2005 May 20;280(20):20154-62 [15778225.001]
  • [Cites] J Virol. 2005 Nov;79(21):13694-704 [16227289.001]
  • [Cites] J Virol. 2006 Jan;80(1):451-9 [16352569.001]
  • [Cites] J Biol Chem. 2006 Jan 27;281(4):1943-55 [16306040.001]
  • [Cites] Nucleic Acids Res. 2007;35(1):256-68 [17164285.001]
  • [Cites] Virology. 2007 Apr 10;360(2):341-9 [17123564.001]
  • [Cites] EMBO J. 2001 Mar 15;20(6):1449-61 [11250910.001]
  • (PMID = 18562520.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Purines; 5Z93L87A1R / Guanine; EC 2.7.7.49 / RNA-Directed DNA Polymerase; EC 3.1.26.4 / Ribonuclease H; JAC85A2161 / Adenine
  • [Other-IDs] NLM/ PMC2519663
  •  go-up   go-down


35. Kanno T, Takahashi T, Tsujisawa T, Ariyoshi W, Nishihara T: Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts. J Cell Biochem; 2007 Aug 1;101(5):1266-77
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Small interfering RNA (siRNA) targeting Rous sarcoma kinase (RAS), an upstream regulator of both ERK1/2 and p38 MAPKs, inhibited stretch-induced ERK1/2 activation, but not mechanically induced p38 MAPK activity.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2007 Wiley-Liss, Inc.
  • (PMID = 17265428.001).
  • [ISSN] 0730-2312
  • [Journal-full-title] Journal of cellular biochemistry
  • [ISO-abbreviation] J. Cell. Biochem.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Core Binding Factor Alpha 1 Subunit; 0 / Enzyme Inhibitors; 0 / RNA, Messenger; 0 / RNA, Small Interfering; 0 / Runx2 protein, mouse; 0 / Runx2 protein, rat; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 1; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 3; EC 3.1.3.1 / Alkaline Phosphatase; EC 3.6.5.2 / ras Proteins
  •  go-up   go-down


36. Oh J, Chang KW, Hughes SH: Integration of rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA. J Virol; 2008 Nov;82(22):11480-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Integration of rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2001 Apr;75(8):3556-67 [11264345.001]
  • [Cites] J Virol. 2008 Sep;82(17):8592-604 [18562520.001]
  • [Cites] J Virol. 2003 Oct;77(20):11150-7 [14512562.001]
  • [Cites] Nucleic Acids Res. 2004;32(4):1539-47 [15004241.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 May;86(9):3065-9 [2524066.001]
  • [Cites] Cell. 1989 Jul 14;58(1):47-54 [2546673.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jul;87(13):5119-23 [2164223.001]
  • [Cites] Cell. 1990 Aug 24;62(4):829-37 [2167180.001]
  • [Cites] Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1339-43 [1847518.001]
  • [Cites] J Virol. 1991 Sep;65(9):4636-44 [1870194.001]
  • [Cites] J Virol. 1991 Oct;65(10):5624-30 [1895409.001]
  • [Cites] J Virol. 1992 Apr;66(4):2359-68 [1548767.001]
  • [Cites] J Virol. 1995 May;69(5):3233-6 [7707558.001]
  • [Cites] J Virol. 1995 Sep;69(9):5904-7 [7637038.001]
  • [Cites] J Virol. 1996 Aug;70(8):5288-96 [8764039.001]
  • [Cites] J Virol. 1996 Dec;70(12):9069-73 [8971046.001]
  • [Cites] J Virol. 1997 Feb;71(2):1025-35 [8995622.001]
  • [Cites] J Virol. 1998 Oct;72(10):8396-402 [9733892.001]
  • [Cites] J Virol. 2004 Dec;78(23):13315-24 [15542682.001]
  • [Cites] J Virol. 2005 Nov;79(21):13694-704 [16227289.001]
  • [Cites] J Virol. 2006 Jan;80(1):451-9 [16352569.001]
  • [Cites] J Virol. 2006 Oct;80(20):10281-4 [17005708.001]
  • [Cites] J Virol. 2008 Jan;82(1):503-12 [17959663.001]
  • [Cites] J Virol. 2003 Jun;77(11):6482-92 [12743305.001]
  • (PMID = 18768972.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; EC 2.7.7.- / Integrases
  • [Other-IDs] NLM/ PMC2573277
  •  go-up   go-down


37. Maeda N, Yoshikai Y: [New molecular mechanisms of virus-mediated carcinogenesis: oncogenic transformation of cells by retroviral structural protein Envelope]. Uirusu; 2007 Dec;57(2):159-70
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RNA tumor viruses as classified in Retroviruses have been isolated and identified to induce tumors in a variety of animals including chickens, mice, and rats, or even in human in the last 100 years, since the first one has been reported in 1908.
  • The RNA tumor viruses have been historically classified into two groups, acute transforming RNA tumor viruses and nonacute RNA tumor viruses.
  • Acute transforming RNA tumor viruses are basically replication-defective and rapidly induce tumors by expressing the viral oncogenes captured from cellular genome in host cells.
  • The first oncogene derived from Rous sarcoma virus was the src non-receptor tyrosine kinase, which has been identified to play the significant roles for signal transduction.
  • On the other hand, nonacute RNA tumor viruses, which consist of only gag, pro, pol, and env regions but do not carry oncogenes, are replication-competent and could activate the cellular proto-oncogenes by inserting the viral long terminal repeat close to the proto-oncogenes to induce tumors with a long incubation period, as is termed a promoter insertion.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18357754.001).
  • [ISSN] 0042-6857
  • [Journal-full-title] Uirusu
  • [ISO-abbreviation] Uirusu
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Viral Envelope Proteins; EC 2.7.10.2 / src-Family Kinases
  • [Number-of-references] 100
  •  go-up   go-down


38. Chen P, Tian J, Kovesdi I, Bruder JT: Promoters influence the kinetics of transgene expression following adenovector gene delivery. J Gene Med; 2008 Feb;10(2):123-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In contrast, transgene expression from the Rous sarcoma virus (RSV) promoter increased over time such that, at 3 weeks, expression was 10-fold higher than that from the CMV promoter-containing vector in all tissues.
  • [MeSH-minor] Animals. Cell Line. Cytomegalovirus / genetics. Female. Humans. Immunity, Cellular. Immunocompetence. Injections, Intravenous. Kinetics. Luciferases / metabolism. Mice. Mice, Inbred BALB C. Mice, Inbred C57BL. Mice, Nude. Muscle, Skeletal / metabolism. Rous sarcoma virus / genetics. Time Factors. Transduction, Genetic

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18064718.001).
  • [ISSN] 1099-498X
  • [Journal-full-title] The journal of gene medicine
  • [ISO-abbreviation] J Gene Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] EC 1.13.12.- / Luciferases
  •  go-up   go-down


39. Weil JE, Beemon KL: A 3' UTR sequence stabilizes termination codons in the unspliced RNA of Rous sarcoma virus. RNA; 2006 Jan;12(1):102-10
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A 3' UTR sequence stabilizes termination codons in the unspliced RNA of Rous sarcoma virus.
  • We termed this 3' UTR region the Rous sarcoma virus (RSV) stability element (RSE).

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] EMBO J. 2002 Jan 15;21(1-2):125-34 [11782432.001]
  • [Cites] Nature. 2005 Mar 17;434(7031):338-45 [15735639.001]
  • [Cites] EMBO Rep. 2002 Mar;3(3):274-9 [11850396.001]
  • [Cites] Science. 2002 Oct 11;298(5592):419-22 [12228722.001]
  • [Cites] Mol Cell Biol. 2002 Dec;22(23):8114-21 [12417715.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):189-92 [12502788.001]
  • [Cites] Mol Cell Biol. 2003 Feb;23(3):842-51 [12529390.001]
  • [Cites] Nucleic Acids Res. 2003 Jul 1;31(13):3406-15 [12824337.001]
  • [Cites] EMBO J. 2003 Aug 1;22(15):3960-70 [12881430.001]
  • [Cites] RNA. 2004 Feb;10(2):200-9 [14730019.001]
  • [Cites] Nucleic Acids Res. 2004;32(2):784-90 [14762205.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 Feb;5(2):89-99 [15040442.001]
  • [Cites] Genome Biol. 2004;5(4):218 [15059251.001]
  • [Cites] J Virol. 2004 May;78(10):5139-46 [15113896.001]
  • [Cites] Curr Opin Cell Biol. 2004 Jun;16(3):279-84 [15145352.001]
  • [Cites] Nucleic Acids Res. 2004;32(11):3304-15 [15210863.001]
  • [Cites] Nat Struct Mol Biol. 2004 Oct;11(10):992-1000 [15361857.001]
  • [Cites] Nat Genet. 2004 Oct;36(10):1073-8 [15448691.001]
  • [Cites] Proc Natl Acad Sci U S A. 1979 Oct;76(10):5134-7 [388431.001]
  • [Cites] J Virol. 1988 Sep;62(9):3328-33 [2841485.001]
  • [Cites] Mol Cell Biol. 1991 May;11(5):2760-8 [1850103.001]
  • [Cites] Genes Dev. 1991 Dec;5(12A):2303-14 [1748286.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):482-6 [8421679.001]
  • [Cites] Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10091-5 [8234261.001]
  • [Cites] Mol Cell Biol. 1994 Mar;14(3):1986-96 [8114730.001]
  • [Cites] Mol Cell Biol. 1995 Apr;15(4):2231-44 [7891717.001]
  • [Cites] J Biol Chem. 1995 Dec 1;270(48):28995-9003 [7499432.001]
  • [Cites] EMBO J. 1996 Nov 1;15(21):5965-75 [8918474.001]
  • [Cites] EMBO J. 1998 Jan 15;17(2):575-89 [9430648.001]
  • [Cites] RNA. 1998 Jul;4(7):801-15 [9671053.001]
  • [Cites] Mol Cell Biol. 1998 Sep;18(9):5272-83 [9710612.001]
  • [Cites] Mol Biol Cell. 1999 Mar;10(3):515-24 [10069800.001]
  • [Cites] Mol Cell. 2005 Apr 29;18(3):307-17 [15866173.001]
  • [Cites] Curr Opin Cell Biol. 2005 Jun;17(3):309-15 [15901502.001]
  • [Cites] Curr Opin Cell Biol. 2005 Jun;17(3):316-25 [15901503.001]
  • [Cites] Nucleic Acids Res. 2000 Jan 1;28(1):85-6 [10592188.001]
  • [Cites] Annu Rev Genet. 1999;33:229-60 [10690409.001]
  • [Cites] Genes Dev. 2000 May 1;14(9):1098-108 [10809668.001]
  • [Cites] Mol Cell. 2000 Mar;5(3):489-99 [10882134.001]
  • [Cites] EMBO J. 2000 Sep 1;19(17):4734-44 [10970865.001]
  • [Cites] EMBO J. 2000 Dec 15;19(24):6860-9 [11118221.001]
  • [Cites] Cell. 2000 Dec 22;103(7):1121-31 [11163187.001]
  • [Cites] Mol Cell Biol. 2001 Mar;21(5):1515-30 [11238889.001]
  • [Cites] EMBO J. 2001 Apr 17;20(8):2062-8 [11296238.001]
  • [Cites] RNA. 2001 Mar;7(3):445-56 [11333024.001]
  • [Cites] Science. 2001 Sep 7;293(5536):1832-6 [11546873.001]
  • [Cites] Gene. 2001 Aug 22;274(1-2):15-25 [11674994.001]
  • [Cites] EMBO Rep. 2001 Dec;2(12):1119-24 [11743026.001]
  • [Cites] Nucleic Acids Res. 2005;33(3):825-37 [15701754.001]
  • [Cites] Nature. 2004 Nov 4;432(7013):112-8 [15525991.001]
  • [Cites] Mol Cell. 2004 Nov 19;16(4):597-607 [15546619.001]
  • [Cites] Nature. 2004 Dec 9;432(7018):695-716 [15592404.001]
  • [Cites] Cell. 2005 Jan 28;120(2):195-208 [15680326.001]
  • [Cites] Trends Genet. 2005 Mar;21(3):143-8 [15734573.001]
  • [Cites] Hum Mol Genet. 2002 Feb 1;11(3):331-5 [11823452.001]
  • (PMID = 16301601.001).
  • [ISSN] 1355-8382
  • [Journal-full-title] RNA (New York, N.Y.)
  • [ISO-abbreviation] RNA
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA048746; United States / NIGMS NIH HHS / GM / T32 GM007231; United States / NCI NIH HHS / CA / R01 CA48746; United States / NIGMS NIH HHS / GM / T32GM07231
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 3' Untranslated Regions; 0 / Codon, Nonsense; 0 / Codon, Terminator; 63231-63-0 / RNA
  • [Other-IDs] NLM/ PMC1370890
  •  go-up   go-down


40. Majhen D, Brozovic A, Buger T, Gabrilovac J, Osmak M, Ambriović-Ristov A: Vincristine-resistant human laryngeal carcinoma cells demonstrate increased Rous sarcoma virus promoter activity. Life Sci; 2010 Oct 9;87(15-16):468-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vincristine-resistant human laryngeal carcinoma cells demonstrate increased Rous sarcoma virus promoter activity.
  • [MeSH-major] Adenoviridae / genetics. Gene Expression Regulation, Neoplastic. Gene Transfer Techniques. Laryngeal Neoplasms / therapy. Rous sarcoma virus / genetics
  • [MeSH-minor] Antineoplastic Agents, Phytogenic / pharmacology. Cell Line, Tumor. Coxsackie and Adenovirus Receptor-Like Membrane Protein. Drug Resistance, Neoplasm. Genetic Therapy / methods. Genetic Vectors. Humans. Promoter Regions, Genetic. Receptors, Virus / metabolism. Reverse Transcriptase Polymerase Chain Reaction. Transgenes. Vincristine / pharmacology

  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20837033.001).
  • [ISSN] 1879-0631
  • [Journal-full-title] Life sciences
  • [ISO-abbreviation] Life Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / CLMP protein, human; 0 / Coxsackie and Adenovirus Receptor-Like Membrane Protein; 0 / Receptors, Virus; 5J49Q6B70F / Vincristine
  •  go-up   go-down


41. Maciolek NL, McNally MT: Characterization of Rous sarcoma virus polyadenylation site use in vitro. Virology; 2008 May 10;374(2):468-76
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characterization of Rous sarcoma virus polyadenylation site use in vitro.
  • Polyadenylation of Rous sarcoma virus (RSV) RNA is inefficient, as approximately 15% of RSV RNAs represent read-through transcripts that use a downstream cellular polyadenylation site (poly(A) site).
  • Read-through transcription has implications for the virus and the host since it is associated with oncogene capture and tumor induction.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Cell Biol. 1989 Oct;9(10):4248-58 [2573828.001]
  • [Cites] RNA. 1997 Dec;3(12):1444-55 [9404895.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1403-7 [1741396.001]
  • [Cites] J Virol. 1992 Jul;66(7):4242-51 [1318403.001]
  • [Cites] RNA. 2000 Feb;6(2):170-7 [10688356.001]
  • [Cites] J Virol. 2001 Dec;75(23):11735-46 [11689654.001]
  • [Cites] Nucleic Acids Res. 2002 Feb 1;30(3):810-7 [11809895.001]
  • [Cites] Nature. 2002 Apr 4;416(6880):499-506 [11932736.001]
  • [Cites] Nucleic Acids Res. 2002 Apr 15;30(8):1842-50 [11937639.001]
  • [Cites] J Biol Chem. 2002 Nov 8;277(45):42733-40 [12200454.001]
  • [Cites] Virology. 2002 Oct 25;302(2):405-12 [12441084.001]
  • [Cites] EMBO J. 2003 Jun 2;22(11):2821-30 [12773396.001]
  • [Cites] EMBO J. 2004 Feb 11;23(3):616-26 [14749727.001]
  • [Cites] J Biol Chem. 2004 Feb 20;279(8):7009-13 [14625303.001]
  • [Cites] Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 [6828386.001]
  • [Cites] Cell. 1983 Mar;32(3):853-69 [6299578.001]
  • [Cites] Cell. 1983 Jun;33(2):357-68 [6305505.001]
  • [Cites] Nucleic Acids Res. 1984 Sep 25;12(18):7035-56 [6091052.001]
  • [Cites] Cell. 1986 Mar 28;44(6):935-40 [2420470.001]
  • [Cites] J Virol. 1986 Nov;60(2):497-505 [3021984.001]
  • [Cites] J Virol. 1988 Apr;62(4):1423-32 [2831403.001]
  • [Cites] J Virol. 1988 Jul;62(7):2437-43 [2897475.001]
  • [Cites] J Virol. 1989 Aug;63(8):3301-6 [2473216.001]
  • [Cites] Mol Cell Biol. 1992 Sep;12(9):3699-705 [1508176.001]
  • [Cites] Mol Cell Biol. 1992 Dec;12(12):5386-93 [1333042.001]
  • [Cites] Cell. 1993 Mar 26;72(6):881-92 [8458082.001]
  • [Cites] Genes Dev. 1993 Apr;7(4):647-59 [8384583.001]
  • [Cites] Cell. 1994 Feb 11;76(3):531-41 [8313473.001]
  • [Cites] Genes Dev. 1994 Mar 1;8(5):576-86 [7926751.001]
  • [Cites] Mol Cell Biol. 1994 Oct;14(10):6647-54 [7935383.001]
  • [Cites] Mol Cell. 1998 Jan;1(2):255-64 [9659922.001]
  • [Cites] RNA. 1998 Dec;4(12):1493-9 [9848648.001]
  • [Cites] J Virol. 1999 Jan;73(1):81-91 [9847310.001]
  • [Cites] J Virol. 1999 Mar;73(3):2385-93 [9971822.001]
  • [Cites] J Virol. 1999 Mar;73(3):2394-400 [9971823.001]
  • [Cites] RNA. 1999 Mar;5(3):333-43 [10094303.001]
  • [Cites] Microbiol Mol Biol Rev. 1999 Jun;63(2):405-45 [10357856.001]
  • [Cites] Nucleic Acids Res. 2005;33(1):201-12 [15647503.001]
  • [Cites] J Virol. 2005 Apr;79(7):4270-88 [15767428.001]
  • [Cites] Mol Cell Biol. 2005 Jun;25(11):4397-405 [15899846.001]
  • [Cites] Genes Dev. 2005 Jun 1;19(11):1315-27 [15937220.001]
  • [Cites] RNA. 2005 Oct;11(10):1485-93 [16131587.001]
  • [Cites] J Biol Chem. 2006 Feb 3;281(5):2478-88 [16308319.001]
  • [Cites] Retrovirology. 2006;3:18 [16545126.001]
  • [Cites] J Virol. 2006 Oct;80(19):9634-40 [16973567.001]
  • [Cites] EMBO J. 2007 Jun 6;26(11):2658-69 [17464285.001]
  • [Cites] J Virol. 2007 Oct;81(20):11208-17 [17670832.001]
  • [Cites] Genes Dev. 1995 Jan 1;9(1):72-83 [7828853.001]
  • [Cites] Nucleic Acids Res. 1995 May 11;23(9):1625-31 [7784220.001]
  • [Cites] Nucleic Acids Res. 1995 Jul 25;23(14):2614-20 [7651822.001]
  • [Cites] Genes Dev. 1995 Nov 1;9(21):2672-83 [7590244.001]
  • [Cites] Genes Dev. 1996 Feb 1;10(3):325-37 [8595883.001]
  • [Cites] J Virol. 1996 Mar;70(3):1612-7 [8627681.001]
  • [Cites] Cell. 1996 Nov 29;87(5):941-52 [8945520.001]
  • [Cites] Genes Dev. 1990 Dec;4(12A):2112-20 [1980119.001]
  • (PMID = 18272196.001).
  • [ISSN] 0042-6822
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA078709-10; United States / NCI NIH HHS / CA / CA078709-08; United States / NCI NIH HHS / CA / R01 CA078709; United States / NCI NIH HHS / CA / R01 CA078709-09; United States / NCI NIH HHS / CA / R01 CA78709; United States / NCI NIH HHS / CA / R01 CA078709-08; United States / NCI NIH HHS / CA / R01 CA078709-10; United States / NCI NIH HHS / CA / CA078709-09
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 3' Untranslated Regions; 0 / Cleavage Stimulation Factor; 0 / RNA, Messenger; 0 / RNA, Viral
  • [Other-IDs] NLM/ NIHMS50251; NLM/ PMC2413101
  •  go-up   go-down


42. Senigl F, Plachý J, Hejnar J: The core element of a CpG island protects avian sarcoma and leukosis virus-derived vectors from transcriptional silencing. J Virol; 2008 Aug;82(16):7818-27
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The core element of a CpG island protects avian sarcoma and leukosis virus-derived vectors from transcriptional silencing.
  • We report here the insertion of this CpG island core element, IE, into the long terminal repeat of a retroviral vector derived from Rous sarcoma virus, which normally suffers from progressive transcriptional silencing in mammalian cells.
  • [MeSH-major] Avian Leukosis Virus / metabolism. CpG Islands. Gene Silencing. Sarcoma, Avian / genetics. Sarcoma, Avian / virology. Transcription, Genetic
  • [MeSH-minor] Animals. Binding Sites. Birds. Flow Cytometry. Genes, Reporter. Humans. Models, Biological. Mutation. Rous sarcoma virus / metabolism. Sp1 Transcription Factor / metabolism. Terminal Repeat Sequences

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Mar;74(6):2671-8 [10684282.001]
  • [Cites] Gene. 1998 Feb 16;208(1):73-82 [9479051.001]
  • [Cites] Gene. 2000 Dec 30;261(1):181-8 [11164049.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):565-9 [11209056.001]
  • [Cites] EMBO J. 2001 Apr 2;20(7):1726-38 [11285236.001]
  • [Cites] J Virol. 2001 Jun;75(11):4973-83 [11333876.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Gene. 1998 Nov 26;223(1-2):157-63 [9858717.001]
  • [Cites] Virology. 1999 Mar 1;255(1):171-81 [10049832.001]
  • [Cites] Nat Genet. 1999 Jun;22(2):203-6 [10369268.001]
  • [Cites] J Biol Chem. 2005 Jan 7;280(1):64-72 [15509558.001]
  • [Cites] J Virol. 2005 Apr;79(8):4610-8 [15795247.001]
  • [Cites] J Virol. 2005 Aug;79(16):10408-19 [16051833.001]
  • [Cites] J Virol. 2005 Nov;79(21):13497-508 [16227270.001]
  • [Cites] Hum Gene Ther. 2005 Nov;16(11):1241-6 [16259557.001]
  • [Cites] Cell. 2007 Feb 23;128(4):721-33 [17320509.001]
  • [Cites] J Virol. 2007 Mar;81(6):2592-604 [17202206.001]
  • [Cites] Gene Ther. 2007 May;14(9):741-51 [17330088.001]
  • [Cites] Blood. 2007 Sep 1;110(5):1448-57 [17456723.001]
  • [Cites] Hum Gene Ther. 2007 Aug;18(8):691-700 [17655493.001]
  • [Cites] J Virol. 2008 Mar;82(5):2313-23 [18094192.001]
  • [Cites] J Biol Chem. 2008 Apr 25;283(17):11509-15 [18308728.001]
  • [Cites] Mol Cell Biol. 2000 Feb;20(3):842-50 [10629041.001]
  • [Cites] J Virol. 2001 Oct;75(19):9526-31 [11533215.001]
  • [Cites] Science. 2001 Dec 14;294(5550):2368-71 [11743206.001]
  • [Cites] J Virol. 2002 Jun;76(11):5422-34 [11991971.001]
  • [Cites] Mol Ther. 2002 May;5(5 Pt 1):589-98 [11991750.001]
  • [Cites] FEBS Lett. 2002 Apr 24;517(1-3):285-6 [12062454.001]
  • [Cites] Cell. 2002 Aug 23;110(4):521-9 [12202041.001]
  • [Cites] Science. 2003 Jun 13;300(5626):1749-51 [12805549.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8764-9 [12857957.001]
  • [Cites] Science. 2003 Oct 17;302(5644):415-9 [14564000.001]
  • [Cites] J Biol Chem. 2004 Jan 2;279(1):34-41 [14559924.001]
  • [Cites] J Virol. 2004 May;78(9):4902-6 [15078971.001]
  • [Cites] Gene Ther. 2004 May;11(10):819-28 [14985785.001]
  • [Cites] PLoS Biol. 2004 Aug;2(8):E234 [15314653.001]
  • [Cites] J Virol. 2004 Nov;78(21):11656-63 [15479807.001]
  • [Cites] Int J Cancer. 1967 Mar 15;2(2):143-52 [6039764.001]
  • [Cites] Cell. 1977 May;11(1):95-103 [194709.001]
  • [Cites] Nucleic Acids Res. 1984 Jul 11;12(13):5193-210 [6205359.001]
  • [Cites] J Virol. 1991 Feb;65(2):904-12 [1702844.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2567-71 [8146155.001]
  • [Cites] Cell Growth Differ. 1994 Mar;5(3):277-85 [8018560.001]
  • [Cites] Virology. 1994 Sep;203(2):211-20 [8053145.001]
  • [Cites] Nature. 1994 Sep 29;371(6496):435-8 [8090226.001]
  • [Cites] Genes Dev. 1994 Oct 1;8(19):2282-92 [7958895.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11241-5 [7972042.001]
  • [Cites] J Virol. 1995 Feb;69(2):748-55 [7815539.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 May 14;93(10):4931-6 [8643506.001]
  • [Cites] J Virol. 1996 Jun;70(6):3922-9 [8648729.001]
  • [Cites] Cell. 1997 May 16;89(4):619-28 [9160753.001]
  • [Cites] J Virol. 2000 May;74(10):4679-87 [10775605.001]
  • (PMID = 18550662.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Sp1 Transcription Factor
  • [Other-IDs] NLM/ PMC2519551
  •  go-up   go-down


43. Jorgenson RL, Vogt VM, Johnson MC: Foreign glycoproteins can be actively recruited to virus assembly sites during pseudotyping. J Virol; 2009 May;83(9):4060-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, in the presence of budding HIV-1 or Rous sarcoma virus (RSV) particles, some glycoproteins, such as those encoded by murine leukemia virus and vesicular stomatitis virus, were dramatically redistributed to viral budding sites.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 1993 Dec;67(12):7067-76 [7693966.001]
  • [Cites] J Virol. 1992 Jun;66(6):3306-15 [1583717.001]
  • [Cites] J Virol. 1995 Jun;69(6):3824-30 [7745730.001]
  • [Cites] Science. 1996 Apr 12;272(5259):263-7 [8602510.001]
  • [Cites] J Biol Chem. 1999 Jan 22;274(4):2038-44 [9890962.001]
  • [Cites] Gene Ther. 1999 May;6(5):715-28 [10505094.001]
  • [Cites] J Virol. 1999 Nov;73(11):9294-302 [10516038.001]
  • [Cites] Virology. 1965 Jun;26:270-6 [14323995.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15453-8 [16230638.001]
  • [Cites] Nat Methods. 2005 Dec;2(12):905-9 [16299475.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14947-52 [17003132.001]
  • [Cites] Cell Host Microbe. 2008 May 15;3(5):285-92 [18474355.001]
  • [Cites] Virology. 1992 Jul;189(1):167-77 [1604808.001]
  • [Cites] J Virol. 2000 Apr;74(7):3264-72 [10708443.001]
  • [Cites] J Virol. 2000 Apr;74(8):3548-54 [10729129.001]
  • [Cites] Virology. 2000 Jul 20;273(1):16-20 [10891403.001]
  • [Cites] J Virol. 2001 May;75(9):4129-38 [11287562.001]
  • [Cites] J Virol. 2001 Aug;75(15):7175-83 [11435598.001]
  • [Cites] J Virol. 2001 Oct;75(19):9339-44 [11533197.001]
  • [Cites] AIDS Res Hum Retroviruses. 2001 Nov 20;17(17):1615-24 [11779349.001]
  • [Cites] J Virol. 2002 Aug;76(15):7518-27 [12097564.001]
  • [Cites] J Gen Virol. 2003 Apr;84(Pt 4):757-68 [12655075.001]
  • [Cites] Traffic. 2003 Nov;4(11):785-801 [14617360.001]
  • [Cites] J Virol. 2004 Apr;78(7):3429-35 [15016865.001]
  • [Cites] Nat New Biol. 1972 Nov 22;240(99):122-4 [4345003.001]
  • [Cites] J Gen Virol. 1982 Nov;63 (Pt 1):15-24 [6757385.001]
  • [Cites] J Virol. 1987 Oct;61(10):2981-8 [3041017.001]
  • [Cites] Science. 1990 Feb 16;247(4944):848-52 [2305256.001]
  • [Cites] Science. 1990 Dec 7;250(4986):1421-3 [2175047.001]
  • [Cites] J Virol. 1995 Mar;69(3):1984-9 [7853546.001]
  • (PMID = 19224995.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI073098-02; United States / NCI NIH HHS / CA / R01 CA020081; United States / NIAID NIH HHS / AI / AI73098; United States / NIAID NIH HHS / AI / R01 AI073098; United States / NCI NIH HHS / CA / CA20081
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, env; 0 / Glycoproteins
  • [Other-IDs] NLM/ PMC2668502
  •  go-up   go-down


44. Klopocki E, Hennig BP, Dathe K, Koll R, de Ravel T, Baten E, Blom E, Gillerot Y, Weigel JF, Krüger G, Hiort O, Seemann P, Mundlos S: Deletion and point mutations of PTHLH cause brachydactyly type E. Am J Hum Genet; 2010 Mar 12;86(3):434-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • On the basis of our initial finding, we tested further individuals with BDE and short stature for mutations in PTHLH.
  • The missense mutation L60P was tested in chicken micromass culture with the replication-competent avian sarcoma leukosis virus retroviral expression system and was shown to result in a loss of function.
  • [MeSH-minor] Animals. Cells, Cultured. Chick Embryo. Codon, Nonsense. Disease Models, Animal. Female. Foot Deformities, Congenital / genetics. Foot Deformities, Congenital / pathology. Genes, Dominant. Growth Disorders / genetics. Growth Disorders / pathology. Hand Deformities, Congenital / genetics. Hand Deformities, Congenital / pathology. Humans. Male. Mice. Mice, Knockout. Mutation, Missense. Pedigree. Phenotype. Point Mutation. Recombinant Proteins / genetics. Recombinant Proteins / metabolism. Sequence Deletion


45. Takayama K, Torashima T, Horiuchi H, Hirai H: Purkinje-cell-preferential transduction by lentiviral vectors with the murine stem cell virus promoter. Neurosci Lett; 2008 Sep 26;443(1):7-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, we prepared lentiviral vectors that express GFP under the control of various ubiquitous promoters derived from murine stem cell virus (MSCV), cytomegalovirus (CMV), CMV early enhancer/chicken beta actin (CAG), and Rous sarcoma virus (RSV) and compared their potential to transduce Purkinje cells.

  • MedlinePlus Health Information. consumer health - Stem Cells.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18675313.001).
  • [ISSN] 0304-3940
  • [Journal-full-title] Neuroscience letters
  • [ISO-abbreviation] Neurosci. Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / Viral Proteins; 147336-22-9 / Green Fluorescent Proteins
  •  go-up   go-down


46. Levy AM, Gilad O, Xia L, Izumiya Y, Choi J, Tsalenko A, Yakhini Z, Witter R, Lee L, Cardona CJ, Kung HJ: Marek's disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: a converging transforming pathway for avian oncoviruses. Proc Natl Acad Sci U S A; 2005 Oct 11;102(41):14831-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Marek's disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: a converging transforming pathway for avian oncoviruses.
  • Marek's disease virus (MDV) is a highly pathogenic and oncogenic herpesvirus of chickens.
  • Taking advantage of the DF-1 chicken embryo fibroblast transformation system, a well established model for studying avian sarcoma and leukemia oncogenes, we probed the transformation properties and pathways of Meq.
  • These data suggest that avian herpesvirus and retrovirus oncogenes use a similar strategy in transformation and oncogenesis.

  • COS Scholar Universe. author profiles.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2000 May 23;97(11):6091-6 [10823954.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Curr Top Microbiol Immunol. 2001;255:245-60 [11217425.001]
  • [Cites] Nature. 2001 May 24;411(6836):494-8 [11373684.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 May 22;98(11):6378-83 [11353853.001]
  • [Cites] Oncogene. 2001 Apr 30;20(19):2365-77 [11402333.001]
  • [Cites] Oncogene. 2001 Nov 8;20(51):7524-35 [11709724.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13601-6 [11698665.001]
  • [Cites] J Biol Chem. 2002 Aug 9;277(32):29094-100 [12034730.001]
  • [Cites] Nature. 2002 Dec 19-26;420(6917):833-7 [12490953.001]
  • [Cites] Oncogene. 2003 Jan 30;22(4):498-506 [12555063.001]
  • [Cites] Oncogene. 2003 Sep 11;22(39):7931-41 [12970741.001]
  • [Cites] Circulation. 2003 Sep 23;108(12):1432-9 [12963638.001]
  • [Cites] J Virol. 2003 Dec;77(23):12841-51 [14610205.001]
  • [Cites] Oncogene. 2004 Mar 25;23(13):2357-66 [14691447.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11815-20 [15289599.001]
  • [Cites] J Virol. 1981 Sep;39(3):920-34 [6169846.001]
  • [Cites] Mol Cell Biol. 1989 Sep;9(9):4038-45 [2674685.001]
  • [Cites] Nature. 1991 Aug 15;352(6336):635-8 [1907719.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 May 1;89(9):4042-6 [1315048.001]
  • [Cites] Science. 1992 Dec 18;258(5090):1941-4 [1470918.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1993 Mar;102(3 Pt 1):215-21 [7681273.001]
  • [Cites] J Virol. 1996 Feb;70(2):1125-31 [8551572.001]
  • [Cites] Growth Factors. 1999;17(1):49-61 [10495962.001]
  • [Cites] Cell Death Differ. 2005 Jun;12(6):554-62 [15818401.001]
  • [Cites] Cancer Cell. 2005 Jul;8(1):25-33 [16023596.001]
  • [Cites] Oncogene. 1996 Jan 4;12(1):135-42 [8552384.001]
  • [Cites] J Virol. 1997 Apr;71(4):3188-96 [9060682.001]
  • [Cites] J Virol. 1998 Jan;72(1):388-95 [9420237.001]
  • [Cites] Virology. 1997 Dec 8;239(1):20-35 [9426443.001]
  • [Cites] J Immunol. 1998 Mar 1;160(5):2065-71 [9498742.001]
  • [Cites] Oncogene. 2000 Jul 20;19(31):3537-45 [10918612.001]
  • (PMID = 16203997.001).
  • [ISSN] 0027-8424
  • [Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America
  • [ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA46613; United States / NCI NIH HHS / CA / CA91574
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Eco-Q protein, Gallid herpesvirus 2; 0 / Oncogene Proteins, Viral; 0 / RNA, Small Interfering; EC 1.13.12.- / Luciferases; EC 2.7.11.24 / JNK Mitogen-Activated Protein Kinases
  • [Other-IDs] NLM/ PMC1253582
  •  go-up   go-down


47. de Marco A, Davey NE, Ulbrich P, Phillips JM, Lux V, Riches JD, Fuzik T, Ruml T, Kräusslich HG, Vogt VM, Briggs JA: Conserved and variable features of Gag structure and arrangement in immature retrovirus particles. J Virol; 2010 Nov;84(22):11729-36
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We have used cryo-electron tomography together with subtomogram averaging to describe the three-dimensional structure of in vitro-assembled Gag particles from human immunodeficiency virus, Mason-Pfizer monkey virus, and Rous sarcoma virus.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Struct Biol. 2002 Jul;9(7):537-43 [12032547.001]
  • [Cites] J Virol. 2002 Jun;76(11):5452-62 [11991973.001]
  • [Cites] J Virol. 2002 Nov;76(22):11177-85 [12388677.001]
  • [Cites] J Virol. 2002 Nov;76(22):11729-37 [12388733.001]
  • [Cites] J Virol. 2004 Jan;78(1):52-60 [14671087.001]
  • [Cites] Nat Struct Mol Biol. 2004 Jul;11(7):672-5 [15208690.001]
  • [Cites] J Comput Chem. 2004 Oct;25(13):1605-12 [15264254.001]
  • [Cites] J Virol. 2004 Sep;78(18):9675-88 [15331700.001]
  • [Cites] J Virol. 2004 Nov;78(22):12378-85 [15507624.001]
  • [Cites] J Virol. 1986 Apr;58(1):50-8 [3005658.001]
  • [Cites] Cell. 1989 Oct 6;59(1):103-12 [2676191.001]
  • [Cites] J Virol. 1992 May;66(5):3230-5 [1560545.001]
  • [Cites] J Virol. 1992 Dec;66(12):7005-11 [1433505.001]
  • [Cites] J Virol. 1995 Feb;69(2):1093-8 [7815488.001]
  • [Cites] J Virol. 1995 Oct;69(10):6487-97 [7666550.001]
  • [Cites] J Struct Biol. 1996 Jan-Feb;116(1):71-6 [8742726.001]
  • [Cites] J Virol. 1997 Jun;71(6):4425-35 [9151833.001]
  • [Cites] J Virol. 1997 Sep;71(9):6765-76 [9261401.001]
  • [Cites] Curr Biol. 1997 Oct 1;7(10):729-38 [9368755.001]
  • [Cites] Eur J Biochem. 1997 Oct 15;249(2):592-600 [9370371.001]
  • [Cites] J Virol. 1998 Mar;72(3):2072-8 [9499062.001]
  • [Cites] J Virol. 1998 Jun;72(6):4798-810 [9573245.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7299-304 [9636143.001]
  • [Cites] J Virol. 1998 Nov;72(11):9313-7 [9765481.001]
  • [Cites] J Virol. 1999 Oct;73(10):8073-82 [10482556.001]
  • [Cites] Protein Sci. 2005 Feb;14(2):375-86 [15659370.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4729-34 [15774580.001]
  • [Cites] J Virol. 2005 Nov;79(21):13463-72 [16227267.001]
  • [Cites] J Mol Biol. 2006 Jan 6;355(1):157-68 [16289202.001]
  • [Cites] J Virol. 2006 Jul;80(14):7089-99 [16809314.001]
  • [Cites] Virology. 2007 Apr 10;360(2):434-46 [17123565.001]
  • [Cites] EMBO J. 2007 Apr 18;26(8):2218-26 [17396149.001]
  • [Cites] Adv Pharmacol. 2007;55:347-87 [17586320.001]
  • [Cites] J Virol. 2009 Mar;83(5):2216-25 [19073719.001]
  • [Cites] Cell. 2009 Jun 26;137(7):1282-92 [19523676.001]
  • [Cites] Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11090-5 [19549863.001]
  • [Cites] Cell. 2007 Oct 5;131(1):70-9 [17923088.001]
  • [Cites] EMBO J. 2008 May 7;27(9):1411-20 [18401344.001]
  • [Cites] J Virol. 2008 Jul;82(14):6788-97 [18448521.001]
  • [Cites] J Struct Biol. 2008 Oct;164(1):161-5 [18691905.001]
  • [Cites] Nature. 2009 Feb 5;457(7230):694-8 [19194444.001]
  • [Cites] Structure. 2000 Jun 15;8(6):617-28 [10873863.001]
  • [Cites] J Virol. 2000 Sep;74(18):8452-9 [10954545.001]
  • [Cites] J Virol. 2001 Jan;75(2):759-71 [11134289.001]
  • [Cites] J Virol. 2001 Mar;75(6):2753-64 [11222698.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10875-9 [11526217.001]
  • [Cites] Nucleic Acids Res. 2002 Jul 15;30(14):3059-66 [12136088.001]
  • (PMID = 20810738.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA020081; United States / NCI NIH HHS / CA / CA20081
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gene Products, gag
  • [Other-IDs] NLM/ PMC2977881
  •  go-up   go-down


48. Suerth JD, Maetzig T, Galla M, Baum C, Schambach A: Self-inactivating alpharetroviral vectors with a split-packaging design. J Virol; 2010 Jul;84(13):6626-35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Comparative analyses of integration sites of different retroviral vectors have elucidated distinct target site preferences, highlighting vectors based on the alpharetrovirus Rous sarcoma virus (RSV) as those with the most neutral integration spectrum.

  • MedlinePlus Health Information. consumer health - Genes and Gene Therapy.
  • SciCrunch. The Antibody Registry: Reagent: Antibodies .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2002 Feb;76(3):1488-95 [11773421.001]
  • [Cites] Gene Ther. 2010 Mar;17(3):400-11 [19847204.001]
  • [Cites] Cell. 2002 Aug 23;110(4):521-9 [12202041.001]
  • [Cites] Nucleic Acids Res. 2001 May 1;29(9):e45 [11328886.001]
  • [Cites] Science. 2003 Jun 13;300(5626):1749-51 [12805549.001]
  • [Cites] Blood. 2003 Dec 1;102(12):3934-7 [12881303.001]
  • [Cites] Genomics. 2004 Jan;83(1):76-84 [14667811.001]
  • [Cites] Gene Ther. 2004 Jun;11(11):879-81 [15057265.001]
  • [Cites] J Virol. 2004 Aug;78(16):8421-36 [15280451.001]
  • [Cites] PLoS Biol. 2004 Aug;2(8):E234 [15314653.001]
  • [Cites] Folia Biol (Praha). 2004;50(3-4):107-19 [15373344.001]
  • [Cites] J Virol. 1982 Nov;44(2):725-30 [6183452.001]
  • [Cites] J Virol. 1983 Dec;48(3):667-75 [6313966.001]
  • [Cites] Virology. 1984 Jul 15;136(1):89-99 [6330999.001]
  • [Cites] EMBO J. 1985 Apr;4(4):949-56 [2990916.001]
  • [Cites] J Virol. 1987 Oct;61(10):3004-12 [3041020.001]
  • [Cites] Cell. 1988 Nov 4;55(3):447-58 [2846182.001]
  • [Cites] J Exp Med. 1992 Oct 1;176(4):1125-35 [1383375.001]
  • [Cites] Methods Cell Biol. 1994;43 Pt A:99-112 [7823872.001]
  • [Cites] Nucleic Acids Res. 1995 Feb 25;23(4):628-33 [7899083.001]
  • [Cites] J Virol. 1995 Dec;69(12):7541-7 [7494260.001]
  • [Cites] J Virol. 1996 Jun;70(6):3834-43 [8648719.001]
  • [Cites] J Virol. 1996 Oct;70(10):6642-52 [8794299.001]
  • [Cites] J Virol. 1998 Nov;72(11):8463-71 [9765382.001]
  • [Cites] J Virol. 1998 Dec;72(12):9873-80 [9811723.001]
  • [Cites] J Mol Biol. 1998 Nov 27;284(2):205-25 [9813113.001]
  • [Cites] Mol Ther. 2006 Feb;13(2):391-400 [16226060.001]
  • [Cites] Gene Ther. 2006 Apr;13(7):641-5 [16355114.001]
  • [Cites] Exp Hematol. 2006 May;34(5):588-92 [16647564.001]
  • [Cites] Blood. 2006 Oct 15;108(8):2545-53 [16825499.001]
  • [Cites] Gene Ther. 2006 Nov;13(21):1524-33 [16763662.001]
  • [Cites] Hum Gene Ther. 2007 Aug;18(8):691-700 [17655493.001]
  • [Cites] Mol Ther. 2008 Mar;16(3):590-8 [18180772.001]
  • [Cites] Mol Ther. 2008 Apr;16(4):718-25 [18334985.001]
  • [Cites] Mol Ther. 2008 Sep;16(9):1617-23 [18578011.001]
  • [Cites] Gene Ther. 2000 Jun;7(12):1063-6 [10871756.001]
  • [Cites] J Virol. 2000 Nov;74(22):10822-6 [11044131.001]
  • [Cites] Gene Ther. 2001 Mar;8(6):477-86 [11313827.001]
  • [Cites] DNA Res. 2001 Oct 31;8(5):221-6 [11759842.001]
  • [Cites] J Clin Invest. 2008 Sep;118(9):3132-42 [18688285.001]
  • [Cites] J Clin Invest. 2008 Sep;118(9):3143-50 [18688286.001]
  • [Cites] J Virol. 2009 Jan;83(1):283-94 [18945765.001]
  • [Cites] J Clin Invest. 2009 Apr;119(4):964-75 [19307726.001]
  • [Cites] Expert Opin Biol Ther. 2009 Nov;9(11):1427-36 [19743892.001]
  • [Cites] Mol Ther. 2009 Nov;17(11):1919-28 [19672245.001]
  • [Cites] Blood. 2002 Aug 1;100(3):823-32 [12130492.001]
  • (PMID = 20410274.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Viral
  • [Other-IDs] NLM/ PMC2903275
  •  go-up   go-down


49. Kawabata K, Sakurai F, Yamaguchi T, Hayakawa T, Mizuguchi H: Efficient gene transfer into mouse embryonic stem cells with adenovirus vectors. Mol Ther; 2005 Sep;12(3):547-54
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We prepared four LacZ-expressing Ad vectors, each of which contained one of the following: Rous sarcoma virus (RSV), cytomegalovirus (CMV), beta-actin promoter/CMV enhancer (CA), or EF-1alpha promoter.
  • [MeSH-minor] Actins / genetics. Alkaline Phosphatase / metabolism. Animals. Avian Sarcoma Viruses / genetics. Blotting, Western. Cell Differentiation. Cytomegalovirus / genetics. DNA, Complementary / metabolism. Embryo, Mammalian / cytology. Enhancer Elements, Genetic / genetics. Gene Expression Regulation. Genetic Therapy / methods. Germ Cells. Lac Operon. Mice. Oligopeptides / chemistry. Peptide Elongation Factor 1 / genetics. Polylysine / chemistry. Promoter Regions, Genetic. RNA / metabolism. Regenerative Medicine. Reverse Transcriptase Polymerase Chain Reaction

  • MedlinePlus Health Information. consumer health - Stem Cells.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15950541.001).
  • [ISSN] 1525-0016
  • [Journal-full-title] Molecular therapy : the journal of the American Society of Gene Therapy
  • [ISO-abbreviation] Mol. Ther.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / DNA, Complementary; 0 / Oligopeptides; 0 / Peptide Elongation Factor 1; 25104-18-1 / Polylysine; 63231-63-0 / RNA; 99896-85-2 / arginyl-glycyl-aspartic acid; EC 3.1.3.1 / Alkaline Phosphatase
  •  go-up   go-down


50. Morita T, Mayanagi T, Yoshio T, Sobue K: Changes in the balance between caldesmon regulated by p21-activated kinases and the Arp2/3 complex govern podosome formation. J Biol Chem; 2007 Mar 16;282(11):8454-63
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we studied the regulatory mode of caldesmon in podosome formation in Rous sarcoma virus-transformed fibroblasts.
  • Taken together, we conclude that in Rous sarcoma virus-transformed cells, changes in the balance between PAK1/2-regulated caldesmon and the Arp2/3 complex govern the formation of podosomes.
  • [MeSH-minor] Actins / chemistry. Animals. Fibroblasts / metabolism. Genetic Vectors. Models, Biological. Phosphorylation. Protein Binding. Rats. Rous sarcoma virus / metabolism. Transfection. Tropomyosin / chemistry. Wiskott-Aldrich Syndrome Protein, Neuronal / chemistry. p21-Activated Kinases

  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17224451.001).
  • [ISSN] 0021-9258
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actin-Related Protein 2; 0 / Actin-Related Protein 3; 0 / Actins; 0 / Calmodulin-Binding Proteins; 0 / Tropomyosin; 0 / Wiskott-Aldrich Syndrome Protein, Neuronal; EC 2.7.11.1 / Pak1 protein, rat; EC 2.7.11.1 / Protein-Serine-Threonine Kinases; EC 2.7.11.1 / p21-Activated Kinases
  •  go-up   go-down


51. Mandelin J, Lin EC, Hu DD, Knowles SK, Do KA, Wang X, Sage EH, Smith JW, Arap W, Pasqualini R: Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontin. Cancer; 2009 Apr 15;115(8):1753-64
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, the authors used human melanoma and sarcoma cell lines to evaluate the effects of soluble osteopontin on metastasis.
  • In the intracellular environment, osteopontin initially induced rapid tyrosine 418 (Tyr-418) dephosphorylation of the cellular homolog of the Rous sarcoma virus (c-Src), with decreases in actin stress fibers and increased binding to the vascular endothelium.
  • This heretofore undescribed Tyr dephosphorylation was followed by a tandem c-Src phosphorylation after tumor cell attachment to the metastatic site.
  • CONCLUSIONS: The results of this study revealed a complex molecular interaction as well as a dual role for osteopontin in metastasis that depends on whether tumor cells are in circulation or attached.

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Cancer Res. 1997 Apr;3(4):605-11 [9815727.001]
  • [Cites] J Biol Chem. 2004 Mar 19;279(12):11051-64 [14704150.001]
  • [Cites] Cancer Res. 1999 Jan 1;59(1):219-26 [9892210.001]
  • [Cites] Oncogene. 2005 Jan 13;24(3):489-501 [15516973.001]
  • [Cites] Nat Immunol. 2004 Mar;5(3):272-9 [14758359.001]
  • [Cites] Cell. 2008 Jun 13;133(6):994-1005 [18555776.001]
  • [Cites] Int J Cancer. 1977 Jul 15;20(1):1-5 [903179.001]
  • [Cites] Proc Natl Acad Sci U S A. 1984 Oct;81(19):5985-8 [6237366.001]
  • [Cites] Science. 1986 Jul 25;233(4762):467-70 [3726541.001]
  • [Cites] Proc Natl Acad Sci U S A. 1986 Dec;83(23):8819-23 [3024151.001]
  • [Cites] Nature. 1994 Jan 13;367(6459):193-6 [8114919.001]
  • [Cites] J Cell Biochem. 1994 Feb;54(2):247-55 [8175899.001]
  • [Cites] Cancer Res. 1994 Sep 15;54(18):4993-8 [7520832.001]
  • [Cites] Endocrinology. 1995 Jul;136(7):2984-92 [7540546.001]
  • [Cites] Exp Cell Res. 1995 Aug;219(2):571-8 [7641809.001]
  • [Cites] Nat Immunol. 2000 Jul;1(1):23-9 [10881170.001]
  • [Cites] Biochemistry. 2001 Feb 27;40(8):2373-8 [11327857.001]
  • [Cites] J Clin Invest. 2001 May;107(9):1055-61 [11342566.001]
  • [Cites] J Biol Chem. 2001 Dec 7;276(49):46024-30 [11590166.001]
  • [Cites] Biochim Biophys Acta. 2001 Dec 28;1552(2):61-85 [11825687.001]
  • [Cites] Curr Mol Med. 2001 Nov;1(5):621-32 [11899236.001]
  • [Cites] Cancer. 2002 Aug 1;95(3):506-12 [12209742.001]
  • [Cites] Curr Opin Cell Biol. 2002 Oct;14(5):608-16 [12231357.001]
  • [Cites] Clin Cancer Res. 2003 Jan;9(1):59-67 [12538452.001]
  • [Cites] Nat Med. 2003 Apr;9(4):416-23 [12640447.001]
  • [Cites] Trends Cell Biol. 2003 Jul;13(7):376-85 [12837608.001]
  • [Cites] Cancer Cell. 2003 Jun;3(6):537-49 [12842083.001]
  • [Cites] Science. 1996 Jan 26;271(5248):509-12 [8560266.001]
  • [Cites] Nat Med. 1996 Nov;2(11):1197-203 [8898745.001]
  • [Cites] Annu Rev Cell Dev Biol. 1996;12:697-715 [8970741.001]
  • [Cites] Nat Biotechnol. 1997 Jun;15(6):542-6 [9181576.001]
  • [Cites] Science. 1998 Jan 16;279(5349):377-80 [9430587.001]
  • [Cites] J Biol Chem. 1998 May 8;273(19):11908-16 [9565618.001]
  • [Cites] Biotechnology (N Y). 1995 Mar;13(3):265-70 [9634769.001]
  • [Cites] J Biol Chem. 2005 Jun 24;280(25):23918-25 [15851473.001]
  • [Cites] Clin Cancer Res. 2006 Feb 15;12(4):1308-16 [16489088.001]
  • [Cites] Trends Cell Biol. 2006 Feb;16(2):79-87 [16406521.001]
  • [Cites] Cell. 2006 Apr 21;125(2):385-98 [16630824.001]
  • [Cites] Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3337-43 [16740755.001]
  • [Cites] Am J Pathol. 2006 Jul;169(1):233-46 [16816376.001]
  • [Cites] Clin Exp Metastasis. 2005;22(8):663-73 [16691370.001]
  • [Cites] Clin Exp Metastasis. 2006;23(2):123-33 [16830223.001]
  • [Cites] Prostate. 2007 Feb 15;67(3):330-40 [17192877.001]
  • [Cites] Am J Pathol. 2007 Aug;171(2):682-92 [17620367.001]
  • [Cites] Cancer Res. 1998 Nov 15;58(22):5206-15 [9823334.001]
  • (PMID = 19224553.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA069306; United States / NCI NIH HHS / CA / CA90270; United States / NCI NIH HHS / CA / P50 CA140388; United States / NCI NIH HHS / CA / CA69306; United States / NCI NIH HHS / CA / P50 CA090270; United States / NCI NIH HHS / CA / CA30199; United States / NCI NIH HHS / CA / P30 CA030199; United States / NCI NIH HHS / CA / CA069306-05; United States / NCI NIH HHS / CA / R01 CA069306-05
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Oligopeptides; 0 / Recombinant Proteins; 106441-73-0 / Osteopontin; 99896-85-2 / arginyl-glycyl-aspartic acid
  • [Other-IDs] NLM/ NIHMS89125; NLM/ PMC2743165
  •  go-up   go-down


52. Masker K, Golden A, Gaffney CJ, Mazack V, Schwindinger WF, Zhang W, Wang LH, Carey DJ, Sudol M: Transcriptional profile of Rous Sarcoma Virus transformed chicken embryo fibroblasts reveals new signaling targets of viral-src. Virology; 2007 Jul 20;364(1):10-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transcriptional profile of Rous Sarcoma Virus transformed chicken embryo fibroblasts reveals new signaling targets of viral-src.
  • Transformation of chicken fibroblasts in vitro by Rous Sarcoma Virus represents a model of cancer in which a single oncogene, viral src, uniformly and rapidly transforms primary cells in culture.
  • We experimentally surveyed the transcriptional program affected by Rous Sarcoma Virus (RSV) in primary culture of chicken embryo fibroblasts.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5472-6 [1608957.001]
  • [Cites] Cell Biol Int Rep. 1992 Oct;16(10):1003-14 [1384993.001]
  • [Cites] Nucleic Acids Res. 1992 Dec 11;20(23):6377-83 [1475199.001]
  • [Cites] Oncogene. 1993 Apr;8(4):823-31 [8455940.001]
  • [Cites] Biochem Cell Biol. 1992 Oct-Nov;70(10-11):980-97 [1297357.001]
  • [Cites] Oncogene. 1994 Sep;9(9):2729-32 [7520150.001]
  • [Cites] Biochem Biophys Res Commun. 1995 Jan 26;206(3):916-26 [7832805.001]
  • [Cites] Cancer Res. 2006 Feb 15;66(4):2028-37 [16489002.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):502-8 [16537708.001]
  • [Cites] J Biol Chem. 2006 Apr 7;281(14):9450-9 [16461772.001]
  • [Cites] Cancer Res. 2006 Jun 1;66(11):5686-95 [16740706.001]
  • [Cites] Int J Oncol. 2006 Jul;29(1):25-32 [16773181.001]
  • [Cites] J Biol Chem. 2006 Jul 28;281(30):20891-901 [16728406.001]
  • [Cites] Nat Cell Biol. 2006 Sep;8(9):945-56 [16892055.001]
  • [Cites] J Hepatol. 2006 Nov;45(5):673-80 [16935389.001]
  • [Cites] Expert Opin Ther Targets. 2007 Jan;11(1):91-100 [17150037.001]
  • [Cites] Cardiovasc Res. 2007 Jan 1;73(1):19-25 [17045254.001]
  • [Cites] Oncogene. 2007 Jan 4;26(1):1-10 [16799638.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4053-8 [15007166.001]
  • [Cites] Oncogene. 2004 Jul 8;23(31):5330-9 [15064726.001]
  • [Cites] Nat Med. 2004 Aug;10(8):789-99 [15286780.001]
  • [Cites] Mol Cell Proteomics. 2004 Oct;3(10):960-9 [15238602.001]
  • [Cites] Oncogene. 2004 Oct 18;23(48):7910-7 [15489909.001]
  • [Cites] Proc Natl Acad Sci U S A. 1969 Jun;63(2):318-25 [4308272.001]
  • [Cites] J Exp Med. 1973 Jan 1;137(1):85-111 [4347290.001]
  • [Cites] Cell. 1977 Jul;11(3):513-21 [195741.001]
  • [Cites] Nature. 1977 Sep 22;269(5626):346-8 [198667.001]
  • [Cites] J Biol Chem. 1978 Aug 25;253(16):5869-74 [78927.001]
  • [Cites] Cancer Res. 1980 Jul;40(7):2300-9 [7190062.001]
  • [Cites] J Biol Chem. 1981 Jan 10;256(1):520-5 [6256355.001]
  • [Cites] Proc Natl Acad Sci U S A. 1981 Sep;78(9):5633-7 [6272310.001]
  • [Cites] J Virol. 1984 Mar;49(3):881-91 [6321772.001]
  • [Cites] Cell. 1984 Oct;38(3):757-65 [6091899.001]
  • [Cites] Mol Cell Endocrinol. 1985 May;40(2-3):245-55 [2408939.001]
  • [Cites] Proc Natl Acad Sci U S A. 1987 Apr;84(8):2251-5 [2436227.001]
  • [Cites] Cell. 1987 May 8;49(3):321-8 [3032449.001]
  • [Cites] Proc Natl Acad Sci U S A. 1987 Oct;84(19):6715-9 [2821543.001]
  • [Cites] Annu Rev Cell Biol. 1987;3:31-56 [2446642.001]
  • [Cites] J Virol. 1989 Jul;63(7):2929-35 [2542604.001]
  • [Cites] J Biol Chem. 1990 Jan 25;265(3):1339-44 [2295632.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Jan;87(2):558-62 [2105487.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Nov;87(21):8592-6 [1700434.001]
  • [Cites] Oncogene. 1991 Jul;6(7):1259-68 [1861868.001]
  • [Cites] Mol Cell Biol. 1996 Feb;16(2):481-6 [8552074.001]
  • [Cites] Cell Growth Differ. 1997 Jan;8(1):113-9 [8993840.001]
  • [Cites] Oncogene. 1997 Oct 16;15(16):1929-36 [9365239.001]
  • [Cites] Biochim Biophys Acta. 1998 Feb 11;1395(3):288-92 [9512662.001]
  • [Cites] Gastroenterology. 1998 Jun;114(6):1287-95 [9609766.001]
  • [Cites] Oncogene. 2004 Nov 4;23(52):8455-63 [15378015.001]
  • [Cites] Carcinogenesis. 2004 Dec;25(12):2467-72 [15308583.001]
  • [Cites] Exp Cell Res. 2001 May 1;265(2):339-47 [11302700.001]
  • [Cites] Nature. 2001 May 17;411(6835):355-65 [11357143.001]
  • [Cites] Oncogene. 2001 Apr 30;20(19):2365-77 [11402333.001]
  • [Cites] Cell. 2002 Jan 25;108(2):135-44 [11832204.001]
  • [Cites] Biochim Biophys Acta. 2002 Jun 21;1602(2):114-30 [12020799.001]
  • [Cites] Nat Rev Cancer. 2002 Oct;2(10):740-9 [12360277.001]
  • [Cites] Oncogene. 2002 Oct 17;21(47):7256-65 [12370817.001]
  • [Cites] Genome Biol. 2003;4(1):R7 [12540299.001]
  • [Cites] Genome Biol. 2003;4(5):P3 [12734009.001]
  • [Cites] Front Biosci. 2004 Jan 1;9:139-44 [14766353.001]
  • [Cites] Nature. 2004 Dec 9;432(7018):695-716 [15592404.001]
  • [Cites] Nature. 2004 Dec 9;432(7018):761-4 [15592415.001]
  • [Cites] Front Biosci. 2005;10:998-1009 [15769600.001]
  • [Cites] FEBS Lett. 2005 Dec 19;579(30):6705-15 [16313905.001]
  • [Cites] Genome Res. 2005 Dec;15(12):1692-8 [16339367.001]
  • [Cites] Cell Commun Adhes. 2005 Jan-Apr;12(1-2):41-57 [16371345.001]
  • [Cites] Cancer Res. 2006 Feb 1;66(3):1543-52 [16452211.001]
  • [Cites] Mol Cell Biol. 1991 Sep;11(9):4448-54 [1875932.001]
  • [Cites] Cell. 1991 Nov 15;67(4):731-40 [1682056.001]
  • [Cites] Oncogene. 1991 Nov;6(11):2129-35 [1682867.001]
  • [Cites] Mol Cell Biol. 1992 Jan;12(1):10-21 [1309586.001]
  • (PMID = 17448514.001).
  • [ISSN] 0042-6822
  • [Journal-full-title] Virology
  • [ISO-abbreviation] Virology
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA029339; United States / NCI NIH HHS / CA / CA29339; United States / NIDDK NIH HHS / DK / DK062345-02; United States / NIDDK NIH HHS / DK / P01 DK062345-02; United States / NIDDK NIH HHS / DK / P01 DK062345-03; United States / NIDDK NIH HHS / DK / P01 DK062345; United States / NIDDK NIH HHS / DK / DK062345-03; United States / NIDDK NIH HHS / DK / DK62345
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA Primers; 0 / DNA, Viral
  • [Other-IDs] NLM/ NIHMS25800; NLM/ PMC1974879
  •  go-up   go-down


53. Oh J, Chang KW, Wierzchoslawski R, Alvord WG, Hughes SH: Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate. J Virol; 2008 Jan;82(1):503-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate.
  • We made mutations in the 5' end of the U3 sequence of the Rous sarcoma virus (RSV)-derived vector RSVP(A)Z.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2005 Nov;79(21):13694-704 [16227289.001]
  • [Cites] EMBO J. 1998 Oct 1;17(19):5832-43 [9755183.001]
  • [Cites] J Virol. 2006 Oct;80(20):10281-4 [17005708.001]
  • [Cites] J Virol. 2001 Feb;75(3):1359-70 [11152509.001]
  • [Cites] J Virol. 2002 Feb;76(4):1762-8 [11799171.001]
  • [Cites] Proc Natl Acad Sci U S A. 1980 Jul;77(7):3937-41 [6254003.001]
  • [Cites] Cell. 1980 Nov;22(2 Pt 2):379-86 [6256079.001]
  • [Cites] Proc Natl Acad Sci U S A. 1981 Jul;78(7):4299-303 [6270669.001]
  • [Cites] Nature. 1983 Nov 10-16;306(5939):155-60 [6316141.001]
  • [Cites] Cell. 1984 Jul;37(3):1043-52 [6204767.001]
  • [Cites] Proc Natl Acad Sci U S A. 1984 Oct;81(20):6461-5 [6208550.001]
  • [Cites] Cell. 1985 Sep;42(2):573-80 [4028161.001]
  • [Cites] J Virol. 1986 Jan;57(1):37-45 [2416955.001]
  • [Cites] Proc Natl Acad Sci U S A. 1989 May;86(9):3065-9 [2524066.001]
  • [Cites] Cell. 1989 Jul 14;58(1):47-54 [2546673.001]
  • [Cites] Cell. 1990 Aug 24;62(4):829-37 [2167180.001]
  • [Cites] J Virol. 1990 Nov;64(11):5475-84 [2170682.001]
  • [Cites] J Virol. 1990 Dec;64(12):5958-65 [2173775.001]
  • [Cites] Mol Cell Biol. 1991 Mar;11(3):1419-30 [1847499.001]
  • [Cites] J Virol. 1991 Sep;65(9):4636-44 [1870194.001]
  • [Cites] J Virol. 1991 Oct;65(10):5624-30 [1895409.001]
  • [Cites] J Virol. 1992 Apr;66(4):2359-68 [1548767.001]
  • [Cites] J Virol. 1992 Dec;66(12):7414-9 [1433523.001]
  • [Cites] J Virol. 1994 Aug;68(8):4768-75 [8035478.001]
  • [Cites] J Virol. 1995 May;69(5):3216-9 [7707554.001]
  • [Cites] J Virol. 1995 Nov;69(11):6687-96 [7474078.001]
  • [Cites] Virology. 1998 Sep 1;248(2):295-304 [9721238.001]
  • [Cites] Virology. 1998 Sep 1;248(2):305-11 [9721239.001]
  • [Cites] J Virol. 1998 Oct;72(10):8396-402 [9733892.001]
  • [Cites] J Virol. 2004 Dec;78(23):13315-24 [15542682.001]
  • [Cites] J Virol. 1999 Nov;73(11):9011-20 [10516007.001]
  • [Cites] J Virol. 2006 Jan;80(1):451-9 [16352569.001]
  • (PMID = 17959663.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral; 0 / RNA, Viral; EC 2.7.7.- / Integrases
  • [Other-IDs] NLM/ PMC2224354
  •  go-up   go-down


54. Bailey GD, Hyun JK, Mitra AK, Kingston RL: Proton-linked dimerization of a retroviral capsid protein initiates capsid assembly. Structure; 2009 May 13;17(5):737-48
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In contrast, other retroviral capsid proteins, including that of Rous sarcoma virus (RSV), do not dimerize with measurable affinity.
  • [MeSH-major] Capsid / metabolism. Capsid Proteins / chemistry. Protons. Rous sarcoma virus / metabolism. Viral Proteins / chemistry

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19446529.001).
  • [ISSN] 0969-2126
  • [Journal-full-title] Structure (London, England : 1993)
  • [ISO-abbreviation] Structure
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Capsid Proteins; 0 / Protons; 0 / Viral Proteins
  •  go-up   go-down


55. Oh J, Chang KW, Alvord WG, Hughes SH: Alternate polypurine tracts affect rous sarcoma virus integration in vivo. J Virol; 2006 Oct;80(20):10281-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Alternate polypurine tracts affect rous sarcoma virus integration in vivo.
  • When the endogenous polypurine tract (PPT) of the Rous sarcoma virus (RSV)-derived vector RSVP(A)Z was replaced with alternate retroviral PPTs, the fraction of unintegrated viral DNA with the normal consensus ends significantly decreased and the retention of part of the PPT significantly increased.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2000 Nov;74(22):10293-303 [11044073.001]
  • [Cites] J Virol. 2002 Feb;76(4):1762-8 [11799171.001]
  • [Cites] J Virol. 2003 Oct;77(20):11150-7 [14512562.001]
  • [Cites] Nucleic Acids Res. 2004;32(4):1539-47 [15004241.001]
  • [Cites] J Mol Biol. 1989 Aug 5;208(3):445-56 [2477553.001]
  • [Cites] J Virol. 2006 Jan;80(1):451-9 [16352569.001]
  • [Cites] J Virol. 1996 Aug;70(8):5288-96 [8764039.001]
  • [Cites] J Virol. 1999 Feb;73(2):948-57 [9882295.001]
  • [Cites] J Virol. 2004 Dec;78(23):13315-24 [15542682.001]
  • [Cites] J Virol. 2005 Nov;79(21):13694-704 [16227289.001]
  • [Cites] J Virol. 1989 Dec;63(12):5319-27 [2555556.001]
  • (PMID = 17005708.001).
  • [ISSN] 0022-538X
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.7.- / Integrases
  • [Other-IDs] NLM/ PMC1617299
  •  go-up   go-down


56. Chen A, Weber IT, Harrison RW, Leis J: Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat Ends. J Biol Chem; 2006 Feb 17;281(7):4173-82
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat Ends.
  • A separate structural alignment of HIV-1, simian sarcoma virus (SIV), and avian sarcoma virus (ASV) INs predicted which of these residues were unique.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2005 Feb;79(4):2493-505 [15681450.001]
  • [Cites] Biochemistry. 1999 Jun 29;38(26):8458-68 [10387092.001]
  • [Cites] BMC Biol. 2004;2:8 [15153244.001]
  • [Cites] J Comput Aided Mol Des. 2004 Dec;18(12):739-60 [16075307.001]
  • [Cites] Nat Rev Drug Discov. 2005 Mar;4(3):236-48 [15729361.001]
  • [Cites] Nucleic Acids Res. 2005;33(3):977-86 [15718297.001]
  • [Cites] J Biol Chem. 1995 Feb 17;270(7):3320-6 [7852418.001]
  • [Cites] J Virol. 1995 May;69(5):2729-36 [7535863.001]
  • [Cites] Science. 1995 Oct 13;270(5234):253-4 [7569973.001]
  • [Cites] Genes Dev. 1995 Oct 15;9(20):2556-67 [7590235.001]
  • [Cites] Biochemistry. 1996 Mar 26;35(12):3837-44 [8620007.001]
  • [Cites] J Biol Chem. 1996 Mar 29;271(13):7712-8 [8631811.001]
  • [Cites] J Virol. 1996 Jun;70(6):3571-80 [8648691.001]
  • [Cites] J Biol Chem. 1996 Aug 16;271(33):19633-6 [8702660.001]
  • [Cites] Protein Eng. 1996 Aug;9(8):679-90 [8875645.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13659-64 [8942990.001]
  • [Cites] Virology. 1996 Dec 15;226(2):306-17 [8955050.001]
  • [Cites] Biochemistry. 1997 Jan 7;36(1):173-80 [8993331.001]
  • [Cites] Cell. 1997 Feb 21;88(4):483-92 [9038339.001]
  • [Cites] Genes Cells. 1997 Jan;2(1):1-12 [9112436.001]
  • [Cites] Biochemistry. 1997 Sep 2;36(35):10655-65 [9271496.001]
  • [Cites] J Biol Chem. 1997 Sep 19;272(38):23938-45 [